Set Analyses:
Advanced Search

Advanced Search

 
Search By
Section (entire)
for


 
or upload a file of gene symbols


Category   Symbol Source: HGNC EntrezGene Ensembl GeneCards RNA genes CroW21
GIFtS

IL2RA Gene

protein-coding   GIFtS: 71
GCID: GC10M006041

Interleukin 2 Receptor, Alpha


(Previous symbol: IL2R)
Microbiology & Infectious Diseases Congress
  See related diseases
at  

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, 10fRNAdb, 12H-InvDB, 13NCBI, 14NONCODE, and/or 15RNAdb)
About This Section

Aliases
Interleukin 2 Receptor, Alpha1 2     TAC Antigen2 3
IL2R1 2 5     IDDM102 5
IL-2-RA2 3     CD252
IL2-RA2 3     TCGFR2
IL-2 Receptor Subunit Alpha2 3     Interleukin-2 Receptor Subunit Alpha2
IL-2R Subunit Alpha2 3     CD25 Antigen3
p552 3     

External Ids:    HGNC: 60081   Entrez Gene: 35592   Ensembl: ENSG000001344607   OMIM: 1477305   UniProtKB: P015893   

Export aliases for IL2RA gene to outside databases

Previous GC identifers: GC10M005997 GC10M006203 GC10M006058 GC10M006059 GC10M006093


(According to Entrez Gene, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

Entrez Gene summary for IL2RA Gene:
The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain
(IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity
receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane
protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis.
Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations
in this gene are associated with interleukin 2 receptor alpha deficiency.(provided by RefSeq, Nov 2009)

GeneCards Summary for IL2RA Gene: 
IL2RA (interleukin 2 receptor, alpha) is a protein-coding gene. Diseases associated with IL2RA include uveitis, and farmer's lung, and among its related super-pathways are STAT3 Pathway and IL2-mediated signaling events. GO annotations related to this gene include drug binding and interleukin-2 binding.

UniProtKB/Swiss-Prot: IL2RA_HUMAN, P01589
Function: Receptor for interleukin-2

summary for IL2RA Gene:
Cytokines are proteinaceous signaling compounds that are major mediators of the immune response. They
control many different cellular functions including proliferation, differentiation and cell
survival/apoptosis but are also involved in several pathophysiological processes including viral infections
and autoimmune diseases. Cytokines are synthesized under various stimuli by a variety of cells of both the
innate (monocytes, macrophages, dendritic cells) and adaptive (T- and B-cells) immune systems. Cytokines can
be classified into two groups: pro- and anti-inflammatory. Pro-inflammatory cytokines, including IFNgamma,
IL-1, IL-6 and TNF-alpha, are predominantly derived from the innate immune cells and Th1 cells.
Anti-inflammatory cytokines, including IL-10, IL-4, IL-13 and IL-5, are synthesized from Th2 immune cells.

Gene Wiki entry for IL2RA Gene


(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 73), Regulatory elements and Epigenetics data according to QIAGEN, SABiosciences, and/or SwitchGear Genomics)
About This Section
RefSeq DNA sequence:
NC_000010.10  NT_008705.16  NC_018921.2  
Regulatory elements:
   SABiosciences Regulatory transcription factor binding sites in the IL2RA gene promoter:
         STAT1   p53   STAT6   IRF-7A   STAT3   STAT5A   NF-kappaB   NF-kappaB1   STAT1alpha   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmids (see all 2): IL2RA promoter sequence
   Search SABiosciences Chromatin IP Primers for IL2RA

Epigenetics:
QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat IL2RA


Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 10p15-p14   Ensembl cytogenetic band:  10p15.1   HGNC cytogenetic band: 10p15-p14

IL2RA Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
IL2RA gene location

GeneLoc information about chromosome 10         GeneLoc Exon Structure

GeneLoc location for GC10M006041:  view genomic region     (about GC identifiers)

Start:
6,052,652 bp from pter      End:
6,104,333 bp from pter
Size:
51,682 bases      Orientation:
minus strand

(According to UniProtKB, HORDE, neXtProt, Ensembl, and/or Reactome, Modification sites according to PhosphoSitePlus, Specific Peptides from DME, Protein expression images according to data from SPIRE 1MOPED, 2PaxDb, and 3MAXQB RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Cloud-Clone Corp.,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Cloud-Clone Corp., Ontologies according to Gene Ontology Consortium 01 Oct 2013 and Entrez Gene, Antibodies by EMD Millipore, R&D Systems, GenScript, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, LSBio, Abcam, and/or Cloud-Clone Corp.)
About This Section

UniProtKB/Swiss-Prot: IL2RA_HUMAN, P01589 (See protein sequence)
Recommended Name: Interleukin-2 receptor subunit alpha precursor  
Size: 272 amino acids; 30819 Da
Subunit: Non-covalent dimer of an alpha and a beta subunit. IL2R exists in 3 different forms: a high affinity
dimer, an intermediate affinity monomer (beta subunit), and a low affinity monomer (alpha subunit). The high and
intermediate affinity forms also associate with a gamma subunit
Subcellular location: Membrane; Single-pass type I membrane protein
6/7 PDB 3D structures from and Proteopedia for IL2RA (see all 7):
1ILM (3D)        1ILN (3D)        1Z92 (3D)        2B5I (3D)        2ERJ (3D)        3IU3 (3D)    
Secondary accessions: Q5W007

Explore the universe of human proteins at neXtProt for IL2RA: NX_P01589

Explore proteomics data for IL2RA at MOPED 

Post-translational modifications:

  • View modification sites using PhosphoSitePlus
  • View neXtProt modification sites for NX_P01589

  • IL2RA Protein expression data from MOPED1, PaxDb2 and MAXQB3 :    About this image 

    IL2RA Protein Expression
    REFSEQ proteins: NP_000408.1  
    ENSEMBL proteins: 
     ENSP00000369293   ENSP00000369287   ENSP00000256876   ENSP00000402024  
    Reactome Protein details: P01589
    Human Recombinant Protein Products for IL2RA: 
    Browse Purified and Recombinant Proteins at EMD Millipore
    R&D Systems Recombinant & Natural Proteins for IL2RA (IL-2 R alpha)
    Browse recombinant and purified proteins available from Enzo Life Sciences
    Browse OriGene full length recombinant human proteins expressed in human HEK293 cells
    OriGene Protein Over-expression Lysate for IL2RA
    OriGene Custom MassSpec 
    OriGene Custom Protein Services for IL2RA
    GenScript Custom Purified and Recombinant Proteins Services for IL2RA
    Novus Biologicals IL2RA Proteins
    Sino Biological Recombinant Protein for IL2RA
    Sino Biological Cell Lysate for IL2RA 
    ProSpec Recombinant Protein for IL2RA
    Browse Proteins at Cloud-Clone Corp. 

    Gene Ontology (GO): 4 cellular component terms (GO ID links to tree view):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005886plasma membrane TAS--
    GO:0009897external side of plasma membrane IEA--
    GO:0009986cell surface ----
    GO:0016021integral to membrane IEA--

    IL2RA for ontologies           About GeneDecksing



    IL2RA Antibody Products: 
    EMD Millipore Mono- and Polyclonal Antibodies for the study of IL2RA
    R&D Systems Antibodies for IL2RA (IL-2 R alpha)
    Cell Signaling Technology (CST) Antibodies for IL2RA 
    OriGene Antibodies for IL2RA
    OriGene Custom Antibody Services for IL2RA
    GenScript Custom Superior Antibodies Services for IL2RA
    Novus Biologicals IL2RA Antibodies
    Abcam antibodies for IL2RA
    Browse Antibodies at Cloud-Clone Corp. 
    ThermoFisher Antibody for IL2RA
    LSBio Antibodies in human, mouse, rat for IL2RA 

    Assay Products for IL2RA: 
    Browse Kits and Assays available from EMD Millipore
    OriGene Custom Assay Services for IL2RA
    R&D Systems ELISAs for IL2RA (IL-2 R alpha)         (see all)
    GenScript Custom Assay Services for IL2RA
    Browse Enzo Life Sciences for kits & assays
    Browse ELISAs at Cloud-Clone Corp. 
    Browse CLIAs at Cloud-Clone Corp.


    (According to HGNC, IUPHAR, InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section
    HGNC Gene Families: 
    CD: CD molecules
    IL: Interleukins and interleukin receptors

    IUPHAR Guide to PHARMACOLOGY protein family classification: Interleukin-2 receptor α subunit 
    IL-2 receptor family

    2 InterPro protein domains:
     IPR015486 IL-2_recpt_a
     IPR000436 Sushi_SCR_CCP

    Graphical View of Domain Structure for InterPro Entry P01589

    ProtoNet protein and cluster: P01589

    1 Blocks protein domain: IPB000436 Sushi domain/SCR domain/CCP module

    UniProtKB/Swiss-Prot: IL2RA_HUMAN, P01589
    Similarity: Contains 2 Sushi (CCP/SCR) domains


    IL2RA for domains           About GeneDecksing


    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013, inGenious Targeting Laboratory, genOway,
    bound targets from SABiosciences, miRNA Gene Targets from miRTarBase, shRNA from OriGene, RNAi from EMD Millipore, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, Gene Editing from DNA2.0, Sirion Biotech, Clones from EMD Millipore, OriGene, SwitchGear Genomics, GenScript, Sino Biological, DNA2.0, Vector BioLabs, and Sirion Biotech, Cell Lines from GenScript, LifeMap BioReagents, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene.)
    About This Section

    Molecular Function:

         UniProtKB/Swiss-Prot Summary: IL2RA_HUMAN, P01589
    Function: Receptor for interleukin-2

         Genatlas biochemistry entry for IL2RA:
    interleukin 2,low affinity receptor,alpha chain 45kDa,expressed in T cell,B lymphoblast lines,peripheral blood
    monocyte

         Gene Ontology (GO): 4 molecular function terms (GO ID links to tree view):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0004911interleukin-2 receptor activity IEA--
    GO:0005515protein binding ----
    GO:0008144drug binding IEA--
    GO:0019976interleukin-2 binding IEA--
         
    IL2RA for ontologies           About GeneDecksing


    Phenotypes:
         3 GenomeRNAi human phenotypes for IL2RA:
     Decreased BPV1 E2 protein expr  Increased HPV18 LCR reporter a  Increased cell death in breast 

         6 MGI mutant phenotypes (inferred from 1 allele(MGI details for Il2ra):
     cellular  digestive/alimentary  growth/size  hematopoietic system  immune system 
     mortality/aging 

    IL2RA for phenotypes           About GeneDecksing

    Animal Models:
         MGI mouse knock-out Il2ratm1Dw for IL2RA

       inGenious Targeting Laboratory - Custom generated mouse model solutions for IL2RA 
       inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for IL2RA

       genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for IL2RA 
       genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for IL2RA 

    miRNA
    Products:
        
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat IL2RA
    8/11 QIAGEN miScript miRNA Assays for microRNAs that regulate IL2RA (see all 11):
    hsa-miR-30c hsa-miR-875-3p hsa-miR-520f hsa-miR-186* hsa-miR-30d hsa-miR-3667-3p hsa-miR-30a hsa-miR-30b
    SwitchGear 3'UTR luciferase reporter plasmidIL2RA 3' UTR sequence
    Inhib. RNA
    Products:
        
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene RNAi products in human, mouse, rat for IL2RA
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat IL2RA

    Gene Editing
    Products:
    DNA2.0 Custom Protein Engineering Service for IL2RA
    Sirion Biotech Customized adenovirus for overexpression of IL2RA

    Clone
    Products:
         
    Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
    OriGene clones in human, mouse for IL2RA (see all 7)
    OriGene ORF clones in mouse, rat for IL2RA
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: IL2RA (NM_000417)
    Sino Biological Human cDNA Clone for IL2RA
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for IL2RA
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IL2RA
    Sirion Biotech Customized lentivirus for stable overexpression of IL2RA 
                         Customized lentivirus expression plasmids for stable overexpression of IL2RA 

    Cell Line
    Products:
         
    GenScript Custom overexpressing Cell Line Services for IL2RA
    Search LifeMap BioReagents cell lines for IL2RA
    In Situ Assay
    Products:
       

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IL2RA


    (Pathways according to EMD Millipore, R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Sino Biological, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to SABiosciences, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene).
    About This Section

    SuperPaths for IL2RA About   (see all 41)                                                                                              See pathways by source

    SuperPathSelected contained pathways About (see all per SuperPath)
    1PEDF Induced Signaling
    NFAT Signaling and Lymphocyte Interactions0.57
    Glucocorticoid Receptor Signaling0.43
    PGC1Alpha Pathway0.51
    Cytokine-cytokine receptor interaction0.43
    STAT3 Pathway0.47
    2IL-2 Signaling pathway
    IL2-mediated signaling events0.49
    IL-2 Signaling pathway0.49
    3Apoptotic Pathways in Synovial Fibroblasts
    Mitochondrial Apoptosis0.85
    PPAR Pathway0.66
    Cellular Apoptosis Pathway0.85
    Rac1 Pathway0.65
    Apoptotic Pathways in Synovial Fibroblasts0.84
    Actin-Based Motility by Rho Family GTPases0.62
    p53 Mediated Apoptosis0.84
    ERK5 Signaling0.61
    4TGF-Beta Pathway
    TGF-Beta Pathway0.60
    JAK-STAT Pathway0.57
    MAPK Family Pathway0.60
    JNK Pathway0.51
    5Interleukin-3, 5 and GM-CSF signaling
    Interleukin receptor SHC signaling0.67
    Interleukin-3, 5 and GM-CSF signaling0.57
    Interleukin-2 signaling0.67
    Signaling by Interleukins0.45

    Pathways by source                                                                                                                                                                 See SuperPaths
    Show all pathways

    3 EMD Millipore Pathways for IL2RA
        Immune response IL-22 signaling pathway
    Immune response IL-12 signaling pathway
    Immune response IL-2 activation and signaling pathway

    3 R&D Systems Pathways for IL2RA
        IL-2 Signaling Pathways
    IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types
    IL-2 Signaling and its Primary Biological Effects in Different Immune Cell Types

    5/38 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for IL2RA (see all 38)
        Nuclear Receptor Activation by Vitamin-A
    THC Differentiation Pathway
    Telomerase Components in Cell Signaling
    Mitochondrial Apoptosis
    Molecular Mechanisms of Cancer

    2 Cell Signaling Technology (CST) Pathways for IL2RA
        Lymphocyte Signaling
    Tyrosine Kinases / Adaptors

    3 Tocris Bioscience Pathways for IL2RA
        Akt Pathway
    Toll-like Receptor Pathway
    MAPK Pathway

    3 GeneGo (Thomson Reuters) Pathways for IL2RA
        Immune response IL-12 signaling pathway
    Immune response IL-22 signaling pathway
    Immune response IL-2 activation and signaling pathway

    5/12 BioSystems Pathways for IL2RA (see all 12)
        IL-2 Signaling pathway
    TSLP Signaling Pathway
    Calcineurin-regulated NFAT-dependent transcription in lymphocytes
    Downstream signaling in naive CD8+ T cells
    IL12-mediated signaling events


    5/6        Reactome Pathways for IL2RA (see all 6)
        Interleukin receptor SHC signaling
    Interleukin-2 signaling
    Cytokine Signaling in Immune system
    Interleukin-3, 5 and GM-CSF signaling
    Signaling by Interleukins


    5/7         Kegg Pathways  (Kegg details for IL2RA) (see all 7):
        Cytokine-cytokine receptor interaction
    Endocytosis
    PI3K-Akt signaling pathway
    Jak-STAT signaling pathway
    Hematopoietic cell lineage


    IL2RA for pathways           About GeneDecksing

    Interactions:

        SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for IL2RA

    STRING Interaction Network Preview (showing 5 interactants - click image to see 25)

    5/88 Interacting proteins for IL2RA (P015892, 3 ENSP000003692934) via UniProtKB, MINT, STRING, and/or I2D (see all 88)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    PASKQ96RG22, 3, ENSP000002340404MINT-8148865 I2D: score=1 STRING: ENSP00000234040
    IL2P605683, ENSP000002267304I2D: score=4 STRING: ENSP00000226730
    ICAM1P053623, ENSP000002648324I2D: score=3 STRING: ENSP00000264832
    IL2RBP147843, ENSP000002162234I2D: score=3 STRING: ENSP00000216223
    NFKB1P198383, ENSP000002265744I2D: score=2 STRING: ENSP00000226574
    About this table

    Gene Ontology (GO): 5/19 biological process terms (GO ID links to tree view) (see all 19):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0002437inflammatory response to antigenic stimulus IEA--
    GO:0006915apoptotic process TAS9096364
    GO:0006924activation-induced cell death of T cells IEA--
    GO:0006955immune response TAS9096364
    GO:0007166cell surface receptor signaling pathway TAS2983318

    IL2RA for ontologies           About GeneDecksing



    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience HMDB, BitterDB, and/or Novoseek, Ligands according to IUPHAR, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB, with drugs/clinical trials/news search links to CenterWatch)
    About This Section

    IL2RA for compounds           About GeneDecksing

    Browse Small Molecules at EMD Millipore
    Browse drugs & compounds from Enzo Life Sciences

    Compounds for IL2RA available from Tocris Bioscience    About this table
    CompoundAction CAS #
    AS 101 Immunomodulator; inhibits IL-10 synthesis and potentiates IL-1alpha, IL-2 and TNF-alpha release [106566-58-9]
    PirfenidoneAntifibrotic agent; regulates cytokine levels in vivo[53179-13-8]
    GIT 27Immunomodulator; reduces production of pro-inflammatory cytokines[6501-72-0]
    4-IPPInhibitor of macrophage migration inhibitory factor (MIF); suicide substrate[41270-96-6]
    ThalidomideTNF-alpha synthesis inhibitor[50-35-1]

    4 DrugBank Compounds for IL2RA    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    AldesleukinIL-2 (see all 4)85898-30-2targetagonist modulator16767920 16864089 11752352 17530023 17216565 17584597 10207608
    DaclizumabAnti-IL-2 (see all 3)152923-56-3targetantibody17564638 19788505 8600944 16304857 11752352 16908318 10607689
    Denileukin diftitoxDiphtheria toxin precursor (see all 3)173146-27-5targetbinder17139284 2786749 3124610 11752352 17187516 17016423 18684057
    Basiliximabchimeric mouse-human antiCD25 (see all 2)152923-56-3targetantibody10567956 12591363 11752352 16908318 10512062 9695721

    10/142 Novoseek inferred chemical compound relationships for IL2RA gene (see all 142)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    daclizumab 86.2 101 11147695 (5), 15919507 (3), 10607689 (2), 9428817 (2) (see all 60)
    basiliximab 85.7 113 12727469 (6), 17440057 (5), 10573065 (4), 15848561 (3) (see all 60)
    neopterin 81 151 15756710 (6), 8260527 (6), 1444001 (5), 8258242 (3) (see all 97)
    okt3 72 30 1858157 (2), 1969884 (2), 1832993 (1), 15591961 (1) (see all 21)
    cyclosporin a 69 97 1864013 (4), 7702403 (3), 1346344 (2), 1812996 (2) (see all 63)
    denileukin diftitox 66.8 15 12149223 (2), 15811959 (2), 14506141 (1), 15744237 (1) (see all 9)
    ionomycin 62.6 33 8557519 (3), 2017664 (3), 2320954 (3), 2315321 (2) (see all 21)
    tacrolimus 62.3 45 8557519 (2), 15162466 (2), 7678231 (1), 9346613 (1) (see all 34)
    mycophenolate mofetil 62 29 20405579 (2), 16980068 (2), 10563181 (1), 10578712 (1) (see all 18)
    thymidine 56.2 52 2382107 (2), 1974593 (2), 9329587 (2), 11904739 (2) (see all 41)

    1 PharmGKB related drug/compound annotation for IL2RA gene    About this table
    Drug/compound PharmGKB Annotation
    denileukin diftitox

    Search CenterWatch for drugs/clinical trials and news about IL2RA

    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 236 Homo sapiens; Apr 25 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    Conferences by KenesGroup, exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from EMD Millipore,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN,
    Tagged/untagged cDNA clones from OriGene, SwitchGear Genomics, GenScript, DNA2.0, Vector BioLabs, Sirion Biotech, Primers from OriGene, SABiosciences, and/or QIAGEN )
    About This Section

    REFSEQ mRNAs for IL2RA gene: 
    NM_000417.2  

    Unigene Cluster for IL2RA:

    Interleukin 2 receptor, alpha
    Hs.231367  [show with all ESTs]
    Unigene Representative Sequence: NM_000417
    4 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000379959(uc001iiz.2 uc009xih.2) ENST00000379954 ENST00000256876(uc001ija.1)
    ENST00000447847
    Congresses - knowledge worth sharing:  
    European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 10 - 13 May 2014

    miRNA
    Products:
         
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat IL2RA
    8/11 QIAGEN miScript miRNA Assays for microRNAs that regulate IL2RA (see all 11):
    hsa-miR-30c hsa-miR-875-3p hsa-miR-520f hsa-miR-186* hsa-miR-30d hsa-miR-3667-3p hsa-miR-30a hsa-miR-30b
    SwitchGear 3'UTR luciferase reporter plasmidIL2RA 3' UTR sequence
    Inhib. RNA
    Products:
         
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene RNAi products in human, mouse, rat for IL2RA
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat IL2RA
    Clone
    Products:
         
    OriGene clones in human, mouse for IL2RA (see all 7)
    OriGene ORF clones in mouse, rat for IL2RA
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: IL2RA (NM_000417)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for IL2RA
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IL2RA
    Sirion Biotech Customized lentivirus for stable overexpression of IL2RA 
                         Customized lentivirus expression plasmids for stable overexpression of IL2RA 
    Primer
    Products:
        
    OriGene qPCR primer pairs and template standards for IL2RA
    OriGene qSTAR qPCR primer pairs in human, mouse for IL2RA
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat IL2RA
      QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat IL2RA
      QIAGEN QuantiFast Probe-based Assays in human, mouse, rat IL2RA

    Additional mRNA sequence: 

    AF008556.1 AK223313.1 AK313847.1 K03122.1 M14098.1 X01057.1 

    3 DOTS entries:

    DT.451929  DT.40128074  DT.121287686 

    24/42 AceView cDNA sequences (see all 42):

    BG232109 BM922713 NM_000417 T28947 BQ574113 AI418535 BP367522 AA641972 
    AW950881 AW575058 AA903496 BF907985 AW444951 K03122 BQ774288 BG536515 
    AI423610 M14098 BG057703 BF439973 CD701954 AF008556 X01057 CD365812 

    GeneLoc Exon Structure

    5 Alternative Splicing Database (ASD) splice patterns (SP) for IL2RA    About this scheme

    ExUns: 1a · 1b · 1c · 1d ^ 2 ^ 3 ^ 4 ^ 5a · 5b ^ 6 ^ 7 ^ 8 ^ 9a · 9b · 9c
    SP1:                          -                                                               
    SP2:                          -                 -     -                                       
    SP3:                          -                 -     -     -                                 
    SP4:                          -                       -                                       
    SP5:                                                                                          


    ECgene alternative splicing isoforms for IL2RA

    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, plus additional links to Genevestigator, and/or SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from SABiosciences, Primers from OriGene, SABiosciences, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    IL2RA expression in normal human tissues (normalized intensities)      IL2RA embryonic expression: see
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS <intensity>2/3
    CGAP TAG: --
    IL2RA Expression
    About this image


    IL2RA expression in embryonic tissues and stem cells    About this table
    Data from LifeMap, the Embryonic Development and Stem Cells Database 
     5/6 selected tissues (see all 6) fully expand
     
     Blood (Hematopoietic System)    fully expand to see all 13 entries
             T-Regulatory Cells Peripheral Blood
             Regulatory T cells
             cd4+ cells   
     
     Thymus (Hematopoietic System)    fully expand to see all 5 entries
             Double Negative 3 Thymocytes Thymus
     
     Prostate (Endocrine System)
             prostate ; glandular cells   
     
     Ovary (Reproductive System)
             Cumulus Cells Antral Follicle
     
     Endothelium (Cardiovascular System)
             cd31+ cells   

    See IL2RA Protein Expression from SPIRE MOPED and PaxDB
    Genevestigator expression for IL2RA

    SOURCE GeneReport for Unigene cluster: Hs.231367
        SABiosciences Expression via Pathway-Focused PCR Arrays including IL2RA (see all 14): 
              Cell Surface Markers in human mouse rat
              NFKB Signaling Targets in human mouse rat
              Multiple Sclerosis in human mouse rat
              T-cell & B-cell Activation in human mouse rat
              Notch Signaling Pathway in human mouse rat

    Primer
    Products:
    OriGene qPCR primer pairs and template standards for IL2RA
    OriGene qSTAR qPCR primer pairs in human, mouse for IL2RA
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat IL2RA
    QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat IL2RA
    QIAGEN QuantiFast Probe-based Assays in human, mouse, rat IL2RA
    In Situ
    Assay Products:
     

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IL2RA

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    This gene was present in the common ancestor of human and mouse.

    Orthologs for IL2RA gene from 1/6 species (see all 6)    About this table
    Organism Taxonomic
    classification
    Gene Description Human
    Similarity
    Orthology
    Type
    Details
    mouse
    (Mus musculus)
    Mammalia Il2ra1 , 5 interleukin 2 receptor, alpha chain1, 5 72.16(n)1
    61.42(a)1
      2 (8.91 cM)5
    161841  NM_008367.31  NP_032393.31 
     116427925 


    ENSEMBL Gene Tree for IL2RA (if available)
    TreeFam Gene Tree for IL2RA (if available)

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68)
    About This Section
    Paralogs for IL2RA gene
    1 SIMAP similar gene for IL2RA using alignment to 4 protein entries:     IL2RA_HUMAN (see all proteins):
    IL2R

    IL2RA for paralogs           About GeneDecksing



    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, 4UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD) and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers from QIAGEN, Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
    About This Section

    10/1360 SNPs in IL2RA are shown (see all 1360)    About this table     
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    significance
    Chr 10 posSequence#AA
    Chg
    TypeMore#Allele
    freq
    PopTotal
    sample
    More
    ----------
    rs1166734671,2
    F--5978993(+) TGATTC/TGCATT 1 -- ds50011Minor allele frequency- T:0.01WA 118
    rs127226101,2
    C,F--5979005(-) GGTCAT/CTTCAG 1 -- ds50014Minor allele frequency- C:0.09NS NA 204
    rs1930336901,2
    --5979149(+) TGGGTA/GGATCA 1 -- ds50010--------
    rs1459463251,2
    C--5979158(+) CACTTA/GAGGTG 1 -- ds50010--------
    rs1857272031,2
    --5979236(+) GGACTG/TGGTGG 1 -- ds50010--------
    rs1898024011,2
    C--5979270(+) TTGGGA/TGGCTG 1 -- ds50010--------
    rs1461629891,2
    C--5979387(+) AAAAA-/CAAAAA 1 -- ds50010--------
    rs1173549301,2
    F--5979406(+) AAAAGC/TACCAA 1 -- ds50011Minor allele frequency- T:0.01NA 120
    rs127226091,2
    C,F--5979477(-) CTTGGT/GTTTTA 1 -- ds50017Minor allele frequency- G:0.17NS NA WA CSA 334
    rs748952461,2
    C,F--5979560(+) ATGACA/CTCATC 1 -- ut311Minor allele frequency- C:0.04EA 120

    HapMap Linkage Disequilibrium report for IL2RA (6052652 - 6104333 bp)

    Structural Variations
         Database of Genomic Variants (DGV) 10/15 variations for IL2RA (see all 15):    About this table     
    Variant IDTypeSubtypePubMed ID
    esv2014648CNV Deletion18987734
    esv1011098CNV Deletion20482838
    esv2731873CNV Deletion23290073
    esv2731884CNV Deletion23290073
    esv1000739CNV Deletion20482838
    esv2731895CNV Deletion23290073
    esv5272CNV Deletion18987735
    esv2516054CNV Deletion19546169
    esv1592945CNV Deletion17803354
    esv4965CNV Deletion18987735


    Human Gene Mutation Database (HGMD): IL2RA

    Locus Specific Mutation Databases (LSDB): IL2RA
    SABiosciences Cancer Mutation PCR Assays
    SeqTarget long-range PCR primers for resequencing IL2RA
    DNA2.0 Custom Variant and Variant Library Synthesis for IL2RA

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Conferences by KenesGroup, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section
    OMIM gene information: 147730   
    OMIM disorders: 606367  601942  
    UniProtKB/Swiss-Prot: IL2RA_HUMAN, P01589
  • Diabetes mellitus, insulin-dependent, 10 (IDDM10) [MIM:601942]: A multifactorial disorder of glucose
    homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical
    features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and
    secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and
    blood vessels. Note=Disease susceptibility is associated with variations affecting the gene represented in this
    entry

  • 20/290 diseases for IL2RA (see all 290):    About MalaCards
    uveitis    farmer's lung    small non-cleaved cell lymphoma    interleukin 2 receptor alpha chain deficiency
    oligoarticular juvenile arthritis    polyarticular onset juvenile idiopathic arthritis    graft versus host disease    acute graft versus host disease
    vogt-koyanagi-harada disease    limited scleroderma    chronic progressive multiple sclerosis    intravascular large b-cell lymphoma
    pleurisy    t-cell large granular lymphocyte leukemia    htlv-1 associated myelopathy/tropical spastic paraparesis    htlv-1 associated myelopathy
    intermediate uveitis    hypothyroidism, autoimmune    mastocytosis    systemic mastocytosis

    11 diseases from the University of Copenhagen DISEASES database for IL2RA:
    Lymphoma     Leukemia     Hypersensitivity reaction type II disease     Hemophagocytic lymphohistiocytosis
    Sarcoidosis     Rheumatoid arthritis     Connective tissue disease     Skin disease
    Multiple sclerosis     Tuberculosis     Severe combined immunodeficiency

    IL2RA for disorders           About GeneDecksing


    Congresses - knowledge worth sharing:  
    The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) 9 - 13 March 2014
    Alzheimer's & Parkinson's Diseases Congress (ADPD) 18 - 22 March 2015

    10/94 Novoseek inferred disease relationships for IL2RA gene (see all 94)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    necrosis 68.4 370 1747228 (3), 8651123 (3), 11505128 (2), 12745543 (2) (see all 99)
    leukemia t-cell 61.9 17 2196176 (1), 1916630 (1), 1719236 (1), 8170951 (1) (see all 16)
    leukemia hairy cell 61.2 11 8329708 (2), 1394125 (2), 8289505 (1), 7820050 (1) (see all 7)
    severe combined immunodeficiency, x-linked 58.9 8 9371254 (1), 7937790 (1), 7907259 (1), 8998263 (1) (see all 7)
    lymphoma t-cell cutaneous 57 16 16830050 (1), 1728640 (1), 8490933 (1), 9486676 (1) (see all 15)
    htlv-i infections 56.5 1 7668218 (1)
    rheumatoid arthritis 55.3 76 2313471 (2), 2118434 (2), 2075380 (2), 8311539 (2) (see all 53)
    autoimmune diseases 54.8 38 7473471 (3), 15843513 (2), 7875652 (1), 8691563 (1) (see all 24)
    tumors 54.3 435 15328201 (4), 1535088 (3), 1747228 (3), 8651123 (3) (see all 99)
    lymphohistiocytosis hemophagocytic 53.9 4 19576122 (1), 15863596 (1), 20511152 (1), 8541568 (1)

    Genatlas disease: IL2RA
    immunodeficiency,severe combined with absence of CD1 and of IL2RA expression on cortical thymocyte

    Genetic Association Database (GAD): IL2RA
    Human Genome Epidemiology (HuGE) Navigator: IL2RA (82 documents)

    Export disorders for IL2RA gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    PubMed articles for IL2RA gene, integrated from 9 sources (see all 2521) (see top 10):
    (articles sorted by number of sources associating them with IL2RA)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. (PubMed id 17676041)1, 2, 4 Lowe C.E.... Todd J.A. (2007)
    2. Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. (PubMed id 19106270)1, 4, 9 Kawasaki E....Eguchi K. (2009)
    3. Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. (PubMed id 19231135)1, 4, 9 Akkad D.A....Epplen J.T. (2009)
    4. Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. (PubMed id 19116909)1, 4, 9 Hinks A.... . (2009)
    5. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). (PubMed id 19125193)1, 4, 9 Alcina A....Matesanz F. (2009)
    6. Risk alleles for multiple sclerosis identified by a genomewide study. (PubMed id 17660530)1, 4, 9  ....Hauser S.L. (2007)
    7. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. (PubMed id 17371467)1, 4, 9 Brand O.J....Gough S.C. (2007)
    8. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. (PubMed id 15776395)1, 4, 9 Vella A....Todd J.A. (2005)
    9. 1000 Genomes-based imputation identifies novel and ref ined associations for the Wellcome Trust Case Control Consortium phase 1 Data. (PubMed id 22293688)1, 4 Huang J....Li Y. (2012)
    10. A genome-wide association study of inflammatory biomar ker changes in response to fenofibrate treatment in the Genetics of Lipid Loweri ng Drug and Diet Network. (PubMed id 22228203)1, 4 Aslibekyan S....Arnett D.K. (2012)
    11. Genetic risk and a primary role for cell-mediated immu ne mechanisms in multiple sclerosis. (PubMed id 21833088)1, 4  ....Compston A. (2011)
    12. Genome-wide meta-analysis identifies novel multiple sc lerosis susceptibility loci. (PubMed id 22190364)1, 4 Patsopoulos N.A....de Bakker P.I. (2011)
    13. Genome-wide association analysis of autoantibody posit ivity in type 1 diabetes cases. (PubMed id 21829393)1, 4 Plagnol V....Todd J.A. (2011)
    14. Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subject s. (PubMed id 20033399)1, 4 Klinker M.W....Ghosh S. (2010)
    15. Genome-wide association study meta-analysis identifie s seven new rheumatoid arthritis risk loci. (PubMed id 20453842)1, 4 Stahl E.A....Plenge R.M. (2010)
    16. Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth. (PubMed id 20140262)1, 4 Ryckman K.K....Jacobsson B. (2010)
    17. Polymorphisms in the IL2, IL2RA and IL2RB genes in mu ltiple sclerosis risk. (PubMed id 20179739)1, 4 Cavanillas M.L....Urcelay E. (2010)
    18. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. (PubMed id 21102463)1, 4 Franke A....Parkes M. (2010)
    19. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. (PubMed id 20362271)1, 4 Ritchie M.D....Roden D.M. (2010)
    20. Interleukin-9 polymorphism in infants with respirator y syncytial virus infection: an opposite effect in boys and girls. (PubMed id 20503287)1, 4 Schuurhof A....Janssen R. (2010)
    21. Genetic heterogeneity in latent autoimmune diabetes i s linked to various degrees of autoimmune activity: results from the Nord-TrA,nd elag Health Study. (PubMed id 19833889)1, 4 Pettersen E....Grill V. (2010)
    22. In silico replication of the genome-wide association results of the Type 1 Diabetes Genetics Consortium. (PubMed id 20378605)1, 4 Qu H.Q....Polychronakos C. (2010)
    23. Association of the protein tyrosine phosphatase nonre ceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population . (PubMed id 20615141)1, 4 Ban Y....Hirano T. (2010)
    24. Genome-wide association study in alopecia areata impl icates both innate and adaptive immunity. (PubMed id 20596022)1, 4 Petukhova L....Christiano A.M. (2010)
    25. Investigation of potential non-HLA rheumatoid arthrit is susceptibility loci in a European cohort increases the evidence for nine mar kers. (PubMed id 20498205)1, 4 Plant D....Worthington J. (2010)
    26. Association of IL-2RA/CD25 with type 1 diabetes in th e Belgian population. (PubMed id 20849903)1, 4 Aminkeng F....Van der Auwera B.J. (2010)
    27. [Haplotypes in the IL2RA region associated with diabe tes and expression of the IL2RA protein on lymphocytes populations] (PubMed id 20346270)1, 4 Plagnol V. (2010)
    28. Variant of TYR and autoimmunity susceptibility loci i n generalized vitiligo. (PubMed id 20410501)1, 4 Jin Y....Spritz R.A. (2010)
    29. Variation at the NFATC2 locus increases the risk of t hiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipr il and rosiglitazone Medication (DREAM) study. (PubMed id 20628086)1, 4 Bailey S.D....Anand S. (2010)
    30. Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis. (PubMed id 20810507)1, 4 RodrA-guez-RodrA-guez L....GonzA!lez-Gay M.A. (2010)
    31. Gene-gene interaction in regulatory T-cell function i n atopy and asthma development in childhood. (PubMed id 20599261)1, 4 Bottema R.W....Koppelman G.H. (2010)
    32. L-type voltage-dependent calcium channel alpha subuni t 1C is a novel candidate gene associated with secondary hyperparathyroidism: a n application of haplotype-based analysis for multiple linked single nucleotide polymorphisms. (PubMed id 20424473)1, 4 Yokoyama K....Hosoya T. (2010)
    33. Genetic susceptibility to type 2 diabetes is associat ed with reduced prostate cancer risk. (PubMed id 20203524)1, 4 Pierce B.L. and Ahsan H. (2010)
    34. Identification of fetal and maternal single nucleotid e polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. (PubMed id 20452482)1, 4 Romero R....Menon R. (2010)
    35. A genetic association study of maternal and fetal can didate genes that predispose to preterm prelabor rupture of membranes (PROM). (PubMed id 20673868)1, 4 Romero R....Menon R. (2010)
    36. Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. (PubMed id 20716621)1, 4 Chang J.S....Buffler P.A. (2010)
    37. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. (PubMed id 19258923)1, 4 Siezen C.L....Janssen R. (2009)
    38. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. (PubMed id 19471255)1, 4 MA!rquez A....Urcelay E. (2009)
    39. Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis. (PubMed id 19265545)1, 4 Carr E.J....Smith K.G. (2009)
    40. Racial disparity in pathophysiologic pathways of pret erm birth based on genetic variants. (PubMed id 19527514)1, 4 Menon R....Thorsen P. (2009)
    41. Meta-analysis of genome scans and replication identif y CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. (PubMed id 19525953)1, 4 De Jager P.L.... J.R. (2009)
    42. Coeliac disease associated risk variants in TNFAIP3 and REL implicate altered NF-{kappa}B signalling. (PubMed id 19240061)1, 4 Trynka G....Wijmenga C. (2009)
    43. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. (PubMed id 19375175)1, 4 Perera D....Rubio J.P. (2009)
    44. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. (PubMed id 19264985)1, 4 Nejentsev S....Todd J.A. (2009)
    45. Integration of genetic risk factors into a clinical a lgorithm for multiple sclerosis susceptibility: a weighted genetic risk score. (PubMed id 19879194)1, 4 De Jager P.L.... E.W. (2009)
    46. Multiple sclerosis susceptibility alleles in African Americans. (PubMed id 19865102)1, 4 Johnson B.A....Oksenberg J.R. (2009)
    47. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. (PubMed id 19430480)1, 4 Barrett J.C....Rich S.S. (2009)
    48. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. (PubMed id 19155502)1, 4 Maier L.M....Hafler D.A. (2009)
    49. Replication of CD58 and CLEC16A as genome-wide signif icant risk genes for multiple sclerosis. (PubMed id 19834503)1, 4 Hoppenbrouwers I.A....Hintzen R.Q. (2009)
    50. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. (PubMed id 19525955)1, 4 (2009)
    51. Risk alleles for multiple sclerosis in multiplex fami lies. (PubMed id 19506219)1, 4 D'Netto M.J....Ebers G.C. (2009)
    52. Variants in TNFAIP3, STAT4, and C12orf30 loci associa ted with multiple autoimmune diseases are also associated with juvenile idiopat hic arthritis. (PubMed id 19565500)1, 4 Prahalad S....Jorde L.B. (2009)
    53. Replication of KIAA0350, IL2RA, RPL5 and CD58 as mult iple sclerosis susceptibility genes in Australians. (PubMed id 18650830)1, 4 Rubio J.P....Kilpatrick T.J. (2008)
    54. Shared and distinct genetic variants in type 1 diabetes and celiac disease. (PubMed id 19073967)1, 4 Smyth D.J....Todd J.A. (2008)
    55. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. (PubMed id 18715339)1, 4 Dhiman N....Poland G.A. (2008)
    56. Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. (PubMed id 19019335)1, 4 Velez D.R....Menon R. (2008)
    57. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. (PubMed id 18354419)1, 4 Weber F....Muller-Myhsok B. (2008)
    58. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. (PubMed id 18593762)1, 4 Skinningsrud B....Undlien D.E. (2008)
    59. Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. (PubMed id 18818748)1, 4 Velez D.R....Menon R. (2008)
    60. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the DPT1 trial. (PubMed id 18556337)1, 4 Butty V....Benoist C. (2008)
    61. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. (PubMed id 18978792)1, 4 Cooper J.D....Todd J.A. (2008)
    62. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. (PubMed id 17152005)1, 4 Dhiman N....Jacobson R.M. (2007)
    63. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. (PubMed id 17395754)1, 4 Qu H.Q....Polychronakos C. (2007)
    64. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. (PubMed id 17703412)1, 4 Janssen R....Hoebee B. (2007)
    65. Association of IL13 with total IgE: evidence against an inverse association of atopy and diabetes. (PubMed id 16750991)1, 4 Maier L.M....Strachan D.P. (2006)
    66. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. (PubMed id 16385451)1, 4 Grupe A....Goate A. (2006)
    67. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. (PubMed id 16477002)1, 2 Stauber D.J.... Wilson I.A. (2006)
    68. Associations of the IL2Ralpha, IL4Ralpha, IL10Ralpha, and IFN (gamma) R1 cytokine receptor genes with AIDS progression in a French AIDS cohort. (PubMed id 16491350)1, 4 Do H....Zagury J.F. (2006)
    69. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. (PubMed id 16293754)1, 2 Wang X.... Garcia K.C. (2005)
    70. The interleukin-2 and interleukin-4 receptors studied by molecular modelling. (PubMed id 7529123)1, 2 Bamborough P.... Richards W.G. (1994)
    71. Structural analysis of recombinant soluble human interleukin-2 receptor. Primary structure, assignment of disulfide bonds and core IL-2 binding structure. (PubMed id 3134887)1, 2 Miedel M.C.... Pan Y.C. (1988)
    72. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. (PubMed id 3030566)1, 2 Cross S.L....Leonard W.J. (1987)
    73. Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. (PubMed id 3925551)1, 3 Leonard W.J....Greene W.C. (1985)
    74. Structure of the human interleukin-2 receptor gene. (PubMed id 2996141)1, 2 Leonard W.J.... Greene W.C. (1985)
    75. Molecular cloning and structure of the human interleukin 2 receptor gene. (PubMed id 2999698)1, 2 Ishida N.... Honjo T. (1985)
    76. Molecular cloning of cDNA encoding human interleukin-2 receptor. (PubMed id 6090949)1, 2 Nikaido T.... Honjo T. (1984)
    77. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. (PubMed id 6090948)1, 2 Leonard W.J....Greene W.C. (1984)
    78. Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. (PubMed id 15328201)1, 9 Jones D....Medeiros L.J. (2004)
    79. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. (PubMed id 19119414)1, 9 Maier L.M....Hafler D.A. (2009)
    80. Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: effects of activation and differentiation. (PubMed id 2016116)1, 9 Zola H....Hapel A.J. (1991)
    81. A novel subpopulation of CD45RA+ CD4+ T cells expressing IL-2 receptor alpha-chain (CD25) and having a functionally transitional nature into memory cells. (PubMed id 1685671)1, 9 Kanegane H....Taniguchi N. (1991)
    82. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours. (PubMed id 17985312)1, 9 Kasprzak A....Zabel M. (2007)
    83. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. (PubMed id 1394441)1, 9 Purvis S.F....Lederman M.M. (1992)
    84. Disengaging the IL-2 receptor with daclizumab enhance s IL-7-mediated proliferation of CD4(+) and CD8(+) T cells. (PubMed id 19788505)7, 9 Monti P....Bonifacio E. (2009)
    85. Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus. (PubMed id 19377213)1, 9 El-Shafey E.M....Selim A.G. (2008)
    86. Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome. (PubMed id 16690518)1, 9 Fabre-Guillevin E....Soubeyran P. (2006)
    87. Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit. (PubMed id 12525482)1, 9 Lindemann M.J....Gaffen S.L. (2003)
    88. Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis. (PubMed id 12581498)1, 9 Frode T.S....Medeiros Y.S. (2002)
    89. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation. (PubMed id 12171778)1, 9 Takatsuka H....Kakishita E. (2002)
    90. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. (PubMed id 10607689)7, 9 Przepiorka D....Light S. (2000)
    91. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness. (PubMed id 9637477)1, 9 Selliah N. and Finkel T.H. (1998)
    92. Disposition and immunodynamics of basiliximab in live r allograft recipients. (PubMed id 9695721)7, 9 Kovarik J....Nashan B. (1998)
    93. Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism. (PubMed id 9203962)1, 9 Horiuchi S....Yamamoto N. (1997)
    94. [Relationship between human cytomegalovirus infection and soluble interleukin-2 receptor level] (PubMed id 15617342)1, 9 Cao Y. and Li A. (1997)
    95. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. (PubMed id 7903128)1, 9 Greenway A.L....Azad A. (1994)
    96. Cell-specific protein phenotypes for the autoimmune l ocus IL2RA using a genotype-selectable human bioresource. (PubMed id 19701192)1, 9 Dendrou C.A....Wicker L.S. (2009)
    97. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor functi on. (PubMed id 19849846)1, 9 Kmieciak M....Manjili M.H. (2009)
    98. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? (PubMed id 19327240)1, 9 Alenius G.M....RantapAoAo Dahlqvist S. (2009)
    99. Serum soluble interleukin-2 receptor levels in patien ts with malignant lymphoma of bone. (PubMed id 19499289)1, 9 Akahane T....Kato H. (2009)
    100. Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma. (PubMed id 17530023)7, 9 Waldmann T.A. (2007)
    101. Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis. (PubMed id 17205058)1, 9 Nakase K....Katayama N. (2007)
    102. A reduced IL2R (CD25) expression level in first and second degree female relatives of autoimmune thyroid disease patients. A sign of a poor capability to preserve tolerance? (PubMed id 16698664)1, 9 Strieder T.G....Wiersinga W.M. (2006)
    103. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors. (PubMed id 16226465)1, 9 Fujita N....Nishida M. (2005)
    104. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. (PubMed id 15365604)1, 9 Vincenti F. (2004)
    105. IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. (PubMed id 15263076)1, 9 Vamosi G....Damjanovich S. (2004)
    106. Serum soluble interleukin-2 receptor in eosinophilia. (PubMed id 12486319)1, 9 Kaito K....Kobayashi M. (2003)
    107. GPI-microdomains (membrane rafts) and signaling of the multi-chain interleukin-2 receptor in human lymphoma/leukemia T cell lines. (PubMed id 11856346)1, 9 Matko J....Damjanovich S. (2002)
    108. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. (PubMed id 12200381)1, 9 Sereti I....Lane H.C. (2002)
    109. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain. (PubMed id 10602027)1, 9 Delespine-Carmagnat M....Bertoglio J. (2000)
    110. Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis: an ap plication to basiliximab in renal transplantation. (PubMed id 10567956)7, 9 MentrAc F....Gerbeau C. (1999)
    111. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. (PubMed id 9096364)1, 9 Sharfe N....Roifman C.M. (1997)
    112. Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus-1 gp120. (PubMed id 9341758)1, 9 Bani L....Theze J. (1997)
    113. Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid (H9) cell line. (PubMed id 7734194)1, 9 Puri R.K....Aggarwal B.B. (1995)
    114. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. (PubMed id 7539755)1, 9 Dianzani U....Pileri A. (1995)
    115. Delineation of an enhancerlike positive regulatory element in the interleukin-2 receptor alpha-chain gene. (PubMed id 2153927)1, 9 Lin B.B....Leonard W.J. (1990)
    116. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated. (PubMed id 2303462)1, 9 Mills G.B....Greene W.C. (1990)
    117. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. (PubMed id 2315327)1, 9 Oyaizu N....Pahwa S. (1990)
    118. The protein pheromone Er-1 of the ciliate Euplotes rai kovi stimulates human T-cell activity: involvement of interleukin-2 system. (PubMed id 23103669)1 Cervia D....Vallesi A. (2013)
    119. Postthymic expansion in human CD4 naive T cells define d by expression of functional high-affinity IL-2 receptors. (PubMed id 23418630)1 Pekalski M.L....Wicker L.S. (2013)
    120. A genome-wide association study of bronchodilator resp onse in asthmatics. (PubMed id 23508266)1 Duan Q.L....Tantisira K.G. (2013)
    121. Association of variants in IL2RA with progression of j oint destruction in rheumatoid arthritis. (PubMed id 23529819)1 Knevel R....van der Helm-van Mil A.H. (2013)
    122. Functional polymorphism rs7072793 C > T affect indi vidual susceptibility to breast cancer by modulating CD25 transcription activity . (PubMed id 22213266)1 Li H....Yu Y. (2013)
    123. Human IL2RA null mutation mediates immunodeficiency wi th lymphoproliferation and autoimmunity. (PubMed id 23416241)1 Goudy K....Bacchetta R. (2013)
    124. CD147 in regulatory T cells. (PubMed id 23665204)1 Landskron J. and Tasken K. (2013)
    125. The expression and significance of CD4+CD25+CD127low/- regulatory T cells and Foxp3 in patients with portal hypertension and hypersple nism. (PubMed id 23282736)1 Guo Y....Zhang Q.Y. (2013)
    126. The predictive value of soluble biomarkers (CD14 subty pe, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemother apy-induced febrile neutropenia. (PubMed id 23510625)1 Urbonas V....Tamuliene I. (2013)
    127. A flow cytometry based assay for the enumeration of re gulatory T cells in whole blood. (PubMed id 22824721)1 Hardy M.Y....Prue R.L. (2013)
    128. Increased level of myeloid-derived suppressor cells, p rogrammed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. (PubMed id 23383287)1 Christiansson L....Loskog A.S. (2013)
    129. Expression of CD25 independently predicts early treatm ent failure of acute myeloid leukaemia (AML). (PubMed id 23116454)1 Cerny J....Nath R. (2013)
    130. Evaluation of the IL2/IL21, IL2RA and IL2RB genetic va riants influence on the endogenous non-anterior uveitis genetic predisposition. (PubMed id 23676143)1 Cenit M.C....Martin J. (2013)
    131. Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population. (PubMed id 23512675)1 Zhu J....Zhou B. (2013)
    132. High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: correlation with poor prognosis and CD4 expression on b last cells. (PubMed id 22537764)1 Nakase K....Katayama N. (2012)
    133. Investigation of rheumatoid arthritis susceptibility l oci in juvenile idiopathic arthritis confirms high degree of overlap. (PubMed id 22294642)1 Hinks A....Thomson W. (2012)
    134. Chronic immune activation in common variable immunodef iciency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. (PubMed id 23121673)1 Litzman J....Hel Z. (2012)
    135. CD25 is a novel marker of hepatic bile canaliculus. (PubMed id 22576476)1 Lu Z.H....Fan Q.H. (2012)
    136. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. (PubMed id 22461703)1 Garg G....Tree T.I. (2012)
    137. Host-microbe interactions have shaped the genetic arch itecture of inflammatory bowel disease. (PubMed id 23128233)1 Jostins L....Cho J.H. (2012)
    138. Polymorphic variants of the IL2RA gene and susceptibil ity to type 1 diabetes in the Polish population. (PubMed id 22211793)1 Fichna M....Nowak J. (2012)
    139. Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata. (PubMed id 22897480)1 Redler S....Betz R.C. (2012)
    140. The autoimmune disease-associated IL2RA locus is invol ved in the clinical manifestations of systemic sclerosis. (PubMed id 22012429)1 Martin J.E....Martin J. (2012)
    141. Fine mapping and replication of genetic risk loci in p rimary sclerosing cholangitis. (PubMed id 22554193)1 Srivastava B....Melum E. (2012)
    142. IL-7 abrogates suppressive activity of human CD4+CD25+ FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. (PubMed id 23129754)1 Heninger A.K....Monti P. (2012)
    143. Compensatory T-cell regulation in unaffected relatives of SLE patients, and opposite IL-2/CD25-mediated effects suggested by coreferen tiality modeling. (PubMed id 22479496)1 Fesel C....Vicente A.M. (2012)
    144. Identification, frequency, activation and function of CD4+ CD25(high)FoxP3+ regulatory T cells in children with juvenile idiopathic ar thritis. (PubMed id 21249500)1 Stelmaszczyk-Emmel A....Wasik M. (2012)
    145. Cell surface expression of CD25 antigen (surface IL-2 receptor a-chain) is not a prognostic marker in chronic lymphocytic leukemia: re sults of a retrospective study of 281 patients. (PubMed id 22623161)1 Shvidel L....Polliack A. (2012)
    146. Serum concentration of interleukin 15, interleukin 2 r eceptor and TNF receptor in patients with polymyositis and dermatomyositis: corr elation to disease activity. (PubMed id 21132303)1 Mielnik P....Olesinska M. (2012)
    147. The interleukin-2 receptor a chain (CD25) plays an imp ortant role in regulating monocyte-derived CD40 expression during anti-porcine c ellular responses. (PubMed id 22564647)1 Sun Z.G....Xu H. (2012)
    148. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell co unt rather than its ratio in peripheral blood is related to long-term survival o f renal allografts. (PubMed id 22310634)1 Liu L....He X. (2012)
    149. Glycodelin-A interferes with IL-2/IL-2R signalling to induce cell growth arrest, loss of effector functions and apoptosis in T-lymphoc ytes. (PubMed id 22313865)1 Soni C. and Karande A.A. (2012)
    150. In-vitro characterization of novel and functional regu latory SNPs in the promoter region of IL2 and IL2R alpha in a Gabonese populatio n. (PubMed id 23217119)1 Huang X....Tp V. (2012)
    151. Effects of glucocorticoid treatment on CD25^-FOXP3^+ p opulation and cytokine-producing cells in rheumatoid arthritis. (PubMed id 22447883)1 de Paz B....Suarez A. (2012)
    152. Amount of CD4+CD25+ regulatory T cells in autoimmune p ancreatitis and pilonidal sinus. (PubMed id 22466163)1 Fukumura Y....Yao T. (2012)
    153. Evaluation of circulating CD4+CD25+ and liver-infiltra ting Foxp3+ cells in HCV-associated liver disease. (PubMed id 22446965)1 Amoroso A....Mazzarino M.C. (2012)
    154. LIF and sIL-2R plasma concentrations in IVF patients o n the day of embryo transfer: predictive markers of IVF outcome. (PubMed id 22436290)1 Gremlich S....Gerber S. (2012)
    155. Foxp3+CD25(high) CD4+ regulatory T cells from indeterm inate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity. (PubMed id 22672991)1 de Araujo F.F....Gomes J.A. (2012)
    156. Preferential expansion of human virus-specific multifu nctional central memory T cells by partial targeting of the IL-2 receptor signal ing pathway: the key role of CD4+ T cells. (PubMed id 22516956)1 Schmueck M....Reinke P. (2012)
    157. Soluble cytokine receptors (sIL-2Ra, sIL-2Rb) induce s ubunit-specific behavioral responses and accumulate in the cerebral cortex and b asal forebrain. (PubMed id 22558434)1 Zalcman S.S....Siegel A. (2012)
    158. Serum soluble interleukin 2 receptor (sIL-2R) as a mar ker of acute rejection in renal transplant children. (PubMed id 22309031)1 Garcia-Roca P....Medeiros M. (2012)
    159. Comparative analyses of regulatory T cell subsets in p atients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cell s. (PubMed id 22419479)1 Kakita N....Hayashi N. (2012)
    160. Circulating CD4+CD25+ regulatory T cells in patients w ith pancreatic cancer. (PubMed id 22158072)1 Yamamoto T....Kwon A.H. (2012)
    161. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criteri on. (PubMed id 22222639)1 Morgado J.M....Escribano L. (2012)
    162. The involvement of inflammatory cytokines in the patho genesis of recurrent miscarriage. (PubMed id 22266274)1 Giannubilo S.R....Emanuelli M. (2012)
    163. [IL-2/IL-2R pathway in dendritic cell modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4 + T lymphocytes]. (PubMed id 19375249)1 Mnasria K....Oueslati R. (2011)
    164. Expansion of CD4+CD25+ helper T cells without regulat ory function in smoking and COPD. (PubMed id 21651772)1 Roos-Engstrand E....Blomberg A. (2011)
    165. A variant of the Il2raa88/a88Cd25 gene predisposing to gr aves' disease is associated with increased levels of soluble interleukin-2 rece ptor. (PubMed id 21815908)1 Chistiakov D.A....Savost'anov K.V. (2011)
    166. Phenotype and function of CD25-expressing B lymphocyt es isolated from human umbilical cord blood. (PubMed id 21941578)1 Amu S. and Brisslert M. (2011)
    167. Monitoring of CD4+CD25highIL-7RI+high activated T cell s in kidney transplant recipients. (PubMed id 21757642)1 Vallotton L....Pascual M. (2011)
    168. CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis. (PubMed id 21300823)1 Baecher-Allan C.M....Hafler D.A. (2011)
    169. Interleukin-2 signaling pathway analysis by quantitati ve phosphoproteomics. (PubMed id 21722762)1 Osinalde N....Kratchmarova I. (2011)
    170. The excellent outcomes of ABO-incompatible kidney tra nsplantation with high titer (>A92048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports. (PubMed id 21839272)1 Koshino K....Yoshimura N. (2011)
    171. Human cord blood CD4+CD25hi regulatory T cells suppre ss prenatally acquired T cell responses to Plasmodium falciparum antigens. (PubMed id 21278348)1 Mackroth M.S....King C.L. (2011)
    172. CD4+CD25+ and CD4+CD2+high regulatory T cells in diss eminated and localized forms of allergic contact dermatitis: relation to specif ic cytokines. (PubMed id 21744325)1 Reduta T....LaudaA8ska H. (2011)
    173. STAT1 hyperphosphorylation and defective IL12R/IL23R s ignaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. (PubMed id 22195034)1 Smeekens S.P....Netea M.G. (2011)
    174. Mechanics of the IL2RA gene activation revealed by mo deling and atomic force microscopy. (PubMed id 21533205)1 Milani P....Arneodo A. (2011)
    175. Interleukin 2 receptor a gene polymorphism and risk of multiple sclerosis: a meta-analysis. (PubMed id 22117963)1 Wang L.M....Sun S.L. (2011)
    176. Human colonic myofibroblasts promote expansion of CD4 + CD25high Foxp3+ regulatory T cells. (PubMed id 21376048)1 Pinchuk I.V....Powell D.W. (2011)
    177. Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4^+CD25^+Foxp3^+ regulatory T cells in COPD. (PubMed id 22032685)1 Yang L....Wang C.Z. (2011)
    178. Aggregation of multiple sclerosis genetic risk variant s in multiple and single case families. (PubMed id 21280076)4 Gourraud P.A....Oksenberg J.R. (2011)
    179. Effect of age on surface molecules and cytokine expre ssion in human dendritic cells. (PubMed id 21571262)1 Ciaramella A....BossA^ P. (2011)
    180. Soluble interleukine-2 receptor and MDR1 gene express ion levels as inflammatory biomarkers for prediction of steroid response in chi ldren with nephrotic syndrome. (PubMed id 21525574)1 Youssef D.M....Amr G.E. (2011)
    181. An interferon-induced helicase (IFIH1) gene polymorph ism associates with different rates of progression from autoimmunity to type 1 diabetes. (PubMed id 21270278)4 Winkler C....Bonifacio E. (2011)
    182. IL2RA gene polymorphism rs2104286 A>G seen in mult iple sclerosis is associated with intermediate uveitis: possible parallel pathw ays? (PubMed id 21911588)1 Lindner E....El-Shabrawi Y. (2011)
    183. Intracerebral human regulatory T cells: analysis of C D4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple s clerosis patients. (PubMed id 21437244)1 Fritzsching B....Wildemann B. (2011)
    184. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. (PubMed id 21557772)1 Zhu J....Qu X. (2011)
    185. Tumor site immune markers associated with risk for sub sequent basal cell carcinomas. (PubMed id 21980389)1 Glaser R....Kiecolt-Glaser J.K. (2011)
    186. Association of IL2RA polymorphisms with susceptibilit y to multiple sclerosis is not explained by missense mutations in IL2RA. (PubMed id 21239413)1 Matiello M....Kantarci O.H. (2011)
    187. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. (PubMed id 21557210)1 Bianchini R....Riccardi C. (2011)
    188. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. (PubMed id 21949691)1 McSorley H.J....Loukas A. (2011)
    189. The vitamin D analog, TX527, promotes a human CD4+CD2 5highCD127low regulatory T cell profile and induces a migratory signature speci fic for homing to sites of inflammation. (PubMed id 21131424)1 Baeke F....Mathieu C. (2011)
    190. CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulator y subset in primary biliary cirrhosis. (PubMed id 20729906)1 Wang D....Sun L. (2010)
    191. Stem cell factor, interleukin-16, and interleukin-2 r eceptor alpha are predictive biomarkers for delayed and slow graft function. (PubMed id 21094786)1 Alachkar N....Rabb H. (2010)
    192. Circulating CD4+CD25hiCD127lo regulatory T-Cell level s do not reflect the extent or severity of carotid and coronary atherosclerosis . (PubMed id 20539016)1 Ammirati E....Norata G.D. (2010)
    193. The impact of IL2ra induction therapy in kidney trans plantation using tacrolimus- and mycophenolate-based immunosuppression. (PubMed id 20595929)1 Gralla J. and Wiseman A.C. (2010)
    194. Decreased CD4+CD25+ cells and increased dimeric IgA-p roducing cells in tonsils in IgA nephropathy. (PubMed id 20213609)1 Huang H....Liu F. (2010)
    195. Deficient CD4+CD25+ T regulatory cell function in pat ients with abdominal aortic aneurysms. (PubMed id 20448211)1 Yin M....Xin S. (2010)
    196. Tissue expression of interleukin 2 (IL-2) and IL-2 re ceptor (IL-2R(alpha)/CD25) in non-Hodgkin B-cell lymphomas in children: correla tions with clinical data. (PubMed id 20562654)1 Kasprzak A....Zabel M. (2010)
    197. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral bloo d of patients with persistent allergic rhinitis. (PubMed id 20403730)1 Han D....Zhang L. (2010)
    198. Plasmodium vivax: induction of CD4+CD25+FoxP3+ regula tory T cells during infection are directly associated with level of circulating parasites. (PubMed id 20224778)1 Bueno L.L....Braga E.M. (2010)
    199. Characterization of protective human CD4CD25 FOXP3 re gulatory T cells generated with IL-2, TGF-I^ and retinoic acid. (PubMed id 21179414)1 Lu L....Horwitz D.A. (2010)
    200. Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheuma toid arthritis in African Americans. (PubMed id 21120996)4 Hughes L.B....Bridges S.L. (2010)
    201. Clinical relevance of elevated levels of serum solubl e interleukin-2 receptor alpha (sIL-2RI+) in patients with non-Hodgkin's lymphom a. (PubMed id 21157146)1 Jo S.A....Lee E.Y. (2010)
    202. The role of rheumatoid arthritis genetic susceptibili ty markers in the prediction of erosive disease in patients with early inflamma tory polyarthritis: results from the Norfolk Arthritis Register. (PubMed id 20219786)1 Plant D....Barton A. (2010)
    203. The genetics of multiple sclerosis: an update 2010. (PubMed id 20450971)1 Hoffjan S. and Akkad D.A. (2010)
    204. CD4+CD25+Foxp3+ regulatory T cells protect the proinf lammatory activation of human umbilical vein endothelial cells. (PubMed id 20930173)1 He S....Li D. (2010)
    205. In vitro enhanced chemotaxis of CD25+ mononuclear cel ls in patients with familial IgAN through glomerulotubular interactions. (PubMed id 20484297)1 Tam K.Y....Lai K.N. (2010)
    206. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. (PubMed id 20368992)1 Jensen C.J....Butzkueven H. (2010)
    207. New genetic associations detected in a host response study to hepatitis B vaccine. (PubMed id 20237496)1 Davila S....Seielstad M. (2010)
    208. B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25+-expressing B cells. (PubMed id 20716663)1 Eriksson P....Ernerudh J. (2010)
    209. Characterization of rabbit antithymocyte globulins-in duced CD25+ regulatory T cells from cells of patients with end-stage renal dise ase. (PubMed id 20164820)1 Sewgobind V.D....Baan C.C. (2010)
    210. [Study on the association between IL-2R and IL-7R gen e polymorphism and idiopathic demyelinating optic neuritis]. (PubMed id 21211217)1 Zhao Y.Y....Yuan H.J. (2010)
    211. Protein phosphatase 2A regulates interleukin-2 recept or complex formation and JAK3/STAT5 activation. (PubMed id 19923221)1 Ross J.A....Kirken R.A. (2010)
    212. Single nucleotide polymorphisms of matrix metalloprot einase 9 (MMP-9) and tumour protein 73 (TP73) interact with Epstein Barr virus in chronic lymphocytic leukemia: results from the European case-control study E piLymph. (PubMed id 21048031)1 Casabonne D....de Sanjose S. (2010)
    213. Structural basis for the blockage of IL-2 signaling b y therapeutic antibody basiliximab. (PubMed id 20032294)1 Du J....Ding J. (2010)
    214. The associations of circulating CD4+CD25high regulato ry T cells and TGF-I^ with disease activity and clinical course in patients with adult-onset Still's disease. (PubMed id 20388015)1 Chen D.Y....Lan J.L. (2010)
    215. T regulatory cells control T-cell proliferation partl y by the release of soluble CD25 in patients with B-cell malignancies. (PubMed id 20518821)1 Lindqvist C.A....Loskog A.S. (2010)
    216. Natural killer T cells constitutively expressing the interleukin-2 receptor I+ chain early in life are primed to respond to lower ant igenic stimulation. (PubMed id 20545784)1 Ladd M....Lavoie P.M. (2010)
    217. Monocyte IL-2Ralpha expression is associated with thr ombosis and the JAK2V617F mutation in myeloproliferative neoplasms. (PubMed id 20483636)1 Goette N.P....Marta R.F. (2010)
    218. Impact of Basiliximab on regulatory T-cells early aft er kidney transplantation: down-regulation of CD25 by receptor modulation. (PubMed id 19951265)1 Vondran F.W....Schwinzer R. (2010)
    219. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. (PubMed id 19956753)1 Brusko T.M....Atkinson M.A. (2009)
    220. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. (PubMed id 19734224)1 Grindebacke H....Rudin A. (2009)
    221. The type I diabetes association of the IL2RA locus. (PubMed id 19956099)1 Qu H.Q....Polychronakos C. (2009)
    222. Gene-centric association signals for lipids and apoli poproteins identified via the HumanCVD BeadChip. (PubMed id 19913121)1 Talmud P.J.... . (2009)
    223. Biomarkers for nononcologic gastrointestinal diseases . (PubMed id 19141347)1 Katial R. (2009)
    224. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphom a and chronic graft-versus-host-disease patients. (PubMed id 19505389)1 Quaglino P....Bernengo M.G. (2009)
    225. Analysis of variation in the IL7RA and IL2RA genes in atopic dermatitis. (PubMed id 19523791)1 Hoffjan S....Epplen J.T. (2009)
    226. [Altered frequency of CD4+CD25-Foxp3+ T cells in pati ents with systemic lupus erythematosus] (PubMed id 19664391)1 Yan B....Liu G. (2009)
    227. Extracorporeal photophoresis augments function of CD4 +CD25+FoxP3+ regulatory T cells by triggering adenosine production. (PubMed id 19667946)1 Schmitt S....Enk A.H. (2009)
    228. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV- 1 infected persons under HAART. (PubMed id 19303058)1 Terzieva V....Yankova M. (2009)
    229. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. (PubMed id 19155519)1 Bonelli M....Scheinecker C. (2009)
    230. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers. (PubMed id 19139102)1 Hornakova T....Renauld J.C. (2009)
    231. [The expression of CD25 in phytohemagglutinin- or int erleukin-2-stimulated human peripheral blood lymphocytes] (PubMed id 19637754)1 Zenin V.V....Marakhova I.I. (2009)
    232. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on c alcineurin inhibitors. (PubMed id 19667950)1 Mittal S.K....Naik S. (2009)
    233. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. (PubMed id 19289595)1 Dong H.Y....Tugulea S. (2009)
    234. IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity. (PubMed id 19447046)1 Wang J....Santamaria P. (2009)
    235. Association of IL2RA and IL2RB with rheumatoid arthri tis: a replication study in a Dutch population. (PubMed id 19822714)1 Kurreeman F.A....Toes R.E. (2009)
    236. A cis-acting regulatory variant in the IL2RA locus. (PubMed id 19794070)1 Qu H.Q....Polychronakos C. (2009)
    237. CD25 shedding by human natural occurring CD4+CD25+ re gulatory T cells does not inhibit the action of IL-2. (PubMed id 19522766)1 Pedersen A.E. and Lauritsen J.P. (2009)
    238. Frequency of Foxp3+CD4CD25+ T cells is associated wit h the phenotypes of allergic asthma. (PubMed id 19192224)1 Matsumoto K....Nakanishi Y. (2009)
    239. Cell contact interaction between adipose-derived stro mal cells and allo-activated T lymphocytes. (PubMed id 19798683)1 Quaedackers M.E....Hoogduijn M.J. (2009)
    240. Tolerogenic semimature dendritic cells induce effecto r T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T- regulatory cells. (PubMed id 19715524)1 Fu B.M....Huang J.F. (2009)
    241. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. (PubMed id 18174382)1 Kondadasula S.V....Carson W.E. (2008)
    242. Aerobic training increases the stimulated percentage of CD4+CD25+ in older men but not older women. (PubMed id 18204854)1 Broadbent S. and Gass G. (2008)
    243. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. (PubMed id 19034005)1 Pons J.A....Parrilla P. (2008)
    244. Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. (PubMed id 18376303)1 Miyoshi H....Okazaki K. (2008)
    245. Impaired function of CD4+/CD25+ T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection. (PubMed id 17645467)1 Perrella A....Perrella O. (2008)
    246. Optimizing denileukin diftitox (Ontak) therapy. (PubMed id 18684057)7 Duvic M. and Talpur R. (2008)
    247. Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. (PubMed id 18451325)1 Cardoso C.R....Silva J.S. (2008)
    248. The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. (PubMed id 18780166)1 Dendrou C.A. and Wicker L.S. (2008)
    249. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. (PubMed id 18390743)1 Dunham R.M....Silvestri G. (2008)
    250. A chimera of interleukin 2 and a binding variant of aerolysin is selectively toxic to cells displaying the interleukin 2 receptor. (PubMed id 17981806)1 Osusky M....Buckley J.T. (2008)
    251. Alterations in the peripheral blood lymphocyte CD25 and Ki67 indices in renal cell carcinoma and their significance: a preliminary study. (PubMed id 19077408)1 Li Y....Shi B. (2008)
    252. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. (PubMed id 18641303)1 Fragale A....Battistini A. (2008)
    253. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome. (PubMed id 18089681)1 Liu M.F....Weng M.Y. (2008)
    254. Expression of CD66c and CD25 in acute lymphoblastic l eukemia as a predictor of the presence of BCR/ABL rearrangement. (PubMed id 20063526)1 Owaidah T.M....Elkum N.B. (2008)
    255. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. (PubMed id 18641304)1 Zheng Y....Sansom D.M. (2008)
    256. Proportional change of CD4+CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. (PubMed id 17543960)1 Yang H....Lin Q. (2008)
    257. Nanometer-scale organization of the alpha subunits of the receptors for IL2 and IL15 in human T lymphoma cells. (PubMed id 18287585)1 de Bakker B.I....Garcia-Parajo M.F. (2008)
    258. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. (PubMed id 18261176)1 Bloom D.D....Knechtle S.J. (2008)
    259. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis. (PubMed id 18162781)1 Hollmann T.J....Hornick J.L. (2008)
    260. Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients. (PubMed id 17237241)1 Schmidt-Lucke C....Dimmeler S. (2007)
    261. Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients. (PubMed id 17302593)1 Baan C.C....Weimar W. (2007)
    262. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells. (PubMed id 17372588)1 Cao M....Nelson D.R. (2007)
    263. Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders. (PubMed id 17187516)7 Turturro F. (2007)
    264. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. (PubMed id 17975141)1 Strauss L....Whiteside T.L. (2007)
    265. Design and characterization of an HIV-1 Tat mutant: i nactivation of viral and cellular functions but not antigenicity. (PubMed id 17604883)1 Mayol K....Guillon C. (2007)
    266. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. (PubMed id 17591854)1 Codarri L....Pantaleo G. (2007)
    267. Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. (PubMed id 17564638)7 Patlolla V....Mandelbrot D.A. (2007)
    268. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. (PubMed id 18021968)1 Korczak-Kowalska G....Gorski A. (2007)
    269. Circulating CD4+CD25+ T cells in rheumatic mitral stenosis. (PubMed id 17944116)1 Yildiz A....Korkmaz S. (2007)
    270. Decreased expression of CD25 on decidual activated T lymphocytes is not mediated by reduced CD25 messenger ribonucleic acid. (PubMed id 17074352)1 Chao K.H....Ho H.N. (2007)
    271. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. (PubMed id 17462597)1 Kim Y.G....Moon H.B. (2007)
    272. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. (PubMed id 17420929)1 Matesanz F....Alcina A. (2007)
    273. Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD. (PubMed id 17313446)1 Zhai Z....Wang Y. (2007)
    274. HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets. (PubMed id 17431094)1 Quaranta M.G....Viora M. (2007)
    275. Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells. (PubMed id 17523134)1 Naranjo-Gomez M....Borras F.E. (2007)
    276. Anti-CD25 treatment and FOXP3-positive regulatory T c ells in heart transplantation. (PubMed id 17584597)7 Vlad G....Suciu-Foca N. (2007)
    277. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. (PubMed id 17389235)1 Nylen S....Sacks D. (2007)
    278. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. (PubMed id 18059223)1 Hahn H.P. and Hornick J.L. (2007)
    279. The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study. (PubMed id 17661330)1 Zwickey H....Buresh R. (2007)
    280. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. (PubMed id 17304105)1 Wisnoski N....Ayala A. (2007)
    281. Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. (PubMed id 17878392)1 Powell D.J....Pastan I. (2007)
    282. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. (PubMed id 17275508)1 Meloni F....Fietta A.M. (2007)
    283. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. (PubMed id 17712998)1 Lyssuk E.Y....Bykovskaia S.N. (2007)
    284. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. (PubMed id 17615291)1 Yang Z.Z....Ansell S.M. (2007)
    285. Anti-Tac (daclizumab, Zenapax) in the treatment of le ukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25 -year personal odyssey. (PubMed id 17216565)7 Waldmann T.A. (2007)
    286. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance. (PubMed id 17175221)1 Jiang S....Lechler R.I. (2006)
    287. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus. (PubMed id 17062437)1 Valencia-Pacheco G....Gonzalez-Amaro R. (2006)
    288. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. (PubMed id 16380476)1 Endl J....Boehm B.O. (2006)
    289. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. (PubMed id 16911870)1 Kim H.P....Leonard W.J. (2006)
    290. [Screening of short peptides binding to cell surface interleukin-2 receptor alpha chain]. (PubMed id 16864089)7 Liu B.Y....Fu N. (2006)
    291. How many drug targets are there? (PubMed id 17139284)7 Overington J.P....Hopkins A.L. (2006)
    292. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. (PubMed id 16955142)1 Vukmanovic-Stejic M....Akbar A.N. (2006)
    293. Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. (PubMed id 16920911)1 Cohen A.C....Lewis D.B. (2006)
    294. Drugs, their targets and the nature and number of dru g targets. (PubMed id 17016423)7 Imming P....Meyer A. (2006)
    295. Plasmapheresis for recurrent posttransplant focal seg mental glomerulosclerosis. (PubMed id 16908318)7 Garcia C.D....Garcia V.D. (2006)
    296. In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. (PubMed id 16410445)1 Beyer M....Schultze J.L. (2006)
    297. CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. (PubMed id 16889540)1 Bharat A....Mohanakumar T. (2006)
    298. Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine. (PubMed id 16758122)1 Hueman M.T....Peoples G.E. (2006)
    299. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. (PubMed id 16339919)1 Guyot-Revol V....Lalvani A. (2006)
    300. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity. (PubMed id 15885081)1 Wenzel J....Tuting T. (2005)
    301. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. (PubMed id 16003241)1 Baan C.C....Weimar W. (2005)
    302. High-affinity CD25-binding IL-2 mutants potently stim ulate persistent T cell growth. (PubMed id 16060678)1 Rao B.M....Wittrup K.D. (2005)
    303. Investigation of possible cytokine induction in peripheral blood mononuclear cells by heat-stable serotypes of Campylobacter jejuni. (PubMed id 15649306)1 Chatzipanagiotou S....Legakis N.J. (2005)
    304. Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by T cell receptor and transforming growth factor-beta. (PubMed id 16087671)1 Kim H.P....Leonard W.J. (2005)
    305. CD25-expressing CD8+ T cells are potent memory cells in old age. (PubMed id 16034095)1 Herndler-Brandstetter D....Grubeck-Loebenstein B. (2005)
    306. Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses. (PubMed id 15731180)1 Darrasse-Jeze G....Klatzmann D. (2005)
    307. A model of the ternary complex of interleukin-10 with its soluble receptors. (PubMed id 15985167)1 Pletnev S....Zdanov A. (2005)
    308. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. (PubMed id 15713622)1 Kumar P.P.... Galande S. (2005)
    309. Interleukin-2alpha receptor in membrane lipid rafts. (PubMed id 15964425)1 Li Q.R....Li J.S. (2005)
    310. A negative regulatory element-dependent inhibitory role of ITF2B on IL-2 receptor alpha gene. (PubMed id 16126178)1 Lu Y....Shen Y.F. (2005)
    311. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. (PubMed id 15972448)1 Zorn E....Ritz J. (2005)
    312. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. (PubMed id 15784911)1 Locher C.P....Levy J.A. (2005)
    313. Allogeneic peripheral blood stem cell transplant (PBS CT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute gra ft versus host disease in steroid refractory Diamond Blackfan anaemia: a case r eport. (PubMed id 16304857)7 Shamsi T.S....Baig M.I. (2005)
    314. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. (PubMed id 15714205)1 Schaefer C....Whiteside T.L. (2005)
    315. Soluble interleukin-2 receptor in cancer. (PubMed id 15353339)1 Murakami S. (2004)
    316. Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. (PubMed id 14680494)1 Garcia-Tunon I....Royuela M. (2004)
    317. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. (PubMed id 15197226)1 Karlsson M.R....Brandtzaeg P. (2004)
    318. An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. (PubMed id 15123239)1 Boisguerin P....Volkmer-Engert R. (2004)
    319. The DNA sequence and comparative analysis of human chromosome 10. (PubMed id 15164054)2 Deloukas P.... Rogers J. (2004)
    320. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer? (PubMed id 15503821)1 Kayhan B....Akdogan M. (2004)
    321. IL2-receptor antagonist (basiliximab) induction thera py is associated with lower morbidity and mortality in renal transplant recipie nts. (PubMed id 12591363)7 Choy B.Y....Lai K.N. (2003)
    322. Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy. (PubMed id 16767920)7 Recchia F....Rea S. (2003)
    323. Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. (PubMed id 12970897)1 Wang K.X....Li C.P. (2003)
    324. Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer. (PubMed id 12698200)1 Bauernhofer T....Whiteside T.L. (2003)
    325. Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders. (PubMed id 11960393)1 Shvidel L....Berrebi A. (2002)
    326. Expression of IL-2alpha and IL-2beta receptors on the membrane surface of human sperm. (PubMed id 12230826)1 Fierro R....Faure G. (2002)
    327. Oligomerization of IL-2Ralpha. (PubMed id 11886175)1 Eicher D.M....Waldmann T.A. (2002)
    328. Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. (PubMed id 11986281)1 Fatoohi A.F....Peyron F. (2002)
    329. [Expression of interleukin-2 receptors on breast cance r cell line MCF-7 cells]. (PubMed id 21180073)1 Zhong Y.Q....Wang G.F. (2002)
    330. TTD: Therapeutic Target Database. (PubMed id 11752352)7 Chen X....Chen Y.Z. (2002)
    331. SATB1 targets chromatin remodelling to regulate genes over long distances. (PubMed id 12374985)1 Yasui D.... Kohwi-Shigematsu T. (2002)
    332. Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus. (PubMed id 11416131)1 Yeh J.H....Imbert J. (2001)
    333. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. (PubMed id 11485747)1 Kim H.P....Leonard W.J. (2001)
    334. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells. (PubMed id 10815800)1 Rameil P....Imbert J. (2000)
    335. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene. (PubMed id 10848593)1 Reeves R.... Nissen M.S. (2000)
    336. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation. (PubMed id 10825200)1 Zhou Y.J....O'Shea J.J. (2000)
    337. A review of interleukin-2 receptor antagonists in sol id organ transplantation. (PubMed id 10512062)7 Berard J.L....Tsunoda S.M. (1999)
    338. Phospholipase A2 inhibitors p-bromophenacyl bromide an d arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes. (PubMed id 10207608)7 Ouyang Y. and Kaminski N.E. (1999)
    339. Free interleukin-2 receptors in children with trisomy 21 (Down's syndrome) and different levels of periodontal disease. (PubMed id 17294624)1 Cutando-Soriano A....Bravo M. (1998)
    340. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. (PubMed id 9223324)1 Li C.J....Pardee A.B. (1997)
    341. Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation. (PubMed id 9268307)1 Kahn-Perles B.... Imbert J. (1997)
    342. [Study on relationship of soluble interleukin-2 receptors in serious hepatitis B patients and the T lymphocyte subgroup] (PubMed id 15619904)1 Zhang P....Yang Y. (1997)
    343. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. (PubMed id 8943338)1 Lecine P....Imbert J. (1996)
    344. Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1. (PubMed id 8752938)1 Gruss H.J....Herrmann F. (1996)
    345. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. (PubMed id 8896456)1 John S.... Leonard W.J. (1996)
    346. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. (PubMed id 8600944)7 Krouwels F.H....Out T.A. (1996)
    347. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. (PubMed id 7853525)1 Greenway A....McPhee D. (1995)
    348. In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. (PubMed id 7588634)1 AlgartAc M....Imbert J. (1995)
    349. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf- 1, HMG-I(Y), and NF-kappa B family proteins. (PubMed id 7862168)1 John S....Leonard W.J. (1995)
    350. Molecular cloning of IL-2R alpha, IL-2R beta, and IL-2R gamma cDNAs from a human oligodendroglioma cell line: presence of IL-2R mRNAs in the human central nervous system. (PubMed id 8530186)1 Otero G.C. and Merrill J.E. (1995)
    351. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. (PubMed id 8125298)1 Maruyama K. and Sugano S. (1994)
    352. The state of DNA methylation in the promoter and exon 1 regions of the human gene for the interleukin-2 receptor alpha chain (IL-2R alpha) in various cell types. (PubMed id 8364583)1 Behn-Krappa A. and Doerfler W. (1993)
    353. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B. (PubMed id 8098618)1 Costello R....Imbert J. (1993)
    354. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. (PubMed id 8493579)1 Chardin P....Bar-Sagi D. (1993)
    355. The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2. (PubMed id 1511461)1 Carter C.R....Rees R.C. (1992)
    356. The interleukin-2 receptor. (PubMed id 1993646)1 Waldmann T.A. (1991)
    357. A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. (PubMed id 1832084)1 Ruegg C.L. and Strand M. (1991)
    358. Sp1 represses IL-2 receptor alpha chain gene expression. (PubMed id 2083254)1 Roman D.G....Leonard W.J. (1990)
    359. The same target sequences are differentially important for activation of the interleukin 2 receptor alpha-chain gene in two distinct T-cell lines. (PubMed id 2308942)1 Toledano M.B....Leonard W.J. (1990)
    360. Interleukin-2 and the IL-2 receptor: new insights into structure and function. (PubMed id 1693645)1 Kuziel W.A. and Greene W.C. (1990)
    361. Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor. (PubMed id 1976256)1 Burton J....Waldmann T.A. (1990)
    362. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. (PubMed id 2785715)1 Hatakeyama M.... Taniguchi T. (1989)
    363. Cytotoxicity of interleukin 2-toxin toward lymphocyte s from patients with adult T-cell leukemia. (PubMed id 2786749)7 Kiyokawa T....Takatsuki K. (1989)
    364. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. (PubMed id 2497520)1 Cross S.L.... Leonard W.J. (1989)
    365. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. (PubMed id 2467293)1 Tsudo M....Miyasaka M. (1989)
    366. A BglI polymorphism for the interleukin-2 receptor gene (IL2R) on chromosome 10. (PubMed id 2901720)1 Ardinger R.H. and Murray J.C. (1988)
    367. Interleukin 2 toxin: a step toward selective immunomo dulation. (PubMed id 3124610)7 Murphy J.R....Strom T.B. (1988)
    368. Lymphocyte activation by HIV-1 envelope glycoprotein. (PubMed id 2843775)1 Kornfeld H....Center D.M. (1988)
    369. Stimulation of the beta-subunit of the IL-2 receptor induces MHC-unrestricted cytotoxicity in T acute lymphoblastic leukemia cells and normal thymocytes. (PubMed id 3135323)1 Colamonici O.R....Neckers L.M. (1988)
    370. Identification of lymphocyte integral membrane proteins as substrates for protein kinase C. Phosphorylation of the interleukin-2 receptor, class I HLA antigens, and T200 glycoprotein. (PubMed id 2941417)1 Shackelford D.A. and Trowbridge I.S. (1986)
    371. High level stable expression of human interleukin-2 receptors in mouse cells generates only low affinity interleukin-2 binding sites. (PubMed id 3097520)1 Cosman D.... Urdal D.L. (1986)
    372. Immunoelectron-microscopic localization of Tac antigen in adult T-cell leukemia/lymphoma. (PubMed id 2990220)1 Shamoto M....Uchiyama T. (1985)
    373. Interleukin 2 regulates its own receptors. (PubMed id 2983318)1 Smith K.A. and Cantrell D.A. (1985)
    374. Cloning, sequence and expression of human interleukin-2 receptor. (PubMed id 6096720)1 Cosman D....Urdal D. (1984)
    375. Cleavage of functional IL-2 receptor alpha chain (CD2 5) from murine corneal and conjunctival epithelia by MMP-9. (PubMed id 19878594)9 De Paiva C.S....Pflugfelder S.C. (2009)
    376. Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro. (PubMed id 1838146)9 Lai K.N....Lai F.M. (1991)
    377. IL-2 receptor (Tac antigen) protein expression is down-regulated by the 5'-untranslated region of the mRNA. (PubMed id 2351826)9 Weinberg A.D. and Swain S.L. (1990)
    378. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70). (PubMed id 2170270)9 Shindo T....Hitomi S. (1990)
    379. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis. (PubMed id 1875055)9 Ward M.M....Hall R.P. (1991)
    380. Serum level of soluble interleukin-2 receptor in patients with seasonal allergic rhinitis. (PubMed id 9122623)9 Ohashi Y....Nakai Y. (1997)
    381. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy. (PubMed id 8814045)9 Ohashi Y....Hayashi M. (1996)
    382. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow. (PubMed id 1371965)9 Gazzola M.V....Keever C.A. (1992)
    383. Subpopulations of fetal thymocytes defined by express ion of T cell receptor/CD3 and IL-2 receptor. CD3 and IL-2 receptor alpha-chain are expressed on reciprocal cell populations. (PubMed id 1824773)9 Guy R....Hodes R.J. (1991)
    384. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus. (PubMed id 2023217)9 Ward M.M....Pisetsky D.S. (1991)
    385. Soluble interleukin 2 receptors in autoimmune chronic active hepatitis. (PubMed id 2379874)9 Lobo-Yeo A....Vergani D. (1990)
    386. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus. (PubMed id 2208793)9 ter Borg E.J....Kallenberg C.G. (1990)
    387. Interleukin-1 alpha, interleukin-2, and soluble interleukin-2 receptors in polymyositis. (PubMed id 2369417)9 Wolf R.E. and Baethge B.A. (1990)
    388. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML. (PubMed id 19321337)9 Terwijn M....Schuurhuis G.J. (2009)
    389. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. (PubMed id 16284445)9 Takizawa K....Yamamoto K. (2005)
    390. Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia. (PubMed id 15756710)9 Kaleli I....Demir S. (2005)
    391. Blockade of intragraft IL-2 receptor-alpha by basiliximab is insufficient to prevent activation of liver graft infiltrating cells. (PubMed id 12727469)9 Kwekkeboom J....Metselaar H.J. (2003)
    392. Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients. (PubMed id 10806443)9 Martin C.M....Estevez E.C. (2000)
    393. Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters. (PubMed id 8731234)9 Spadaro A....Zoppini A. (1996)
    394. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression. (PubMed id 8866788)9 Lin J....Bromberg J.S. (1995)
    395. Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma. (PubMed id 8260527)9 Piccinini L....Barbieri F. (1993)
    396. Soluble interleukin-2 receptor levels in lupus nephritis. (PubMed id 1424303)9 Laut J....Glicklich D. (1992)
    397. In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies. (PubMed id 1281560)9 Noronha I.L....Waldherr R. (1992)
    398. Recombinant interleukin-4 promotes expression of the CD25 (Tac) antigen at the plasma membrane of high-density human tonsillar B lymphocytes. (PubMed id 2179130)9 Butcher R.D....Cushley W. (1990)
    399. Soluble interleukin 2 receptors in patients after bone marrow transplantation. (PubMed id 2207458)9 Siegert W....Huhn D. (1990)
    400. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer. (PubMed id 12402066)9 Sakata H....Hirayama R. (2002)
    401. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway. (PubMed id 11781710)9 Vockerodt M....Kube D. (2001)
    402. Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells. (PubMed id 8808460)9 Memoli B....Andreucci V.E. (1996)
    403. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. (PubMed id 8557519)9 Ryffel B....Woerly G. (1995)
    404. Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients. (PubMed id 8141226)9 Hurteau J.A....Mills G.B. (1994)
    405. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer. (PubMed id 7525035)9 Murakami S....Hashimoto T. (1994)
    406. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies. (PubMed id 7889544)9 Mantovani G....Pusceddu G. (1993)
    407. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle. (PubMed id 7670532)9 Kierszenbaum F....Sztein M.B. (1993)
    408. Soluble interleukin 2 receptors in patients with sarcoidosis. Possible origin. (PubMed id 1327664)9 Ina Y....Morishita M. (1992)
    409. Detection of canine interleukin-2 receptors by flow cytometry. (PubMed id 1632078)9 Somberg R.L....Felsburg P.J. (1992)
    410. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. (PubMed id 1402672)9 Arima N....Uchiyama T. (1992)
    411. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets. (PubMed id 1668858)9 Shahabuddin S. (1991)
    412. Induction of the interleukin-2 receptor (p55) by interferons. (PubMed id 1680935)9 Onji M....Ohta Y. (1991)
    413. The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitus. (PubMed id 1812996)9 Vialettes B....Vague P. (1991)
    414. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions] (PubMed id 2355670)9 Kojiro N....Kokubu T. (1990)
    415. Soluble interleukin-2 receptors in pulmonary tuberculosis. (PubMed id 2101408)9 Ito M....Kokubu T. (1990)
    416. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy d ogs and dogs with osteosarcoma. (PubMed id 20197202)9 Rissetto K.C....Reinero C.R. (2010)
    417. Long-term efficacy of induction therapy with anti-int erleukin-2 receptor antibodies or thymoglobulin compared with no induction ther apy in renal transplantation. (PubMed id 19100399)9 Taber D.J....Baliga P.K. (2008)
    418. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab. (PubMed id 17440057)9 Binder M....Trepel M. (2007)
    419. Tuning of T cell clone size and activation threshold by control of CD25 expression through mitogen-activated protein kinase pathways. (PubMed id 12021552)9 Bitegye C....Demotz S. (2002)
    420. Dysregulated expression of CD69 and IL-2 receptor alpha and beta chains on CD8+ T lymphocytes in flaky skin mice. (PubMed id 11114969)9 Abernethy N.J....Watson J.D. (2000)
    421. Contribution of the expression of ICAM-1, HLA-DR and IL-2R to the diagnosis of acute rejection in renal allograft aspirative cytology. (PubMed id 9664936)9 Ribeiro-David D.S....Ianhez I.E. (1998)
    422. Interleukin 2 receptor regulation and IL-2 function in the human infant. (PubMed id 9757943)9 Zola H....Macardle P.J. (1998)
    423. Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia. (PubMed id 9111583)9 Zhang X.L....Sakurai M. (1997)
    424. Induction of CD25 expression in human B lymphocytes by pharmacological activators of cellular signalling pathways. (PubMed id 9162220)9 McKay C.E. and Cushley W. (1996)
    425. Effect of rapamycin on the expression of the IL-2 receptor (CD25). (PubMed id 8565319)9 Woerly G....Ryffel B. (1996)
    426. Early calcium signaling and calcium requirements for the IL-2 receptor expression and IL-2 production in stimulated lymphocytes. (PubMed id 8912879)9 Komada H....Izutsu K. (1996)
    427. CD25-negative hairy cell leukaemia: intracytoplasmic detection of Tac antigen and interferon-induced surface expression. (PubMed id 7472778)9 Tison T....Poletti A. (1995)
    428. Interleukin-2 receptor expression in salivary glands of patients with Sjogren's syndrome. (PubMed id 7473471)9 Coll J....Corominas J. (1995)
    429. Altered gene transcription after burn injury results in depressed T-lymphocyte activation. (PubMed id 8092900)9 Horgan A.F....Rodrick M.L. (1994)
    430. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. (PubMed id 8455368)9 Noronha I.L....Waldherr R. (1993)
    431. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis. (PubMed id 8340196)9 Elias A.N....Rohan M.K. (1993)
    432. [Induction of gene (mRNA) expression of CD23, CD25 and CD4 on eosinophils by eosinophilopoietic growth lymphokines] (PubMed id 8492430)9 Chihara J. and Nakajima S. (1993)
    433. [Changes in expression of interleukin-2 and interleukin-2 receptor in lymphocytes in patients with burns] (PubMed id 1298528)9 Sun S.R. (1992)
    434. Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5). (PubMed id 1533800)9 Chihara J....Capron M. (1992)
    435. [Neopterin and interleukin 2 soluble receptors as biochemical markers of cellular immune response to surgical trauma] (PubMed id 1444001)9 Delogu G....Martinelli V. (1992)
    436. Phorbol esters up-regulate p55 and down-regulate p75 expression of interleukin-2 receptors in human T cells. (PubMed id 1581584)9 Onishi R....Uchiyama T. (1992)
    437. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease. (PubMed id 1541420)9 Schreiber S....MacDermott R.P. (1992)
    438. Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25). (PubMed id 1708315)9 Zola H....Rhodes D. (1991)
    439. Prothymosin alpha enhances interleukin 2 receptor expression in normal human T-lymphocytes. (PubMed id 1814846)9 Cordero O.J....Nogueira M. (1991)
    440. Soluble interleukin-2 receptor in sera of patients with Graves' disease. (PubMed id 1813855)9 Balazs C. and Farid N.R. (1991)
    441. Pentoxifylline and other methyl xanthines inhibit interleukin-2 receptor expression in human lymphocytes. (PubMed id 1709825)9 Rao K.M....Cohen H.J. (1991)
    442. Cell free serum interleukin-2 receptor levels after heart transplantation. (PubMed id 1958685)9 McNally C.M....Penny R. (1991)
    443. Soluble interleukin 2 receptor and tissue polypeptide antigen serum concentrations in end-stage renal failure. (PubMed id 2243570)9 Walz G....Distler A. (1990)
    444. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. (PubMed id 2113446)9 Matsubara T....Yabuta K. (1990)
    445. Interaction of bovine uterine luminal protein with in terleukin-2 and the interleukin-2 receptor of T lymphocytes. (PubMed id 2289014)9 Segerson E.C. and Libby D.W. (1990)
    446. Cellular source of soluble interleukin 2 receptors in serum of mice after recombinant interleukin 2 administration. (PubMed id 1715768)9 Wagner D.K....Nelson D.L. (1990)
    447. IL-5 up-regulates but IL-4 down-regulates IL-2R expression on a cloned B lymphoma line. (PubMed id 2295790)9 Yoshimoto T....Higashino K. (1990)
    448. Interleukin 2 receptor expression in renal biopsies and the diagnosis of acute allograft rejection. (PubMed id 16625964)9 Mathan A....Abraham G. (2006)
    449. Phenotypic and functional characterization of human CD25+ B cells. (PubMed id 16556269)9 Brisslert M....Tarkowski A. (2006)
    450. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection. (PubMed id 14997990)9 Gupta R.K....Sharma R.K. (2004)
    451. Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer. (PubMed id 11924909)9 Dickerson E.B....Helfand S.C. (2002)
    452. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer. (PubMed id 11961349)9 Murakami S....Hirayama R. (2002)
    453. Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation. (PubMed id 10950894)9 Koura T....Horie T. (2000)
    454. The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients. (PubMed id 10791856)9 Kawashima O....Morishita Y. (2000)
    455. Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies. (PubMed id 9166099)9 Nichols J....Schwartz G. (1997)
    456. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. (PubMed id 8856584)9 Bross D.A....Bousvaros A. (1996)
    457. The action of interleukin-2 receptor subunits defines a new type of signaling mechanism for hematopoietin receptors in hepatic cells and fibroblasts. (PubMed id 7713938)9 Morella K.K....Gearing D.P. (1995)
    458. T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. (PubMed id 7696095)9 Topaloglu R....Kansu E. (1994)
    459. Independent expression of p55 and p75 interleukin-2 r eceptors (IL-2R) during intravenous or subcutaneous administration of recombina nt interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells. (PubMed id 7522954)9 Zambello R....Semenzato G. (1994)
    460. Immunomodulation by interleukin-2 receptor targeted therapy. (PubMed id 8019399)9 Gupta D. and Naik S. (1994)
    461. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts. (PubMed id 8445947)9 Pizzolo G....Semenzato G. (1993)
    462. The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75). (PubMed id 1565844)9 Scheibenbogen C....Hunstein W. (1992)
    463. Induction of HLA class II antigen and interleukin 2 r eceptor expression in acute vascular rejection of human kidney allografts. (PubMed id 1585471)9 von Willebrand E....HAoyry P. (1992)
    464. Elevated level of soluble interleukin-2 receptor in bronchoalveolar lavage fluid from sarcoidosis patients. (PubMed id 1678021)9 Ogushi F....Honda M. (1991)
    465. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes. (PubMed id 1835747)9 Zambello R....Pizzolo G. (1991)
    466. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. (PubMed id 2022743)9 Boumpas D.T....Balow J.E. (1991)
    467. Immunodeficiency in ESRD-patients is linked to altered IL-2 receptor density on T cell subsets. (PubMed id 1668284)9 Stachowski J....Baldamus C.A. (1991)
    468. Expression of low-, intermediate-, and high-affinity IL-2 receptors on B cell lines derived from patients with undifferentiated lymphoma of Burkitt's and non-Burkitt's types. (PubMed id 2364438)9 Benjamin D....Colamonici O.R. (1990)
    469. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. (PubMed id 2298368)9 Mueller C....Zielinski C.C. (1990)
    470. Interleukin 2 receptors. (PubMed id 2201821)9 Allouche M....Georgoulias V. (1990)
    471. The interleukin-2 receptor on cord blood and nulliparous mononuclear cells is downregulated by maternal and cord blood serum. (PubMed id 2249873)9 Vanderbeeken Y.E....Lucas A. (1990)
    472. T cells in sputum of asthmatic patients are activated independently of disease severity or control. (PubMed id 19850398)9 LourenAso O....Taborda-Barata L. (2009)
    473. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review. (PubMed id 15691216)9 Nashan B. (2005)
    474. Efficacy of different targeting agents in the photolysis of interleukin-2 receptor bearing cells. (PubMed id 15542358)9 Linares R....Good T.A. (2004)
    475. [Changes of serum IL-1, IL-2R and TNF-alpha levels in divers after 150 m Heliox saturation -182 m excursion in the open sea diving] (PubMed id 14594044)9 Fang Y.Q....Yu F.T. (2003)
    476. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. (PubMed id 12911439)9 Madazli R....Tolun N. (2003)
    477. Growth inhibition of interleukin-2 receptor gene-transduced peripheral blood lymphocytes on human ovarian cancer cells. (PubMed id 11780319)9 Ye D....Cheng B. (2001)
    478. Soluble interleukin-2 receptor and interleukin-8 plas ma levels during and after cardiopulmonary bypass: correlations with creatine k inase and creatine kinase MB. (PubMed id 11467397)9 AlataA9 O....Tanriverdi B. (2001)
    479. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. (PubMed id 11474148)9 Dollner H....Austgulen R. (2001)
    480. Efficient depletion of alloreactive donor T lymphocyt es based on expression of two activation-induced antigens (CD25 and CD69). (PubMed id 10886218)9 Fehse B....Zander A.R. (2000)
    481. Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis. (PubMed id 10954656)9 Krueger J.G....Gottlieb A.B. (2000)
    482. Population pharmacokinetics and exposure-response rel ationships for basiliximab in kidney transplantation. The U.S. Simulect Renal T ransplant Study Group. (PubMed id 10573065)9 Kovarik J.M....Hall M.L. (1999)
    483. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor. (PubMed id 10573078)9 Woodward J.E....Baliga P. (1999)
    484. Triiodothyronine enhances expression of the interleukin-2 receptor alpha chain. (PubMed id 10503997)9 Nakanishi K....Onji M. (1999)
    485. Alterations of T-lymphocyte subsets, soluble IL-2 receptor, and IgE in peripheral blood of children with acute asthma attacks. (PubMed id 10069870)9 Shi H.Z....Jiang J.D. (1999)
    486. Cytokines in leprosy, I. Serum cytokine profile in leprosy. (PubMed id 9802682)9 Moubasher A.D....Raheem D.D. (1998)
    487. Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis. (PubMed id 9496694)9 Ohashi Y....Yamada K. (1998)
    488. Elevated soluble interleukin 2 receptor levels found among kidney transplant recipients. (PubMed id 9355841)9 Pickeral J.J....Nghiem D.D. (1997)
    489. Changes on receptor expression and production of interleukin-2 in circulating lymphocyte population after open heart surgery. (PubMed id 11360554)9 Luo A....Jin S. (1997)
    490. Immunological effects of the anti-IL-2 receptor monoc lonal antibody BT 563 in liver allografted patients. (PubMed id 8581408)9 Nashan B....Pichlmayr R. (1995)
    491. Circulating soluble IL-2 receptor levels are low in patients with hypothyroid autoimmune thyroiditis. (PubMed id 7875652)9 Loviselli A....Caradonna A. (1994)
    492. Transmembrane signaling by the interleukin-2 receptor: progress and conundrums. (PubMed id 8260651)9 Mills G.B....Truitt K.E. (1993)
    493. Serum interleukin-2 receptor levels in Hodgkin disease and other solid tumors of childhood. (PubMed id 8394483)9 Pui C.H....Crist W.M. (1993)
    494. Selection of internalization-deficient cells by inter leukin-2-Pseudomonas exotoxin chimeric protein: the cytoplasmic domain of the i nterleukin-2 receptor beta chain does not contribute to internalization of inte rleukin-2. (PubMed id 8258333)9 Furse R.K. and Malek T.R. (1993)
    495. Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor. (PubMed id 8425202)9 Kanakura Y....Matsuzawa Y. (1993)
    496. Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men. (PubMed id 8093435)9 Chopra R.K....Margolick J.B. (1993)
    497. Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease. (PubMed id 8477089)9 Ambrosetti A....Semenzato G. (1993)
    498. [Effect of hepatocellular carcinoma-specific transfer factor (HCC-S-TF) on IL-2 activity and IL-2R expression] (PubMed id 8200281)9 Pen G.Y. (1993)
    499. Expression of a functional c-kit receptor on a subset of natural killer cells. (PubMed id 7688785)9 Matos M.E....Caligiuri M.A. (1993)
    500. In vivo and in vitro productions of interleukin-2, interleukin-2 receptor and gamma-interferon in multitransfused thalassemic patients. (PubMed id 1626446)9 Hwang K.C....Lin K.H. (1992)
    501. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells. (PubMed id 1581211)9 Nakase K....Tsutani H. (1992)
    502. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells. (PubMed id 1588792)9 Sahraoui Y....Georgoulias V. (1992)
    503. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. (PubMed id 1362727)9 Chadburn A....Knowles D.M. (1992)
    504. Flow cytometric studies of IL-4-stimulated expression of the CD25 antigen by quiescent human B lymphocyte subpopulations. (PubMed id 1769698)9 Butcher R.D. and Cushley W. (1991)
    505. Effect of swainsonine on interleukin-2 alpha chain receptor expression and proliferation of human lymphocytes. (PubMed id 1904326)9 Myc A....Darzynkiewicz Z. (1991)
    506. Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A. (PubMed id 1864013)9 Yoshimura N....Imanishi J. (1991)
    507. The effects of blockade of interleukin 2 receptors and interleukin 4 receptors on cytokine production. (PubMed id 1904250)9 Lai K.N....Ritter M.A. (1991)
    508. Effect of UVB plus tar therapy on serum levels of interleukin-2 receptors in patients with psoriasis. (PubMed id 1794191)9 Betti R....Crosti C. (1991)
    509. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. (PubMed id 1968925)9 Martinez O.M....Aronson F.R. (1990)
    510. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis. (PubMed id 2171882)9 Keicho N....Yotsumoto H. (1990)
    511. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. (PubMed id 2258606)9 Honda M....Kishimoto T. (1990)
    512. Expression of serum IL-2, IL-2R, and CD8 levels during hyposensitization in house-dust-sensitive asthmatics. (PubMed id 2122966)9 Tsai L.C....Tsai S.J. (1990)
    513. Distributional characteristics of CD25 and CD127 on C D4+ T cell subsets in chronic HCV infection. (PubMed id 20204427)9 Shen T....Liu S. (2010)
    514. The role of IL-2 and soluble IL-2R in depression and antidepressant response. (PubMed id 19579169)9 Eller T....Maron E. (2009)
    515. Early serum interleukin-8 evaluation may prove useful in localizing abnormally implanted human gestations after in vitro fertilization. (PubMed id 18249366)9 Morelli S.S....Noyes N. (2008)
    516. Analysis of cytokine levels in human lymphangiomas. (PubMed id 18468411)9 Wiegand S....Folz B.J. (2008)
    517. The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure. (PubMed id 17497476)9 Kadiroglu A.K....Yilmaz M.E. (2007)
    518. Alemtuzumab induction in deceased donor kidney transp lantation. (PubMed id 17984833)9 Huang E....Bunnapradist S. (2007)
    519. Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib. (PubMed id 16835747)9 Kanazawa S....Nomura S. (2006)
    520. Antitumor action of lymphokin-activated cells of patients with soft tissue sarcomas and melanomas in dependence on expression of MHC classes I and II antigenes. (PubMed id 17080018)9 Berezhnaya N.M....Baranovich V.V. (2006)
    521. Sequential blood level monitoring of basiliximab duri ng multisession plasmapheresis in a kidney transplant recipient. (PubMed id 15848561)9 Nojima M....Shima H. (2005)
    522. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. (PubMed id 15792187)9 Davutoglu V....Aksoy M. (2005)
    523. Experimental isolation and transplantation of hepatoc ytes with the use of antibody against interleukin-2 receptor (daclizumab) as im munosuppressive agent. (PubMed id 15919507)9 Tsiolis I....Papadimitriou I. (2005)
    524. Recombinant Der p 1 and Der f 1 with in vitro enzymatic activity to cleave human CD23, CD25 and alpha1-antitrypsin, and in vivo IgE-eliciting activity in mice. (PubMed id 15947475)9 Takai T....Ogawa H. (2005)
    525. Evidence for a dual pathway of activation in CD43-stimulated Th2 cells: differential requirement for the Lck tyrosine kinase. (PubMed id 15237112)9 Fernandez-Cabezudo M.J....al-Ramadi B.K. (2004)
    526. Cytokine profile and nitric oxide levels in sera from patients with brucellosis. (PubMed id 15517081)9 Refik M....Ersoy Y. (2004)
    527. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. (PubMed id 12745543)9 Kart L....Ozesmi M. (2003)
    528. Associations among plasma selenium, zinc, copper, and iron concentrations and immunoregulatory cytokine levels in patients with cutaneous leishmaniasis. (PubMed id 12666825)9 Kocyigit A....Gurel M.S. (2002)
    529. The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits. (PubMed id 12467977)9 Kierszenbaum F....Sztein M.B. (2002)
    530. Low serum levels of CD44, CD44v6, and neopterin indicate immune dysfunction in chronic pancreatitis. (PubMed id 11668200)9 Schlosser W....Beger H.G. (2001)
    531. Serum interleukin-15 is elevated in systemic lupus erythematosus. (PubMed id 11511756)9 Aringer M....Graninger W.B. (2001)
    532. The role of immune activation in endotoxin-induced atherogenesis. (PubMed id 11717590)9 Wiedermann C.J....Willeit J. (2001)
    533. Evaluation of selected parameters of the cytokine system in burn wounds in children. (PubMed id 10663844)9 Andrzejewska E. and Niewiadomska H. (2000)
    534. Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response. (PubMed id 11027188)9 Fallon E.M. and Lauffenburger D.A. (2000)
    535. Effect of parathyroid adenoma excision on interleukin-6 (IL-6) and IL-2 receptor levels. (PubMed id 10690943)9 Halabe A. and Shohat B. (2000)
    536. Improvement of lymphocyte proliferation in human immu nodeficiency virus infection after recombinant interleukin-2 treatment. (PubMed id 10576122)9 Afzelius P....Hansen J.E. (1999)
    537. Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes. (PubMed id 10211553)9 Riesbeck K. (1999)
    538. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. (PubMed id 10389289)9 Huang Y.S....Lee S.D. (1999)
    539. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in BehAset's disease. (PubMed id 10651074)9 Kosar A....DA1ndar S. (1999)
    540. Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis. (PubMed id 9865756)9 Ohashi Y....Hayashi M. (1998)
    541. Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. (PubMed id 9736739)9 David D....ThA"ze J. (1998)
    542. [Study on cellular immunity in children with respiratory syncytial virus associated acute lower respiratory infection] (PubMed id 15617344)9 Chen Z....Li G. (1997)
    543. Ouabain effects on activated lymphocytes: augmentatio n of CD25 expression on TPA-stimulated cells and of CD69 on PHA-and TPA-stimula ted cells. (PubMed id 9306153)9 Pires V....Rumjanek V.M. (1997)
    544. Suppression of dialysis patients' lymphocyte IL-2R ex pression by glucocorticoids and cyclosporine. (PubMed id 9245491)9 Briggs W.A....Burdick J.F. (1997)
    545. Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn's disease. (PubMed id 9159031)9 Lee H.B....Ahn D.S. (1997)
    546. Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. (PubMed id 9014956)9 Segal J.L....Brunnemann S.R. (1997)
    547. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. (PubMed id 9045904)9 Carson W.E....Caligiuri M.A. (1997)
    548. Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study. (PubMed id 8881918)9 Chan E.Y....Zola H. (1996)
    549. [IL-2, IL-2R mRNA gene expression and protein production] (PubMed id 9275499)9 Li Y....Qiu C.C. (1996)
    550. Trifluoperazine reduces the expression of CD69 in phytohemagglutinin-activated lymphocytes. (PubMed id 8736111)9 Pires V....Rumjanek V.M. (1996)
    551. Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers. (PubMed id 8617977)9 Coventry B.J....Skinner J.M. (1996)
    552. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). (PubMed id 8733879)9 Heuer M....Scherbaum W.A. (1996)
    553. AML blasts variably express interleukin 2 receptor alpha, beta or gamma chains without measurable effects on proliferation, cytokine message expression or surface expression of adhesion molecules upon stimulation with interleukin 2. (PubMed id 7637393)9 Weidmann E....Mitrou P.S. (1995)
    554. Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. (PubMed id 8562975)9 Mantovani G....Del Giacco G.S. (1995)
    555. Co-operative effect between insulin-like growth factor-1 and interleukin-2 on DNA synthesis and interleukin-2 receptor-alpha chain expression in human lymphocytes. (PubMed id 7493771)9 Schillaci R....RoldA!n A. (1995)
    556. Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis. (PubMed id 7702403)9 Crilly A....Madhok R. (1995)
    557. Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells. (PubMed id 8535662)9 Paietta E....Wiernik P.H. (1995)
    558. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. (PubMed id 7594483)9 Lin W.C....Whiteside T.L. (1995)
    559. Interleukin-2 as a neuroregulatory cytokine. (PubMed id 8806016)9 Hanisch U.K. and Quirion R. (1995)
    560. Differential soluble interleukin-2R levels in bilater al bronchoalveolar lavage after single lung transplantation. (PubMed id 7865531)9 Ross D.J....Jordan S.C. (1994)
    561. Detection of urinary interleukin-2, interleukin-2 receptor, and tumor necrosis factor levels in patients with superficial bladder tumors after intravesical BCG immunotherapy. (PubMed id 8116114)9 Balbay D....Remzi D. (1994)
    562. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. (PubMed id 7699643)9 Madson K.L....Osborn T.G. (1994)
    563. IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T cells. Distinct requirement for costimulatory signals through adhesion molecules. (PubMed id 8120374)9 Lagoo A.S....Hardy K.J. (1994)
    564. IL-10 enhances expression of the IL-2 receptor alpha chain on T cells. (PubMed id 7835955)9 Cohen S.B....Londei M. (1994)
    565. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts. (PubMed id 8061361)9 Loertscher R....Quinn T. (1994)
    566. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells. (PubMed id 8206753)9 Batuman O.A....Pomerantz R.J. (1994)
    567. Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. (PubMed id 7679684)9 Park C.S....Lee H.B. (1993)
    568. Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth. (PubMed id 8217083)9 Lin W.C....Whiteside T.L. (1993)
    569. Kinetics of human T-cell expression of LFA-1, IL-2 receptor, and ICAM-1 following antigenic stimulation in vitro. (PubMed id 7707342)9 Hviid L....Theander T.G. (1993)
    570. Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritis. (PubMed id 8258242)9 Kullich W. (1993)
    571. Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with the IL-2 receptor beta-subunit. (PubMed id 7693677)9 Kirken R.A....Farrar W.L. (1993)
    572. Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain. (PubMed id 7681595)9 Voss S.D....Robb R.J. (1993)
    573. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy. (PubMed id 8476907)9 Jordan S.C....Trento A. (1993)
    574. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors. (PubMed id 8509130)9 Chu J.W. and Sharom F.J. (1993)
    575. Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells. (PubMed id 8431210)9 Sfikakis P.P....Panayiotidis P.P. (1993)
    576. Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. (PubMed id 8358720)9 LeMaistre C.F....Woodworth T. (1993)
    577. [Immune activity and serum interleukin-2-receptor concentration in autoimmune thyroid diseases] (PubMed id 8243248)9 Wagner R....Reinwein D. (1993)
    578. Stimulated cellular immune system in patients with congestive heart failure. (PubMed id 8490055)9 Fuchs D....Wachter H. (1993)
    579. [The effect of IL-2 on IL-2 production and on the IL-2R expression of spleen cell from mice infected with M. tuberculosis H37Rv] (PubMed id 8242814)9 Shan W.S. (1993)
    580. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. (PubMed id 8450329)9 Mathiesen T....von Holst H. (1993)
    581. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells. (PubMed id 1472476)9 Mills G.B....Greene W.C. (1992)
    582. Pattern of the action of a suppressor factor produced by a human macrophage-like cell line, U937. (PubMed id 1398777)9 Ohnishi K....Kishimoto S. (1992)
    583. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. (PubMed id 1601521)9 Vitolo D....Whiteside T.L. (1992)
    584. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra). (PubMed id 1535451)9 Conti P....Dempsey R.A. (1992)
    585. Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression. (PubMed id 1612749)9 Blanchard D.K....Djeu J.Y. (1992)
    586. Two distinct P70 interleukin-2 receptors on a murine large granular lymphocyte clone Y479. (PubMed id 1791035)9 Takemoto H....Ide M. (1991)
    587. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation. (PubMed id 2017664)9 Hashimoto S....Michalski J.P. (1991)
    588. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? (PubMed id 2062256)9 Smith R.S. (1991)
    589. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI). (PubMed id 1774603)9 Reddy M.M....Grieco M.H. (1991)
    590. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. (PubMed id 1848580)9 Krause D.S. and Deutsch C. (1991)
    591. Interleukin-4 regulates the interleukin-2 receptors on human peripheral blood B lymphocytes. (PubMed id 2004488)9 Tomizawa K....Matsumoto S. (1991)
    592. Changes of intracellular IP3 with the expression of interleukin 2 receptor in human peripheral blood T lymphocytes. (PubMed id 1816420)9 Li P.L. (1991)
    593. Blood lymphocyte proliferation, cytokine secretion an d appearance of T cells with activation surface markers in cultures with Helico bacter pylori. Comparison of the responses of subjects with and without antibod ies to H. pylori. (PubMed id 1900743)9 Karttunen R. (1991)
    594. Intrathecal immune response in patients with the post-polio syndrome. (PubMed id 1651456)9 Sharief M.K....Ciardi M. (1991)
    595. Kappa B-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation. (PubMed id 1768652)9 Molitor J.A....Greene W.C. (1991)
    596. Proliferative responses induced by the activation of protein kinase C during the development of human T lymphocytes. (PubMed id 1991483)9 GonzA!lez-FernA!ndez A....GambA^n Deza F. (1991)
    597. [Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions] (PubMed id 2112909)9 Matsubara T. (1990)
    598. Both dendritic cells and monocytes induce autologous and allogeneic T cells receptive to interleukin 2. (PubMed id 2137256)9 Vakkila J. and Hurme M. (1990)
    599. Activation of human T lymphocytes by phorbol-12,13-dibutyrate and ionomycin. (PubMed id 2320954)9 Larsen C.S. (1990)
    600. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil. (PubMed id 2213757)9 Clements P.J....Furst D.E. (1990)
    601. Normal expression of p55 interleukin 2 receptor (CD25) by lymphocytes from former blood donors seropositive for human T lymphotropic virus. (PubMed id 1700938)9 Prince H.E. and Jackson A.L. (1990)
    602. IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells. (PubMed id 2329278)9 Lee H.K....Choi Y.S. (1990)
    603. An associated molecule, p64, with high-affinity interleukin 2 receptor. (PubMed id 2085489)9 Takeshita T....Sugamura K. (1990)
    604. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. (PubMed id 2101599)9 Choy M.Y....MacDonald T.T. (1990)
    605. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding. (PubMed id 2105168)9 Rigby W.F....Waugh M.G. (1990)
    606. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. (PubMed id 2208797)9 Mahida Y.R....Hawkey C.J. (1990)
    607. Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin. (PubMed id 2114831)9 Takematsu H. and Tagami H. (1990)
    608. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection. (PubMed id 1696861)9 Allouche M....Georgoulias V. (1990)
    609. Predictors of renal dysfunction at 1 year in heart tr ansplant patients. (PubMed id 20405579)9 Navarro-ManchA^n J....Salvador Sanz A. (2010)
    610. Evidence that cervical cancer cells secrete IL-2, whi ch becomes an autocrine growth factor. (PubMed id 20227890)9 Rangel-Corona R....Weiss-Steider B. (2010)
    611. The effect of IL-28A on human cord blood CD4+ T cells . (PubMed id 20148705)9 Arasteh J....Farahmandian T. (2010)
    612. Short-term anti-CD25 monoclonal antibody administrati on down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation. (PubMed id 19141125)9 Wang Z....Wang Q. (2009)
    613. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation. (PubMed id 19935462)9 Sampaio M.S....Bunnapradist S. (2009)
    614. [Development of genetic engineering regulatory T cell s mediated by the self-inactivating lentiviral vectors] (PubMed id 19954640)9 Cao J....Xu K.L. (2009)
    615. Increased frequency and compromised function of T reg ulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and T GFbeta expression. (PubMed id 19543397)9 Radstake T.R....Lafyatis R. (2009)
    616. Role of extracellular calcium ions at early stages of human T-lymphocyte polyclonal activation in vitro. (PubMed id 19364320)9 Litvinov I.S....Kirpichnikov M.P. (2009)
    617. The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases. (PubMed id 19250272)9 Jiskra J....LacinovA! Z. (2009)
    618. Soluble interleukin-2 receptor and tumor necrosis fac tor levels in depressed patients in Estonia. (PubMed id 20173400)9 Eller T....Vasar V. (2009)
    619. Could cytokines levels or adhesion molecules expression be predictor of IFN-beta treatment response in multiple sclerosis patients? (PubMed id 18396372)9 Sega S....Ihan A. (2008)
    620. Psychological stress, endocrine and immune response in patients with lichen planus. (PubMed id 18986442)9 Krasowska D....RoliA8ski J. (2008)
    621. Spotlight on anti-CD25: daclizumab in MS. (PubMed id 18808743)9 Schippling D.S. and Martin R. (2008)
    622. Reduction of plasma levels of soluble tumor necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column. (PubMed id 19140848)9 Lentz M. and Kumar K. (2008)
    623. Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. (PubMed id 18569641)9 Capriotti E....Hess A.D. (2008)
    624. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. (PubMed id 18199598)9 Zhang B....Lipsky P.E. (2008)
    625. Evidence that human serum with high levels of estroge ns interferes with immune system both by decreasing CD25 expression on T-cell a nd by increasing interleukin-2 availability. (PubMed id 19050329)9 MacciA^ A....Mantovani G. (2008)
    626. Upregulation of molecules associated with T-regulatory function by thymoglobulin pretreatment of human CD4+ cells. (PubMed id 19034013)9 Liu Z....Xu H. (2008)
    627. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. (PubMed id 18923710)9 Milne K....Nelson B.H. (2008)
    628. Platelet storage time and cytokine (IL-2R, IL-8, TNF-alpha) levels. (PubMed id 17546909)9 Bayraktaroglu Z....GA1l E. (2007)
    629. Severe FOXP3+ and naive T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. (PubMed id 17484867)9 Zuber J....Bandeira A. (2007)
    630. Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. (PubMed id 17389732)9 Rolland Y.M....Morley J.E. (2007)
    631. Effect of leptin on activation and cytokine synthesis in peripheral blood lymphocytes of malnourished infected children. (PubMed id 17355247)9 RodrA-guez L....Ortiz R. (2007)
    632. Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus. (PubMed id 16864902)9 Pereira F.O....Medeiros Y.S. (2006)
    633. Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist. (PubMed id 16565744)9 Funke V.A....Pasquini R. (2006)
    634. Cytokine alterations in lichen sclerosus: an immunohistochemical study. (PubMed id 17034521)9 Farrell A.M....Wojnarowska F. (2006)
    635. [Preparation of placental-eluted gamma globulin and its immunosuppressive effect in vitro and in vivo] (PubMed id 16800936)9 Liu F. and Lu D.P. (2006)
    636. Effect of partially hydrolyzed soluble glucan produced by glucosyltrasferases of Streptococcus mutans on stimulating human T cell. (PubMed id 16614478)9 Choi I....Lee E.H. (2006)
    637. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. (PubMed id 16504995)9 Sanders J.S....Stegeman C.A. (2006)
    638. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease. (PubMed id 16669958)9 Creed T.J....Dayan C.M. (2006)
    639. Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation. (PubMed id 16980068)9 Kamar N....Budde K. (2006)
    640. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides. (PubMed id 16451200)9 Li X....Li Z. (2006)
    641. A divalent human leukocyte antigen-B7 fusion-protein up-regulates CD25 and CD69 in alloreactive CD8+ T cells bypassing CD28 costimulation. (PubMed id 16699464)9 Rickert U....Zavazava N. (2006)
    642. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. (PubMed id 16603634)9 Van Assche G....Shames R.S. (2006)
    643. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. (PubMed id 17028180)9 Chen C....Wells A.D. (2006)
    644. Daclizumab: humanized monoclonal antibody to the inte rleukin-2 receptor. (PubMed id 20476985)9 Pescovitz M.D. (2005)
    645. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. (PubMed id 15695127)9 Nijm J....Jonasson L. (2005)
    646. A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma. (PubMed id 15811959)9 Foss F....DiVenuti G. (2005)
    647. Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123. (PubMed id 15528977)9 Si M.S....Borie D.C. (2005)
    648. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection. (PubMed id 16166750)9 Rouschop K.M....Florquin S. (2005)
    649. Gene expression analysis of the CD4+ T-cell clones derived from gingival tissues of periodontitis patients. (PubMed id 16238600)9 Ito H....Yamazaki K. (2005)
    650. [TNF-alpha and soluble interleukin-2 receptor and glomerular sclerosis in primary nephrotic syndrome in children] (PubMed id 16060083)9 Pogan A....MiezyA8ski W. (2005)
    651. Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract. (PubMed id 16043986)9 Straumann A....Simon H.U. (2005)
    652. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. (PubMed id 16425355)9 Zekri A.R....Abu-Shady M.A. (2005)
    653. In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101. (PubMed id 15953089)9 Shohat M....David M. (2005)
    654. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy. (PubMed id 16162103)9 Stalder M....Morris R.E. (2005)
    655. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis? (PubMed id 16171525)9 Gur A....Sarac A.J. (2005)
    656. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. (PubMed id 16088321)9 LuczyA8ski W....Malinowska I. (2005)
    657. Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy. (PubMed id 15488124)9 Wang Z....He J. (2004)
    658. The inhibitory role of lactacystin and beta-lactacystin on T-cell activation and proliferation. (PubMed id 14970908)9 Song P.H....Wu J. (2004)
    659. The effects of laparascopic cholecystectomy operation on C-reactive protein, hormones, and cytokines. (PubMed id 15129803)9 Sari R. and Sevinc A. (2004)
    660. Effects of selenium on peripheral blood mononuclear cell membrane fluidity, interleukin-2 production and interleukin-2 receptor expression in patients with chronic hepatitis. (PubMed id 15526380)9 He S.X....Qiao W. (2004)
    661. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis. (PubMed id 15211436)9 Kawasaki Y....Suzuki H. (2004)
    662. Effect of interleukin-7 and -15 on activation of purified umbilical cord blood and adult peripheral blood CD4+ T cells. (PubMed id 14631159)9 Lin S.J. and Cheng P.J. (2004)
    663. [Effect of kidney-warming and astringent therapy on plasma endothelin and interleukin-2 receptor in patients with nephrotic syndrome] (PubMed id 15339495)9 Lu H....Wang C.L. (2004)
    664. Markedly elevated levels of inflammatory cytokines in maternal serum and peritoneal washing during arrested labor. (PubMed id 15005783)9 Abramov Y....Barak V. (2004)
    665. Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. (PubMed id 15105393)9 Fasouliotis S.J....Rosenwaks Z. (2004)
    666. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes] (PubMed id 15346634)9 HorA!k P....Scudla V. (2004)
    667. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. (PubMed id 14760073)9 Ladanyi A....Timar J. (2004)
    668. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori. (PubMed id 15164624)9 Mehmet N....Yildirim B. (2004)
    669. Expression of an active p110 catalytic subunit of phosphatidylinositol 3-kinase alters the proliferative capacity of interleukin-2 receptor signals. (PubMed id 12969321)9 Gala S....Williamson P. (2003)
    670. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. (PubMed id 12661993)9 Ziegenhagen M.W....MA1ller-Quernheim J. (2003)
    671. Decreased renal excretion of soluble interleukin-2 re ceptor alpha after treatment with daclizumab. (PubMed id 12846768)9 ter Meulen C.G....Hoitsma A.J. (2003)
    672. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. (PubMed id 12672048)9 Simon H.U....Levi-Schaffer F. (2003)
    673. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency. (PubMed id 12877452)9 Lin S.J....Yan D.C. (2003)
    674. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. (PubMed id 12892739)9 Li Z....Nussenblatt R.B. (2003)
    675. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. (PubMed id 12749440)9 Soriano D....Darai E. (2003)
    676. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. (PubMed id 14639362)9 Georgiannos S.N....Sheaff M. (2003)
    677. Differential gene expression of cytokine and cell surface molecules in T cell subpopulation derived from mammary gland secretion of cows. (PubMed id 14750552)9 Asai K....Kumagai K. (2003)
    678. Vascular expression of adhesion molecules in acute an d chronic rejection of kidney allografts. (PubMed id 19774735)9 JurciA8 V. and Ferluga D. (2003)
    679. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. (PubMed id 12689974)9 Adu D....Wheatley K. (2003)
    680. The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study. (PubMed id 12619182)9 GA1r A....SaraAs A.J. (2003)
    681. Activation of the inflammatory response system in autism. (PubMed id 11803234)9 Croonenberghs J....Maes M. (2002)
    682. Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. (PubMed id 11895146)9 Schauder P....Schenk H.D. (2002)
    683. Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment. (PubMed id 12394376)9 Romaldini C.C....CanAsado E.L. (2002)
    684. Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-kappaB activation. (PubMed id 12389026)9 Prasad A.S....Sarkar F.H. (2002)
    685. Arginine butyrate increases the cytotoxicity of DAB(389)IL-2 in leukemia and lymphoma cells by upregulation of IL-2Rbeta gene. (PubMed id 12443879)9 Shao R.H....Foss F.M. (2002)
    686. Serum cytokine levels in Bell's palsy. (PubMed id 11997069)9 Yilmaz M....Kanlikama M. (2002)
    687. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study] (PubMed id 11979748)9 Ohno H....Uchiyama T. (2002)
    688. Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis. (PubMed id 12150485)9 Tsao T.C....Tsao K.C. (2002)
    689. Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens. (PubMed id 12563472)9 Antas P.R....Sampaio E.P. (2002)
    690. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma. (PubMed id 11904739)9 Wakao D....Bessho M. (2002)
    691. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. (PubMed id 11431768)9 Davenport M....Howard E.R. (2001)
    692. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. (PubMed id 11246052)9 Caforio A.L....McKenna W.J. (2001)
    693. Microinvasive Nd:YAG laser therapy of early glottic carcinoma and its effect on soluble interleukin-2 receptor, interleukin-2, and natural killer cells. (PubMed id 11568609)9 Lai J.P....Betz C.S. (2001)
    694. Efficacy and tolerability of interleukin-2 receptor b lockade with basiliximab in pediatric renal transplant recipients. (PubMed id 11472610)9 Vester U....Hoyer P.F. (2001)
    695. Immune function, telomerase, and angiogenesis in pati ents with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features. (PubMed id 11745200)9 Toomey D....Bouchier-Hayes D. (2001)
    696. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. (PubMed id 11330541)9 Garrity E.R....Vigneswaran W.T. (2001)
    697. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. (PubMed id 11120395)9 Maes M....Neveu P.J. (2001)
    698. Complex perioperative immuno-dysfunction in patients with renal cell carcinoma. (PubMed id 11490228)9 BAPhm M....Allhoff E.P. (2001)
    699. Soluble interleukin-2 receptor and interleukin-4 in sera of asthmatic children before and after a prednisolone course. (PubMed id 11289331)9 Tang R.B. and Chen S.J. (2001)
    700. T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis. (PubMed id 11231343)9 van Riemsdijk I.C....Weimar W. (2001)
    701. Upregulation of IFN-gamma and soluble interleukin-2 receptor release and altered serum cortisol and prolactin concentration during general anesthesia. (PubMed id 11710990)9 Brand J.M....Kirchner H. (2001)
    702. LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity. (PubMed id 11359803)9 Ni H.T....Mescher M.F. (2001)
    703. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. (PubMed id 11683970)9 Orhan I....ArdiAsoglu A. (2001)
    704. Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production. (PubMed id 11238664)9 Corrigall V.M....Panayi G.S. (2001)
    705. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis. (PubMed id 11247328)9 Lee Y.J....Song Y.W. (2001)
    706. A functional role for interleukin (IL)-4-driven cyclic amp accumulation in human b lymphocytes. (PubMed id 10843754)9 McKay C.E....Cushley W. (2000)
    707. Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. (PubMed id 10700427)9 Berner B....Reuss-Borst M.A. (2000)
    708. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours. (PubMed id 10755214)9 Komorowski J....StepieA8 H. (2000)
    709. [Monoclonal interleukin-2 receptor antibodies and the ir use in clinical kidney transplantation: basiliximab and daclizumab] (PubMed id 11059309)9 Madsen M. and Svendsen U.G. (2000)
    710. Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody. (PubMed id 10844492)9 Owen C.M. and Harrison P.V. (2000)
    711. Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery. (PubMed id 10659917)9 Alvarez-de-la-Rosa M....Gonzalez Gonzalez A. (2000)
    712. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease. (PubMed id 10953974)9 Kami M....Muto Y. (2000)
    713. Compensatory effect of TNFalpha on low natural killer activity in the elderly. (PubMed id 11051195)9 MyA9liwska J....MyA9liwski A. (2000)
    714. T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation. (PubMed id 10931379)9 Perola O....Pelkonen J. (2000)
    715. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. (PubMed id 11130570)9 Murta E.F....Bighetti S. (2000)
    716. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. (PubMed id 10919040)9 TA1lek N....Yildiz M. (2000)
    717. [The effect of 6 week treatment with theophylline on spirometric parameters, nonspecific bronchial reactivity and the concentration of soluble interleukin 2 receptor in serum of asthmatic patients] (PubMed id 10946603)9 WroA8ska J....Droszcz W. (2000)
    718. Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events. (PubMed id 11147695)9 Goebel J....Roszman T.L. (2000)
    719. Activation of the interleukin 2 receptor: a possible role for tyrosine phosphatases. (PubMed id 10889465)9 Ellery J.M....Nicholls P.J. (2000)
    720. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology. (PubMed id 10942367)9 Akin C....Metcalfe D.D. (2000)
    721. Regulation of lymphocyte proliferation by uterine serpin: interleukin-2 mRNA production, CD25 expression and responsiveness to interleukin-2. (PubMed id 10632964)9 Peltier M.R....Hansen P.J. (2000)
    722. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes. (PubMed id 10958860)9 Heinschink A....Muller M.M. (2000)
    723. Gene expression of inflammatory mediators in different chambers of the human heart. (PubMed id 10969681)9 Valen G....Vaage J. (2000)
    724. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. (PubMed id 10976007)9 Cava F....GonzA!lez-Buitrago J.M. (2000)
    725. Activation of peripheral blood T cells by interaction and migration through endothelium: role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15. (PubMed id 9920837)9 Sancho D....Sanchez-Madrid F. (1999)
    726. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery. (PubMed id 10037026)9 Witthuhn B.A....Uckun F.M. (1999)
    727. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. (PubMed id 10579621)9 Aboulghar M.A....Shaarawy M. (1999)
    728. Expression of interleukin-2 receptor, CD25, on CD4 lymphocytes in response to varicella-zoster virus antigen among patients with malignancies immunized with live attenuated varicella vaccine. (PubMed id 10200133)9 Oitani K. (1999)
    729. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies. (PubMed id 10063270)9 Chen C.K....Huang S.C. (1999)
    730. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica. (PubMed id 10090303)9 Ung A....Hildesheim A. (1999)
    731. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. (PubMed id 10227112)9 Akiyama K. (1999)
    732. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with BehAset's disease and Vogt-Koyanagi-Harada's disease. (PubMed id 10342043)9 Uchio E....Ohno S. (1999)
    733. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. (PubMed id 10418750)9 Berthier F....Bienvenu J. (1999)
    734. Clinical application of maternal serum cytokine determination in premature rupture of membranes--interleukin-6, an early predictor of neonatal infection? (PubMed id 10535339)9 Pfeiffer K.A....Krebs D. (1999)
    735. Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. (PubMed id 10418818)9 Grosser M....MA1ller M. (1999)
    736. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway. (PubMed id 10097788)9 Kilic M....Markert U.R. (1999)
    737. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. (PubMed id 10408971)9 Lombardi V.R....Cacabelos R. (1999)
    738. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from subjects coinfected with human immunodeficiency virus and Leishmania infantum. (PubMed id 9988338)9 Nigro L....Nunnari A. (1999)
    739. Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study). (PubMed id 10629645)9 Demir G....Berkarda B. (1999)
    740. Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. (PubMed id 9683554)9 Smeets T.J....Tak P.P. (1998)
    741. Activated lymphocytes (CD25+ CD69+ cells) and decreased CD19+ cells in well-nourished chronic alcoholics without ethanol-related diseases. (PubMed id 9660319)9 Sacanella E....Urbano-MA!rquez A. (1998)
    742. Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. (PubMed id 9528846)9 Viviani S....Bonadonna G. (1998)
    743. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma] (PubMed id 9732831)9 PAcrez Encinas M....Cadarso C. (1998)
    744. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. (PubMed id 9855088)9 Messmann H....SchAPlmerich J. (1998)
    745. Interleukin-15 as a potential regulator of the innate immune response. (PubMed id 9686173)9 Carson W. and Caligiuri M.A. (1998)
    746. Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus. (PubMed id 9586675)9 Itoh M....Ohashi H. (1998)
    747. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. (PubMed id 9428817)9 Vincenti F....Burdick J. (1998)
    748. Serum neopterin, beta2-microglobulin, soluble interleukin-2 receptors, and immunoglobulin levels in healthy adolescents. (PubMed id 9714695)9 Satoh T....Tollerud D.J. (1998)
    749. Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. (PubMed id 9725205)9 Dooms H....Grooten J. (1998)
    750. Activation and proliferation of CD8+ T cells in lymph oid tissues of HIV-1-infected individuals in the absence of the high-affinity I L-2 receptor. (PubMed id 9833741)9 Brinchmann J.E....Spurkland A. (1998)
    751. Specific immunotherapy downregulates peripheral blood CD4 and CD8 T-lymphocyte activation in grass pollen-sensitive asthma. (PubMed id 9657564)9 Majori M....Pesci A. (1998)
    752. Expression of activation surface markers, interleukin-2 synthesis and apoptosis rate in fresh or cultured lymphocytes from HIV-infected children. (PubMed id 9745333)9 Voiculescu C....Turculeanu A. (1998)
    753. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. (PubMed id 9108409)9 Mori A....Okudaira H. (1997)
    754. The soluble interleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis. (PubMed id 9058629)9 Balzano A....Castello G. (1997)
    755. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. (PubMed id 9325019)9 De Jongh R....Heylen R. (1997)
    756. Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts. (PubMed id 9422405)9 Kovarik J....Soulillou J.P. (1997)
    757. A selective impairment of the IL-2 system in lymphocytes of patients with glioblastomas: increased level of soluble IL-2R and reduced protein tyrosine phosphorylation. (PubMed id 9326745)9 Ashkenazi E....Brodie C. (1997)
    758. The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression. (PubMed id 9073589)9 Geiselhart L.A....Freed B.M. (1997)
    759. [Effects of mitogens on the expression of interleukin-2 receptor and the cytotoxicity of human monocytes] (PubMed id 15622621)9 Chen J. and Dong H. (1997)
    760. Trimetazidine does not modify blood levels and immuno suppressant effects of cyclosporine A in renal allograft recipients. (PubMed id 9431838)9 Simon N....Tillement J.P. (1997)
    761. Effect of 5-fluorouracil on interleukin-1 and interle ukin-2 receptor expression. (PubMed id 9238541)9 Balaji K.N. and Nayak R. (1997)
    762. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma. (PubMed id 9407562)9 Lanz M.J....White C.W. (1997)
    763. Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. (PubMed id 9373194)9 Trentin L....Semenzato G. (1997)
    764. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. (PubMed id 9274442)9 Mantovani G....Del Giacco G.S. (1997)
    765. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone] (PubMed id 9396353)9 Yagi Y....Nakamura Y. (1997)
    766. Phenotypic differences between human blood monocyte subpopulations in psoriasis and atopic dermatitis. (PubMed id 9241965)9 Zheng M. and Mrowietz U. (1997)
    767. Quantification of IL-2 and IL-2 receptor mRNA in peripheral blood mononuclear cells by the RT-PCR based SHARP Signal system. (PubMed id 9287242)9 Lee B.N....Reuben J.M. (1997)
    768. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. (PubMed id 8978293)9 Zambello R....Semenzato G. (1997)
    769. Selective expression of the interleukin-2 gene discriminates between the auto- and allo-mixed lymphocyte reaction. (PubMed id 9106332)9 Moudgil A....Jordan S.C. (1997)
    770. Expression of adhesion molecules and activation markers on lymphocytes and monocytes during hemodialysis. (PubMed id 9087813)9 Braun N. (1997)
    771. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain. (PubMed id 9129156)9 Adachi M....Imai K. (1997)
    772. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis. (PubMed id 9101499)9 Nassonov E.L....Fuchs D. (1997)
    773. Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls. (PubMed id 9329587)9 Micke O....Willich N. (1997)
    774. Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. (PubMed id 9130649)9 Wesch D....Kabelitz D. (1997)
    775. Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma. (PubMed id 8660801)9 Saito S....Morikawa H. (1996)
    776. Inflammatory and immunological markers in preterm infants: correlation with disease. (PubMed id 8809148)9 Jurges E.S. and Henderson D.C. (1996)
    777. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis. (PubMed id 8981529)9 Lu Y....Brauner A. (1996)
    778. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels. (PubMed id 8730122)9 Polisson R.P....Simon L.S. (1996)
    779. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. (PubMed id 8752945)9 Agostini C....Semenzato G. (1996)
    780. T-cell activation, expression of adhesion molecules and response to ethanol in alcoholic cirrhosis. (PubMed id 8803617)9 Santos-Perez J.L....Gutierrez-Gea F. (1996)
    781. [Effect of dexamethasone on the human interleukin-2 receptor alpha chain gene expression] (PubMed id 9208595)9 Guan Z....Shen Y. (1996)
    782. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration] (PubMed id 8779781)9 Tanaka K....Oizumi K. (1996)
    783. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients. (PubMed id 8915517)9 Frydecka I. and Mazur G. (1996)
    784. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. (PubMed id 8734356)9 Kennedy M.K. and Park L.S. (1996)
    785. Interleukin-7 receptor expression in cutaneous T-cell lymphomas. (PubMed id 8915148)9 Bagot M....Wechsler J. (1996)
    786. Prognostic potential of cytokines, nitrates, and APACHE II score in sepsis. (PubMed id 8879360)9 Bencosme A....Verme C. (1996)
    787. Mite-specific induction of interleukin-2 receptor on T lymphocytes from children with mite-sensitive asthma: modified immune response with immunotherapy. (PubMed id 8621854)9 Bonno M....Sakurai M. (1996)
    788. [Study on the level of soluble interleukin-2 receptor, expression of membrane interleukin-2 receptor and T lymphocyte subpopulations in pulmonary tuberculosis] (PubMed id 9275389)9 Liu C....Xing S. (1996)
    789. The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells. (PubMed id 8702434)9 Hernandez-Garcia C....Jover J.A. (1996)
    790. Soluble CD40 ligand induces expression of CD25 and CD23 in resting human tonsillar B lymphocytes. (PubMed id 8647169)9 Burlinson E.L....Cushley W. (1996)
    791. Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer. (PubMed id 8693411)9 Izzo F....Castello G. (1996)
    792. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. (PubMed id 8678641)9 Deng M.C....Scheld H.H. (1996)
    793. Flow cytometric characterisation of the 'false naive' (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis. (PubMed id 8853229)9 Neidhart M....BrA1hlmann P. (1996)
    794. Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers. (PubMed id 8602457)9 Khalfoun B....Lebranchu Y. (1996)
    795. An upregulation of interleukin-2 receptor, transferrin receptor expression and cytokine production mediated by hemin in human peripheral blood mononuclear cells. (PubMed id 8776616)9 Tsuji A....Nakamura H. (1996)
    796. Correlation of serum interleukin-2 receptor-alpha levels with clinical manifestations in pulmonary tuberculosis. (PubMed id 8796256)9 Rajalingam R....Singla R. (1996)
    797. Submicromolar La3+ concentrations block the calcium release-activated channel, and impair CD69 and CD25 expression in CD3- or thapsigargin-activated Jurkat cells. (PubMed id 8611174)9 Aussel C....Breittmayer J.P. (1996)
    798. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma. (PubMed id 8907203)9 Filella X....Ballesta A.M. (1996)
    799. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (PubMed id 8651123)9 Munger M.A....Gilbert E.M. (1996)
    800. Serum levels of interleukin-2 receptor (CD 25) in patients with Hodgkin's disease, with special reference to age and prognosis. (PubMed id 7710984)9 Enblad G....Glimelius B. (1995)
    801. A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. (PubMed id 7813103)9 Davies K.A....Walport M.J. (1995)
    802. Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression. (PubMed id 7558935)9 HernA!ndez-Caselles T....Aparicio P. (1995)
    803. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain. (PubMed id 7834394)9 Lederman M.M....Goldberg D. (1995)
    804. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. (PubMed id 7639234)9 Nielsen O.H....Kirman I. (1995)
    805. Evaluation by histology, immunohistology and PCR of p rotocollized renal biopsies 1 week post-transplant in relation to subsequent re jection episodes. (PubMed id 7566615)9 Kooijmans-Coutinho M.F....van der Woude F.J. (1995)
    806. Serum levels of soluble interleukin-2 receptor in asthma patients. (PubMed id 7559266)9 Motojima S....Makino S. (1995)
    807. Immune responsiveness in orthopedic surgery patients after transfusion of autologous or allogeneic blood. (PubMed id 7740607)9 Tietze M....Kirchner H. (1995)
    808. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma] (PubMed id 7933620)9 Setoyama Y....Uchiyama T. (1994)
    809. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. (PubMed id 7923917)9 Kahaly G....Dienes H.P. (1994)
    810. High concentration of soluble interleukin-2 receptors in ejaculate with low sperm motility. (PubMed id 8046017)9 Shimonovitz S....Ron M. (1994)
    811. Immune activation during infancy in healthy humans. (PubMed id 8195312)9 Cummins A.G....Roberton D.M. (1994)
    812. High cytokine serum levels in patients with autoimmune hemolytic anemia (AIHA). (PubMed id 7851962)9 Fagiolo E....Pozzetto U. (1994)
    813. Lymphocyte subpopulations in patients with primary fibromyalgia. (PubMed id 7869321)9 Hernanz W....Sanchez B. (1994)
    814. Increased concentrations of neopterin in carotid atherosclerosis. (PubMed id 8060386)9 Weiss G....Wachter H. (1994)
    815. Cell kinetic analysis of interleukin-2 receptor-tested chronic lymphocytic leukemia using the AgNOR silver stain. (PubMed id 8135185)9 Mourad W.A....Keating M.J. (1994)
    816. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis. (PubMed id 7809492)9 Tsutsumi T....Izumi T. (1994)
    817. Impaired erythropoietin responsiveness in anaemic rheumatoid arthritis patients: potential relation to immune mechanisms. (PubMed id 8033517)9 Stockenhuber F....Balcke P. (1994)
    818. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions. (PubMed id 8047718)9 Chiang C.S....Chu J.J. (1994)
    819. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sezary syndrome. (PubMed id 8113839)9 Foss F.M....Sausville E.A. (1994)
    820. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis. (PubMed id 7911833)9 van den Brink H.R....Bijlsma J.W. (1994)
    821. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. (PubMed id 7528668)9 Nielsen M....Odum N. (1994)
    822. Induction of cell surface interleukin 2 receptor alpha chain expression on non-T lymphoid leukemia cells. (PubMed id 7526079)9 Nakase K....Tsudo M. (1994)
    823. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. (PubMed id 7956620)9 Quiroga J.A....CarreA+o V. (1994)
    824. The effect of azathioprine on serum levels of interleukin 6 and soluble interleukin 2 receptor. (PubMed id 8165444)9 Crilly A....Madhok R. (1994)
    825. Serotonin-stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factor. (PubMed id 7514199)9 Katz M.F....Beer D.J. (1994)
    826. Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1. (PubMed id 7496937)9 Matsuda J....Kinoshita T. (1994)
    827. T lymphocyte activation in Graves' disease. (PubMed id 7995258)9 Marazuela M....Alvarez-Mon M. (1994)
    828. Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study. (PubMed id 8080984)9 Foss F.M....Woodworth T. (1994)
    829. Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma. (PubMed id 8131525)9 Matsumoto K....Takagi K. (1994)
    830. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer. (PubMed id 8157196)9 Gadducci A....Facchini V. (1994)
    831. [Increase of interleukin-2 soluble receptors in multiple sclerosis: preliminary study in 26 patients] (PubMed id 7826250)9 Tilbery C.P....Scheinberg M.A. (1994)
    832. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells. (PubMed id 8090033)9 Tsilivakos V....Georgoulias V. (1994)
    833. Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone. (PubMed id 8067791)9 Greally P....Price J.F. (1994)
    834. V delta 1 gene usage, interleukin-2 receptors and adhesion molecules on gamma delta+ T cells in inflammatory diseases of the nervous system. (PubMed id 7507498)9 Mix E....Link H. (1994)
    835. Secretion of a novel T-lymphocyte cytokine possessing both chemotactic and growth factor activity by serotonin-stimulated human aortic endothelial cells. (PubMed id 8174633)9 Katz M.F....Farber H.W. (1994)
    836. Restricted cytokine expression in rheumatoid arthritis. (PubMed id 8318038)9 Chen E....Fish E.N. (1993)
    837. MHC class II molecules deliver costimulatory signals in human T cells through a functional linkage with IL-2-receptors. (PubMed id 8515060)9 Odum N....Svejgaard A. (1993)
    838. Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis. (PubMed id 7693581)9 Yacyshyn B.R. (1993)
    839. Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis. (PubMed id 8431208)9 Harrington L....Hoffman S. (1993)
    840. Zinc supplementation stimulates tetanus antibody formation and soluble interleukin-2 receptor levels in chronic hemodialysis patients. (PubMed id 8374246)9 Holtkamp W....Falkner C. (1993)
    841. Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome. (PubMed id 8508408)9 Ambrosetti A....Maggi E. (1993)
    842. In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment. (PubMed id 8398338)9 Vitolo D....Whiteside T.L. (1993)
    843. Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum. (PubMed id 8227305)9 Confalonieri P....Mantegazza R. (1993)
    844. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. (PubMed id 8393676)9 Barrera P....van der Meer J.W. (1993)
    845. [The number, distribution and effects of interleukin-2 receptor and CD4 antigens in benign and malignant lymphoproliferative diseases] (PubMed id 8340084)9 Liu W....Zhang Z. (1993)
    846. Soluble interleukin-2 receptor in sputum from patients with bronchial asthma. (PubMed id 8507158)9 Motojima S....Makino S. (1993)
    847. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. (PubMed id 8443817)9 Alexander J.P....Bukowski R.M. (1993)
    848. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. (PubMed id 8255102)9 Beguin Y....Fillet G. (1993)
    849. Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification. (PubMed id 8457472)9 Schwonzen M....Diehl V. (1993)
    850. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma. (PubMed id 8494993)9 Kalmanti M....Kalmantis T. (1993)
    851. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8. (PubMed id 8308770)9 Dooley M.A....Pisetsky D.S. (1993)
    852. The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation. (PubMed id 8318457)9 Perkins G.R....Collins M.K. (1993)
    853. Soluble receptors for tumor necrosis factor: occurrence in association with normal delivery at term. (PubMed id 8395036)9 Austgulen R....Espevik T. (1993)
    854. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. (PubMed id 8311539)9 Matsumoto T. and Iwasaki K. (1993)
    855. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. (PubMed id 8506943)9 Tesch H....Diehl V. (1993)
    856. Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy. (PubMed id 8350327)9 Kirkham B.W....Panayi G.S. (1993)
    857. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro. (PubMed id 8095271)9 Giordano C....Galluzzo A. (1993)
    858. Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble interleukin-2 receptor, and interleukin-6 in asthmatic children. (PubMed id 8238800)9 Van Bever H.P....Stevens W.J. (1993)
    859. [Urine levels of soluble interleukin 2 receptor and free light chain immunoglobulins in lupus nephritis] (PubMed id 8143195)9 Ling S.H. (1993)
    860. Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins. (PubMed id 1398765)9 Bonnefoy-Berard N....Revillard J.P. (1992)
    861. An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate -affinity IL-2 receptor complex. (PubMed id 1545122)9 Takeshita T....Sugamura K. (1992)
    862. Differential effect of tumour necrosis factor on human thymocyte subpopulations. (PubMed id 1526653)9 MuA+oz-FernA!ndez M.A....Fresno M. (1992)
    863. Soluble interleukin-2 receptors in children with juvenile chronic arthritis. (PubMed id 1376493)9 Fassbender K....MA1ller W. (1992)
    864. Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HI V-1) infection. (PubMed id 1430108)9 Zambello R....Semenzato G. (1992)
    865. Circulating activated T lymphocytes in autoeczematization. (PubMed id 1599265)9 Kasteler J.S....Zone J.J. (1992)
    866. New markers in serum for lymphocyte activation for predicting allograft rejection. Neopterin and soluble interleukin-2 receptor. (PubMed id 1563242)9 Carlson I.H. (1992)
    867. Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cells. (PubMed id 1405755)9 Sahraoui Y....Georgoulias V. (1992)
    868. Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levels. (PubMed id 1346344)9 Li B....Suthanthiran M. (1992)
    869. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma. (PubMed id 1333270)9 Gause A....Pfreundschuh M. (1992)
    870. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein). (PubMed id 1737371)9 List J....Grimm E.A. (1992)
    871. Case report: distinctive immune abnormalities in a patient with procainamide-induced lupus and serositis. (PubMed id 1371640)9 Klimas N.G....Fletcher M.A. (1992)
    872. Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen-specific T helper clones. T cell receptor/CD3 complex transmits CD4-dependent and CD4-independent signals. (PubMed id 1534818)9 Oyaizu N....Pahwa S. (1992)
    873. Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas. (PubMed id 1289190)9 Stasi R....Papa G. (1992)
    874. Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis. (PubMed id 1405353)9 Yokoyama H....Kobayashi K. (1992)
    875. Interleukin 2 receptor membrane bound and in soluble form in the aqueous humor and peripheral blood of patients with acute untreated uveitis. (PubMed id 1433001)9 Scheinberg M.A....Mota I.M. (1992)
    876. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis. (PubMed id 1593571)9 Wolf R.E....Adams S.B. (1992)
    877. Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus. (PubMed id 1582127)9 Airo P....Cattaneo R. (1992)
    878. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. (PubMed id 1477183)9 Fox F.E....Nowell P.C. (1992)
    879. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. (PubMed id 1477299)9 Carrieri P.B....Perrella O. (1992)
    880. Soluble interleukin-2 receptor levels in patients with malignant melanoma and renal cell cancer. (PubMed id 1632975)9 Ostenstad B. (1992)
    881. Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes. (PubMed id 1462123)9 Waalen K....rre O. (1992)
    882. Variable expression of the interleukin-2 receptor alpha chain and MYC genes in lymphocytes from renal cell carcinoma patients treated with interleukin-2. (PubMed id 1511423)9 Hayat K....Goyns M.H. (1992)
    883. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. (PubMed id 1394222)9 Weidmann E....Whiteside T.L. (1992)
    884. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease. (PubMed id 1635294)9 Kogiso M....Mimura Y. (1992)
    885. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. (PubMed id 1430106)9 Beckham J.C....Weinberg J.B. (1992)
    886. Tumour necrosis factor receptor distribution in human lymphoid tissue. (PubMed id 1663076)9 Ryffel B....Gudat F. (1991)
    887. Evidence that genistein, a protein-tyrosine kinase inhibitor, inhibits CD28 monoclonal-antibody-stimulated human T cell proliferation. (PubMed id 1847252)9 Atluru S. and Atluru D. (1991)
    888. Dynamics of soluble interleukin-2 receptor levels imm ediately after heart transplantation. Attenuation of increase by OKT3 therapy. (PubMed id 1858157)9 Windsor N.T....Lawrence E.C. (1991)
    889. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. (PubMed id 1902614)9 Musolino C....Squadrito G. (1991)
    890. Syncytiotrophoblast plasma membrane inhibits membrane expression of activation markers on PHA-stimulated human lymphocytes. (PubMed id 1753387)9 Degenne D....Bardos P. (1991)
    891. Sequential interleukin 2 and interleukin 2 receptor levels distinguish rejection from cyclosporine toxicity in liver allograft recipients. (PubMed id 2039359)9 Simpson M.A....Monaco A.P. (1991)
    892. Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancy. (PubMed id 1874577)9 Bacha P.A....Nichols J.C. (1991)
    893. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus. (PubMed id 1680190)9 Raziuddin S....al-Wabel A.A. (1991)
    894. Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease. (PubMed id 1832452)9 McFarlane C.G. and Meikle M.C. (1991)
    895. Effect of alpha-IFN on cytokine-induced antigen expre ssion and secretion of TNF, LT and IgM in HCL. (PubMed id 1921451)9 Hassan I.B....SundstrAPm C. (1991)
    896. Elevated levels of soluble interleukin 2 receptor and tumor necrosis factor in nasopharyngeal carcinoma. (PubMed id 1747228)9 Hsu M.M....Chang Y.L. (1991)
    897. Severe head injury: effect upon cellular immune function. (PubMed id 1675441)9 Quattrocchi K.B....Wagner F.C. (1991)
    898. Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptor. (PubMed id 1903212)9 Jensen H.S....Bendtzen K. (1991)
    899. Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. (PubMed id 1934593)9 North M.E....Farrant J. (1991)
    900. Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease. (PubMed id 1683085)9 Nakanishi K....Ohta Y. (1991)
    901. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. (PubMed id 1889695)9 Schreiber S....Nash G.S. (1991)
    902. Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. (PubMed id 1998956)9 Schiller J.H....Voss S.D. (1991)
    903. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels. (PubMed id 1684468)9 Kapp A....SchAPpf E. (1991)
    904. Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis. (PubMed id 1716642)9 Fesenmeier J.T....Walker D.P. (1991)
    905. Increased level of soluble interleukin-2 receptor in sera of patients with Graves' disease. (PubMed id 1760523)9 BalA!zs C.S. (1991)
    906. [A study on interleukin 2 and soluble interleukin 2 receptor in serum and bronchoalveolar lavage fluid from patients with farmer's lung] (PubMed id 1770680)9 Ninomiya Y....Konishi K. (1991)
    907. Regulatory mechanisms for the expression of a functional beta chain of interleukin 2 receptor on T4 chronic lymphocytic leukemia cells. (PubMed id 1764265)9 Maeda Y....Takatsuki K. (1991)
    908. Fibronectin augments anti-CD3-mediated IL-2 receptor (CD25) expression on human peripheral blood lymphocytes. (PubMed id 1826861)9 Cardarelli P.M....Morgan E.L. (1991)
    909. Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. (PubMed id 1902247)9 Brown A.E....White N.J. (1991)
    910. Elevation of cyclic adenosine monophosphate levels independently down regulates IL-1, IL-2, and IL-2 receptor (CD25) syntheses. (PubMed id 2177038)9 Iwaz J....Revillard J.P. (1990)
    911. Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis. (PubMed id 2313471)9 Carpenter A.B....Ip S.H. (1990)
    912. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS. (PubMed id 2127261)9 Reddy M.M....Grieco M.H. (1990)
    913. Activation of resting human T cells requires prolonged stimulation of protein kinase C. (PubMed id 2315321)9 Berry N....Nishizuka Y. (1990)
    914. Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes. (PubMed id 2110548)9 Rodriguez M.A....Abadi I. (1990)
    915. Lymphokine-regulated differential expression of mRNA for p75kDa-IL-2R and p55kDa-IL-2R in a cloned B lymphoma line (BLC1-CL-3 cells). (PubMed id 2117031)9 Nakanishi K....Higashino K. (1990)
    916. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase. (PubMed id 2172380)9 Trevillyan J.M....Bjorndahl J.M. (1990)
    917. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. (PubMed id 1690915)9 Woo J....Thomson A.W. (1990)
    918. Proliferation, interleukin-2 production and receptor expression in peripheral blood mononuclear cells from colorectal cancer patients. (PubMed id 1974593)9 Chang K.J....Chen K.M. (1990)
    919. Selective suppression of lymphokine production by human hybridoma suppressor factor (HSF). (PubMed id 2125575)9 Tomita Y....Cathcart M.K. (1990)
    920. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. (PubMed id 2113934)9 Griffin D.E....Cornblath D.R. (1990)
    921. Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 111 in coeliac disease. (PubMed id 2228030)9 Penttila I.A....LaBrooy J.T. (1990)
    922. Serum levels of soluble interleukin-2 receptor in pulmonary tuberculosis. (PubMed id 2271510)9 Choi S.J....Kim D.S. (1990)
    923. Interleukin-2, soluble interleukin-2 receptor and tumor necrosis factor in sera from patients with rheumatoid arthritis. (PubMed id 2075380)9 Corvetta A....Danieli G. (1990)
    924. Cyclosporin A inhibits the interleukin 2 receptor alp ha chain gene transcription but not its cell surface expression: the alpha chai n stability can explain this discrepancy. (PubMed id 2269327)9 HAcmar A. and Dautry-Varsat A. (1990)
    925. Immunoregulatory functions of paf-acether. III. Down- regulation of CD4+ T cells high-affinity IL-2 receptor expression. (PubMed id 1969884)9 Dulioust A....Thomas Y. (1990)
    926. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes. (PubMed id 2146981)9 Zambello R....Semenzato G. (1990)
    927. Expression of cell-surface transferrin receptor following in vitro stimulation of peripheral blood lymphocytes in patients with beta-thalassaemia and iron-deficiency anaemia. (PubMed id 2328791)9 Pattanapanyasat K. (1990)
    928. The effect of carbimazole therapy on interleukin 2, interleukin 2 receptors and free radicals. (PubMed id 2129783)9 Wilson R....Thomson J.A. (1990)
    929. Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation. (PubMed id 2138932)9 Stuber G....Klein E. (1990)
    930. Elevated levels of soluble interleukin-2 receptors in tuberculous pleural effusions. (PubMed id 2331910)9 Ito M....Kokubu T. (1990)
    931. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells. (PubMed id 2145171)9 MoirAc N....Senik A. (1990)
    932. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. (PubMed id 1970229)9 Corrigan C.J. and Kay A.B. (1990)
    933. Time-course studies of immediate and delayed immune r eactivity in patients with atopic dermatitis treated with herbal drugs. (PubMed id 1705106)9 SA...Thestrup-Pedersen K. (1990)
    934. Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity. (PubMed id 2359067)9 Rubin L.A....Keystone E.C. (1990)
    935. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. (PubMed id 1967191)9 Fahey J.L....Giorgi J.V. (1990)
    936. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. (PubMed id 2242792)9 WA1thrich B....Grob P.J. (1990)
    937. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. (PubMed id 2397608)9 Famularo G....Tonietti G. (1990)
    938. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. (PubMed id 2260855)9 Adachi K....Araki S. (1990)
    939. Ciclosporin-induced immunosuppression in vitro. II. Variation in sensitivity and binding capacity. (PubMed id 2382107)9 Povlsen J.V....Lamm L.U. (1990)
    940. IL-1 and IL-4 as reciprocal regulators of IL-2 induced lymphocyte cytotoxicity. (PubMed id 1699593)9 Ebina N....Golub S.H. (1990)
    941. Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis. (PubMed id 2118434)9 Zielinski C.C....MA1ller C. (1990)
    942. Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. (PubMed id 2317223)9 Degiannis D....Raska K. (1990)
    943. Surface markers on human activated T lymphocytes. IV. Comparison of high-affinity E-rosette receptor expression with the expression of other activation markers (receptor for interleukin 2, MHC class II (antigens). (PubMed id 1718236)9 Kontny E. and Ryzewska A. (1990)
    944. Cyclosporin A inhibits induction of IL-2 receptor alp ha chain expression by affecting activation of NF-kB-like factor(s) in cultured human T lymphocytes. (PubMed id 2129797)9 Brini A.T....Farrar W.L. (1990)
    945. Defects in IL-2R signaling contribute to diminished m aintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 di abetic subjects. (PubMed id 19875613)9 Long S.A....Buckner J.H. (2010)
    946. Foxp3-transduced polyclonal regulatory T cells suppre ss NK cell functions in a TGF-beta dependent manner. (PubMed id 20166879)9 Zhou H....Zou P. (2010)
    947. Intragraft expression of the IL-10 gene is up-regulat ed in renal protocol biopsies with early interstitial fibrosis, tubular atrophy , and subclinical rejection. (PubMed id 20150436)9 Hueso M....SerA^n D. (2010)
    948. Aberrant cytokines/chemokines production correlate wi th proteinuria in patients with overt diabetic nephropathy. (PubMed id 20138168)9 Wu C.C....Lin Y.F. (2010)
    949. [Early diagnosis and treatment of invasive pulmonary aspergillosis following kidney transplantation] (PubMed id 20356494)9 Wang W....Zhang X.D. (2010)
    950. Regulatory function of cytomegalovirus-specific CD4+C D27-CD28- T cells. (PubMed id 20034645)9 Tovar-Salazar A....Weinberg A. (2010)
    951. Sarcoidosis following Cushing's syndrome: A report of two cases and review of the literature. (PubMed id 20162506)9 Schaefer S....Kann P.H. (2010)
    952. Tec protein tyrosine kinase inhibits CD25 expression in human T-lymphocyte. (PubMed id 19883687)9 Susaki K....Ishida T. (2010)
    953. Genetic variants in human CLOCK associate with total energy intake and cytokine sleep factors in overweight subjects (GOLDN populati on). (PubMed id 19888304)9 Garaulet M....Ordovas J.M. (2010)
    954. Prolonged interleukin-2Ralpha expression on virus-spe cific CD8+ T cells favors terminal-effector differentiation in vivo. (PubMed id 20096608)9 Kalia V....Ahmed R. (2010)
    955. Oxytocin both increases proliferative response of per ipheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppress ive estrogen activity. (PubMed id 20363988)9 MacciA^ A....Mantovani G. (2010)
    956. Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. (PubMed id 19864382)9 Juffroy O....Chakrabarti L.A. (2010)
    957. Anti-IL-6 receptor antibody suppressed T cell activat ion by inhibiting IL-2 production and inducing regulatory T cells. (PubMed id 20184875)9 Yoshida H....Mihara M. (2010)
    958. Calcineurin inhibitor-related cholestasis complicatin g lung transplantation. (PubMed id 20417810)9 Oto T....Miyoshi S. (2010)
    959. Long-term follow-up of patients with moderate aplasti c anemia and pure red cell aplasia treated with daclizumab. (PubMed id 20207845)9 Sloand E.M....Young N.S. (2010)
    960. The first autopsy case of pandemic influenza (A/H1N1p dm) virus infection in Japan: detection of a high copy number of the virus in t ype II alveolar epithelial cells by pathological and virological examination. (PubMed id 20093768)9 Nakajima N....Sata T. (2010)
    961. Immune response parameters during labor and early neo natal life. (PubMed id 20133986)9 Protonotariou E....Sarandakou A. (2010)
    962. The serum levels of soluble interleukin-2 receptor al pha and lactate dehydrogenase but not of B2-microglobulin correlate with select ed clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas. (PubMed id 19693535)9 Bien E....Balcerska A. (2010)
    963. [Intravascular large B-cell lymphoma with pontine inv olvement successfully treated with R-hyper-CVAD/R-MTX-Ara-C regimen] (PubMed id 20379108)9 Nakazato T....Kakimoto T. (2010)
    964. Cross-reactivity of anti-human, anti-porcine and anti -bovine cytokine antibodies with cetacean tissues. (PubMed id 20163803)9 Jaber J.R....FernA!ndez A. (2010)
    965. Soluble TRAIL prevents RANTES-dependent restenosis af ter percutaneous coronary intervention in patients with coronary artery disease . (PubMed id 19533303)9 Satoh D....Nomura S. (2010)
    966. Engineered interleukin-2 antagonists for the inhibiti on of regulatory T cells. (PubMed id 19816193)9 Liu D.V....Wittrup K.D. (2009)
    967. [Regulatory T cells in children with acute lymphoblas tic leukaemia] (PubMed id 19648661)9 Stasiak-Barmuta A....SzymaA8ski M. (2009)
    968. How do regulatory T cells work? (PubMed id 19751267)9 Corthay A. (2009)
    969. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupu s patients regulatory T cells? (PubMed id 19821980)9 Yang H.X....Zhang X. (2009)
    970. HSCT recipients have specific tolerance to MSC but no t to the MSC donor. (PubMed id 19561533)9 Sundin M....Blanc K.L. (2009)
    971. The mechanism of chemokine receptor 9 internalization triggered by interleukin 2 and interleukin 4. (PubMed id 19567201)9 Tong X....Zhang Q. (2009)
    972. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. (PubMed id 18804210)9 Kabagambe E.K....Arnett D.K. (2009)
    973. Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inh ibit CD4 T cell survival: regulation by theaflavins. (PubMed id 19812686)9 Chattopadhyay S....Das T. (2009)
    974. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. (PubMed id 18771523)9 Braitch M....Constantinescu C.S. (2009)
    975. A case of membranous nephropathy associated with chronic sinusitis. (PubMed id 19384848)9 Kanazawa I....Sugimoto T. (2009)
    976. KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis. (PubMed id 19304328)9 Goris A....Dubois B. (2009)
    977. Basiliximab induction therapy in kidney transplantati on: benefits for long term allograft function after 10 years? (PubMed id 19707395)9 Koch M....Nashan B. (2009)
    978. A Phase II trial of Denileukin Diftitox in patients w ith previously treated advanced non-small cell lung cancer. (PubMed id 19433964)9 Gerena-Lewis M....Jazieh A.R. (2009)
    979. Daclizumab in treatment of multiple sclerosis patients. (PubMed id 19136546)9 Ali E.N....Khoury S.J. (2009)
    980. Soluble interleukin-2 receptor retains prognostic val ue in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy. (PubMed id 19074749)9 Ennishi D....Hatake K. (2009)
    981. [Activation processes in the lymphocytes of patients with latent sensitization] (PubMed id 19382620)9 (2009)
    982. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. (PubMed id 19160404)9 Ebbens F.A....Fokkens W.J. (2009)
    983. Follicular dendritic cell sarcoma of small intestine with aberrant T-cell marker expression. (PubMed id 19883432)9 Yamada Y....Matsuno Y. (2009)
    984. Amniotic membrane transplantation induces apoptosis i n T lymphocytes in murine corneas with experimental herpetic stromal keratitis. (PubMed id 19255156)9 Bauer D....Heiligenhaus A. (2009)
    985. ATG-induced expression of FOXP3 in human CD4(+) T cel ls in vitro is associated with T-cell activation and not the induction of FOXP3 (+) T regulatory cells. (PubMed id 19822903)9 Broady R....Levings M.K. (2009)
    986. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. (PubMed id 19301261)9 Wong V.K....Liu L. (2009)
    987. Evaluation of receptor expression on immune system ce lls in the peripheral blood of asthmatic children undergoing food challenges. (PubMed id 19571570)9 Krogulska A....Chrul S. (2009)
    988. Preoperative statin treatment reduces systemic inflam matory response and myocardial damage in cardiac surgery. (PubMed id 19581104)9 MartA-nez-Comendador J.M....Bengochea J. (2009)
    989. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabe tes. (PubMed id 19547759)9 A8uczyA8ski W....GA^rska M. (2009)
    990. Crossreactivity of antibodies to canine CD25 and Foxp 3 and identification of canine CD4+CD25 +Foxp3+ cells in canine peripheral bloo d. (PubMed id 20046022)9 Mizuno T....Okuda M. (2009)
    991. Analysis of 19 genes for association with type I diab etes in the Type I Diabetes Genetics Consortium families. (PubMed id 19956106)9 Howson J.M....Todd J.A. (2009)
    992. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). (PubMed id 19410243)9 Cao T....Li L. (2009)
    993. Levels of proinflammatory cytokines and hs-CRP in pat ients with homozygous familial hypercholesterolaemia. (PubMed id 20058505)9 Gokalp D....Bahceci S. (2009)
    994. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. (PubMed id 19325510)9 Castillo L. and Carcillo J. (2009)
    995. Calcineurin inhibitor sparing immunosuppressive regim ens in kidney allograft recipients. (PubMed id 19579814)9 Baczkowska T. and Durlik M. (2009)
    996. Conversion from calcineurin inhibitor to mycophenolat e mofetil-based immunosuppression changes the frequency and phenotype of CD4+FO XP3+ regulatory T cells. (PubMed id 19352129)9 Demirkiran A....van der Laan L.J. (2009)
    997. Efficient induction and expansion of human alloantige n-specific CD8 regulatory T cells from naive precursors by CD40-activated B cel ls. (PubMed id 19684082)9 Zheng J....Tu W. (2009)
    998. The influence of human papillomavirus type and HIV st atus on the lymphomononuclear cell profile in patients with cervical intraepith elial lesions of different severity. (PubMed id 19689792)9 GonAsalves M.A....Donadi E.A. (2009)
    999. Peripheral CD4+CD8+cells are the activated T cells ex pressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th 1/Th2 cytokines. (PubMed id 19616200)9 Xie D....Zhang J. (2009)
    1000. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. (PubMed id 19242524)9 Wolfe D....Fink D.J. (2009)
    1001. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. (PubMed id 19414743)9 Lin J.T....Wu L. (2009)
    1002. Effects of 5-FU on DNA synthesis and cytotoxicity of human lymphocytes induced by IL-2, TGF-beta3 and PGE2. (PubMed id 19846930)9 Eisenthal A....Skornick Y. (2009)
    1003. [Characteristics of autoimmune reactions in chronic c ardiac failure of different etiology] (PubMed id 19514417)9 Zykov K.A....Belenkov I.u.N. (2009)
    1004. New immunosuppressive agents and risk for invasive fu ngal infections. (PubMed id 19857382)9 Maschmeyer G. and Patterson T.F. (2009)
    1005. [Case of pulmonary tuberculosis with miliary granules , mediastinal lymph node enlargement and elevation of soluble interleukin-2 rec eptor] (PubMed id 19588853)9 Tabata H....Tsukamoto H. (2009)
    1006. Outcomes in African-Americans vs. Caucasians using th ymoglobulin or interleukin-2 receptor inhibitor induction: analysis of USRDS da tabase. (PubMed id 19060477)9 Jindal R.M....Abbott K.C. (2009)
    1007. Pancreas transplantation in african american patients using basiliximab induction. (PubMed id 19295415)9 Zhang R....Slakey D. (2009)
    1008. Delayed graft function is reduced with antithymocyte globulin induction in pediatric kidney transplantation. (PubMed id 19715923)9 Vilalta R....Nieto J. (2009)
    1009. [Monoclonal antibodies in renal transplantation] (PubMed id 19642461)9 Bonvoisin C....Krzesinski J.M. (2009)
    1010. Early sirolimus therapy in renal transplant recipient s at high risk: is it justified? (PubMed id 19765435)9 Halim M.A....Nampoory M.R. (2009)
    1011. Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patients. (PubMed id 19147373)9 BAPhler T....Kamar N. (2009)
    1012. 18F-FDG PET, genotype-corrected ACE and sIL-2R in new ly diagnosed sarcoidosis. (PubMed id 19259660)9 Keijsers R.G....Grutters J.C. (2009)
    1013. [Immunosuppression after liver transplantation] (PubMed id 19651486)9 Calmus Y. (2009)
    1014. [The early diagnosis and clinical analysis of 57 case s of acquired hemophagocytic lymphohistiocytosis] (PubMed id 19576122)9 Wang Z....Chen X. (2009)
    1015. Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. (PubMed id 18235249)9 Zeiser R. and Negrin R.S. (2008)
    1016. [A comparison of clinical outcomes between unrelated donor and HLA-haploidentical donor hematopoietic stem cell transplantation] (PubMed id 18681306)9 Chen F....Chang W.R. (2008)
    1017. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. (PubMed id 18190460)9 Sitohy B....Hammarstrom M.L. (2008)
    1018. Monitoring non-immediate allergic reactions to iodine contrast media. (PubMed id 18341616)9 Torres M.J....Blanca M. (2008)
    1019. IL-27 inhibits the development of regulatory T cells via STAT3. (PubMed id 18156621)9 Huber M....Lohoff M. (2008)
    1020. [Recent advances in studies of clinical treatment of uveitis] (PubMed id 19176129)9 Zheng Y.Z. (2008)
    1021. High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. (PubMed id 18571896)9 Yeh S....Nussenblatt R.B. (2008)
    1022. Disease-modifying agents for multiple sclerosis: rece nt advances and future prospects. (PubMed id 19016573)9 Menge T....StA1ve O. (2008)
    1023. [Molecular genetics of type 1 diabetes mellitus: achievements and future trends] (PubMed id 18988535)9 Nosikov V.V. and Seregin I.u.A. (2008)
    1024. Transient silencing of synaptic transmitter release from specific neuronal types by recombinant tetanus toxin light chain fused to antibody variable region. (PubMed id 18775748)9 Kobayashi T....Kobayashi K. (2008)
    1025. [Impaired activation and costimulation of T CD4+ lymphocytes during chronic hepatitis C infection] (PubMed id 18846776)9 Barboza L....Berrueta L. (2008)
    1026. The immunogenetics of multiple sclerosis. (PubMed id 18461312)9 Svejgaard A. (2008)
    1027. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. (PubMed id 18625637)9 Sodsai P....Palaga T. (2008)
    1028. Frequency of Regulatory T Cells is Not Affected by Transient B Cell Depletion Using Anti-CD20 Antibodies in Rheumatoid Arthritis. (PubMed id 19156222)9 Feuchtenberger M....Tony H.P. (2008)
    1029. ABO incompatible renal transplantation in an HIV-sero positive patient. (PubMed id 18622297)9 Campara M....Kaplan B. (2008)
    1030. Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia/hypereosinophilic syndrome with FIP1L1-PDGFR alpha fusion gene. (PubMed id 18365140)9 Kataoka K....Kurokawa M. (2008)
    1031. Graft-verse-host disease after liver transplantation: a report of two cases and review of literature. (PubMed id 18240363)9 Guo Z.Y....Huang J.F. (2008)
    1032. RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus. (PubMed id 18786256)9 Ludwig L.B. (2008)
    1033. Anti CD25 treatment of human dendritic cells modulate s both their cytokine synthesis profiles and their capacity to activate allogen eic CD4 T cells: a potential tolerogenic effect. (PubMed id 18279795)9 Mnasria K....Oueslati R. (2008)
    1034. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. (PubMed id 18710386)9 Masuda A....Yatomi Y. (2008)
    1035. Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. (PubMed id 18435801)9 Tiittanen M....Vaarala O. (2008)
    1036. (123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma. (PubMed id 17929011)9 Loose D....Van de Wiele C. (2008)
    1037. Biologic agents in the management of inflammatory eye diseases. (PubMed id 18606088)9 Michalova K. and Lim L. (2008)
    1038. A case of adult onset Still's disease showing marked accumulation in the liver and spleen, on positron emission tomography-CT images. (PubMed id 18443796)9 Funauchi M....Kinoshita K. (2008)
    1039. Immunopathogenesis of folliculitis decalvans: clues in early lesions. (PubMed id 18794044)9 Chiarini C....Fabbri P. (2008)
    1040. Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25. (PubMed id 18719339)9 Saito K....Kurosawa S. (2008)
    1041. Effect of retroperitoneal laparoscopic radical nephrectomy of renal carcinoma (nephroma) on perioperative cell immunity. (PubMed id 18811573)9 Peng B....Li H. (2008)
    1042. Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients. (PubMed id 18498809)9 Castellheim A....Mollnes T.E. (2008)
    1043. Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain. (PubMed id 18829468)9 Malka Y....Henis Y.I. (2008)
    1044. Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua. (PubMed id 18628237)9 Amsalem H....Rachmilewitz J. (2008)
    1045. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation. (PubMed id 18367292)9 Kitamura K....Miyagawa S. (2008)
    1046. Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients. (PubMed id 18387521)9 BAPhler T....Kamar N. (2008)
    1047. Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transb ronchial biopsies. (PubMed id 18347533)9 Burton C.M....Andersen C.B. (2008)
    1048. Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes. (PubMed id 18684941)9 Kasprzycka M....Wasik M.A. (2008)
    1049. Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases. (PubMed id 18330725)9 Lehman H.K. and Ballow M. (2008)
    1050. Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. (PubMed id 18451706)9 Anderton S.M. and Liblau R.S. (2008)
    1051. Atherosclerosis in hemodialysis patients--the role of microinflammation. (PubMed id 19016154)9 Bevc S....Hojs R. (2008)
    1052. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients. (PubMed id 18442793)9 PentA^n-Rol G....LA^pez-Saura P. (2008)
    1053. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. (PubMed id 19382534)9 Keijsers R.G....Grutters J.C. (2008)
    1054. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. (PubMed id 18593438)9 Adurthi S....Jayshree R.S. (2008)
    1055. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. (PubMed id 18424069)9 Zhang C....Wu C. (2008)
    1056. Systemic and local cytokine kinetics after total hip replacement surgery. (PubMed id 18815447)9 Bastian D....ReikerAYs O. (2008)
    1057. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. (PubMed id 18641362)9 Savage N.D....Ottenhoff T.H. (2008)
    1058. Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation. (PubMed id 18158117)9 BAPhler T....Klupp J. (2008)
    1059. [Role of heart transplantation in pediatric heart sur gery. The first successful pediatric heart transplantation in Hungary] (PubMed id 18508738)9 HartyA!nszky I....SzatmA!ri A. (2008)
    1060. [rAAV/BA46-transfected dendritic cells can induce specific cellular immunity] (PubMed id 19114342)9 You C.X....Luo R.C. (2008)
    1061. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis. (PubMed id 18250419)9 Aricha R....Souroujon M.C. (2008)
    1062. Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix. (PubMed id 19245171)9 Mindiola R....Mosquera J. (2008)
    1063. A humanized monoclonal antibody against interleukin-2 that can inactivate the cytokine/receptor complex. (PubMed id 17000002)9 Volkland J....Pflanz S. (2007)
    1064. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas. (PubMed id 17398005)9 Chen L....Kanno T. (2007)
    1065. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. (PubMed id 17264811)9 Bharat A....Mohanakumar T. (2007)
    1066. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. (PubMed id 18005852)9 Ritter T....Pleyer U. (2007)
    1067. Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma. (PubMed id 18030581)9 Kita T....Kosuda S. (2007)
    1068. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interle ukin-2 receptor antibody versus anti-thymocyte globulin. (PubMed id 17459076)9 van de Linde P....Roep B.O. (2007)
    1069. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. (PubMed id 17173927)9 Hartigan-O'Connor D.J....McCune J.M. (2007)
    1070. Chronic antigen stimulation in vivo induces a distinct population of antigen-specific Foxp3 CD25 regulatory T cells. (PubMed id 18056346)9 Hansen W....Buer J. (2007)
    1071. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. (PubMed id 17182569)9 Strauss L....Zippelius A. (2007)
    1072. Interpretation of interleukin-2 receptor alpha positive cells during induction chemotherapy for adult acute myelogenous leukaemia patients. (PubMed id 17200986)9 Min W.S....Kim C.C. (2007)
    1073. Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes. (PubMed id 17349012)9 Douglas R.S....Smith T.J. (2007)
    1074. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. (PubMed id 16968902)9 Clark R.A. and Kupper T.S. (2007)
    1075. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjogren's syndrome. (PubMed id 18050367)9 Li X....Harris D.C. (2007)
    1076. Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease. (PubMed id 17465640)9 Dartois C....Girard P. (2007)
    1077. The role of basiliximab induction therapy in organ transplantation. (PubMed id 17150025)9 Ramirez C.B. and Marino I.R. (2007)
    1078. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer. (PubMed id 17691114)9 Strauss L....Whiteside T.L. (2007)
    1079. Genetic admixture, adipocytokines, and adiposity in Black Americans: the Health, Aging, and Body Composition study. (PubMed id 17390149)9 Wassel Fyr C.L....Ziv E. (2007)
    1080. Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and ster oids: results of follow up to 30 months post-transplant. (PubMed id 17488375)9 Mourad G....Rostaing L. (2007)
    1081. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. (PubMed id 17878369)9 Rieck M....Buckner J.H. (2007)
    1082. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. (PubMed id 17709711)9 Rose J.W....Carlson N.G. (2007)
    1083. Alexithymia and interleukin variations in somatoform disorder. (PubMed id 18073498)9 Pedrosa Gil F....Schmidmaier R. (2007)
    1084. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. (PubMed id 17377532)9 Ono M....Sakaguchi S. (2007)
    1085. [Effects of humanized recombinant CD25 monoclonal ant ibody on activation and proliferation of t lymphocytes] (PubMed id 17490539)9 Liu W. and Ren H.Y. (2007)
    1086. Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients. (PubMed id 17109733)9 Kreijveld E....Joosten I. (2007)
    1087. [Asian variant of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy] (PubMed id 17313078)9 Tadokoro J....Mitani K. (2007)
    1088. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. (PubMed id 17878328)9 Gary-Gouy H....Dalloul A. (2007)
    1089. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus. (PubMed id 17889127)9 Lauzurica R....Romero R. (2007)
    1090. Reactive peripheral blood plasmacytosis in a patient with acute hepatitis A. (PubMed id 17483053)9 Wada T....Yachie A. (2007)
    1091. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. (PubMed id 17654407)9 MAPssner R....Riederer P. (2007)
    1092. Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions. (PubMed id 17720157)9 Sugita S....Mochizuki M. (2007)
    1093. [The implications of nasal associated lymphoid tissue in development of respiratory allergic diseases in children] (PubMed id 17625281)9 Zakrzewska A....GA^rski P. (2007)
    1094. Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. (PubMed id 18025173)9 Thomas R.M....Wells A.D. (2007)
    1095. Increased serum high mobility group box-1 level in Churg-Strauss syndrome. (PubMed id 17437420)9 Taira T....Arimura K. (2007)
    1096. Could diabetic retinopathy be an autoimmune disease? (PubMed id 17125935)9 Kastelan S....Kastelan Z. (2007)
    1097. Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. (PubMed id 17668069)9 Craddock R.M....Bahn S. (2007)
    1098. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. (PubMed id 17108990)9 Bucheton B....Dessein A.J. (2007)
    1099. Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells. (PubMed id 17202384)9 Nagato T....Tateno M. (2007)
    1100. CD25-expressing B-lymphocytes in rheumatic diseases. (PubMed id 17257224)9 Amu S....Brisslert M. (2007)
    1101. [Contribution of indicators of sensitized T lymphocytes in the diagnosis of IgE independent and IgE dependent cow's allergy in children] (PubMed id 17965461)9 GoA8ebiowska-Wawrzyniak M....Wawrzyniak Z.M. (2007)
    1102. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. (PubMed id 17627234)9 Biagi E....Biondi A. (2007)
    1103. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. (PubMed id 17444956)9 Agnholt J....Sorensen E.S. (2007)
    1104. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. (PubMed id 17545278)9 Yates J....Garden O.A. (2007)
    1105. IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood. (PubMed id 17258077)9 Nakamura S....Kibata M. (2007)
    1106. Role of basiliximab in the prevention of acute cellul ar rejection in adult to adult living-related liver transplantation: a single c enter experience. (PubMed id 19707350)9 Gruttadauria S....Gridelli B. (2007)
    1107. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. (PubMed id 17304154)9 BAPhler T....Klupp J. (2007)
    1108. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. (PubMed id 18025172)9 Elpek K.G....Shirwan H. (2007)
    1109. CTLA-4 and CD4+ CD25+ regulatory T cells inhibit protective immunity to filarial parasites in vivo. (PubMed id 17878360)9 Taylor M.D....Maizels R.M. (2007)
    1110. A brief primer on treatments of cutaneous T cell lymphoma, newly approved or late in development. (PubMed id 17763605)9 Scheinfeld N. (2007)
    1111. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease. (PubMed id 17302896)9 Baker C....Dayan C.M. (2007)
    1112. Successful ABO-incompatible liver transplantation usi ng A2 donors. (PubMed id 17098033)9 Skogsberg U....BAockman L. (2006)
    1113. Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers--a cross-sectional study. (PubMed id 17142136)9 Rolland Y.M....Morley J.E. (2006)
    1114. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. (PubMed id 16555324)9 Langrehr J.M....Neumann U.P. (2006)
    1115. Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV-infected patients responding to antiretroviral therapy. (PubMed id 16956389)9 Lim A.Y....French M.A. (2006)
    1116. Effect of docosahexaenoic acid on interleukin-2 receptor signaling pathway in lipid rafts. (PubMed id 16544577)9 Li Q....Li J. (2006)
    1117. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy. (PubMed id 16699371)9 Liu S....Parkhurst M. (2006)
    1118. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. (PubMed id 16549178)9 Basturk B....Haberal M. (2006)
    1119. Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation. (PubMed id 17333724)9 Veerasubramanian P....Walsh D.S. (2006)
    1120. Mycosis fungoides in a hemodialysis patient with intractable pruritus. (PubMed id 16817798)9 Miyoshi M....Takaichi K. (2006)
    1121. [Activation markers of lymphocytes as indicators of immune system dysregulation in inflammation] (PubMed id 16607883)9 Poriadin G.V....KazimiskiA- A.N. (2006)
    1122. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. (PubMed id 16623817)9 Lautenschlager I....Taskinen E. (2006)
    1123. IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells. (PubMed id 16611649)9 Riou C....Sekaly R.P. (2006)
    1124. Cytokine assay of the epidural space lavage in patients with lumbar intervertebral disk herniation and radiculopathy. (PubMed id 16778661)9 Scuderi G.J....Hallab N. (2006)
    1125. Adult ABO-incompatible liver transplantation, using A and B donors. (PubMed id 16623811)9 Skogsberg U....BAockman L. (2006)
    1126. Two-dose basiliximab compared with two-dose daclizuma b in renal transplantation: a clinical study. (PubMed id 16824149)9 Lin M....Zhao M. (2006)
    1127. The purification and functional analysis of human CD4+CD25high regulatory T cells. (PubMed id 18432975)9 Baecher-Allan C.M. and Hafler D.A. (2006)
    1128. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. (PubMed id 15941839)9 Kuuliala A....Leirisalo-Repo M. (2006)
    1129. Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties. (PubMed id 16830050)9 Kawakami K....Nagai R. (2006)
    1130. Gene therapy: is IL2RG oncogenic in T-cell development? (PubMed id 16988660)9 Pike-Overzet K....Staal F.J. (2006)
    1131. Tubulin polymerization modulates interleukin-2 recept or signal transduction in human T cells. (PubMed id 16595340)9 Goebel J....Roszman T.L. (2006)
    1132. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro. (PubMed id 16596236)9 Ouyang G.F....Takami T. (2006)
    1133. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. (PubMed id 16586370)9 Campanelli A.P....Silva J.S. (2006)
    1134. Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines. (PubMed id 17100778)9 Tsukamoto K....Sharma V. (2006)
    1135. [Modern immunosuppression following renal transplanta tion. Standard or tailor made?] (PubMed id 16328215)9 Budde K....Glander P. (2006)
    1136. In vitro immunomodulatory activities of a newly concocted traditional Chinese medicine formula: VI-28. (PubMed id 16909439)9 Lee S.K....Lam C.W. (2006)
    1137. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. (PubMed id 16690490)9 Martins T.B....Carlquist J.F. (2006)
    1138. Toxic effect of zinc on NF-kappaB, IL-2, IL-2 receptor alpha, and TNF-alpha in HUT-78 (Th(0)) cells. (PubMed id 16930873)9 Bao B....Sarkar F. (2006)
    1139. Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. (PubMed id 17076671)9 Poehlmann T.G....Markert U.R. (2006)
    1140. Intraocular soluble IL-2 receptor alpha in a patient with adult T cell leukaemia with intraocular invasion. (PubMed id 16929066)9 Sugita S....Mochizuki M. (2006)
    1141. Relationship between plasma concentrations of cytokin es, ratio of CD4 and CD8, lymphocyte proliferative responses, and depressive an d anxiety state in bulimia nervosa. (PubMed id 16380316)9 Nagata T....Kiriike N. (2006)
    1142. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. (PubMed id 16271309)9 Wadwa R.P....Rewers M. (2006)
    1143. T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct. (PubMed id 16032400)9 Schlereth B....Baeuerle P.A. (2006)
    1144. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). (PubMed id 16505276)9 Horny H.P....Grabbe J. (2006)
    1145. Chronic graft-versus-host disease: Pathogenesis and c linical management. (PubMed id 16789791)9 PAcrez-SimA^n J.A....San Miguel J. (2006)
    1146. Novel treatment of SAczary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody). (PubMed id 16911291)9 Osborne G.E....du Vivier A.W. (2006)
    1147. Airway inflammation in asymptomatic children with episodic wheeze. (PubMed id 16617454)9 Maclennan C....Freezer N.J. (2006)
    1148. Effects of electro-acupuncture on serum cytokine level and peripheral blood lymphocyte subpopulation at immune-related and non-immune-related points. (PubMed id 17063830)9 Jong M.S....Chen F.P. (2006)
    1149. Correction of interleukin-2 gene expression by in vitro zinc addition to mononuclear cells from zinc-deficient human subjects: a specific test for zinc deficiency in humans. (PubMed id 17162254)9 Prasad A.S....Sarkar F.H. (2006)
    1150. Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. (PubMed id 16487941)9 Wichers M.C....Maes M. (2006)
    1151. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable? (PubMed id 16987266)9 Rao V....Moen T. (2006)
    1152. Brief communication: Successful treatment of pure red -cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab). (PubMed id 16461962)9 Sloand E.M....Young N.S. (2006)
    1153. Anti-interleukin-2 receptor antibody (daclizumab) tre atment of corticosteroid-refractory autoimmune thrombocytopenic purpura. (PubMed id 16461323)9 Fogarty P.F....Rick M.E. (2006)
    1154. TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma. (PubMed id 17172648)9 McGee H.S. and Agrawal D.K. (2006)
    1155. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. (PubMed id 17002703)9 Van Zele T....Bachert C. (2006)
    1156. Gene therapy: X-SCID transgene leukaemogenicity. (PubMed id 16988659)9 Thrasher A.J....Fischer A. (2006)
    1157. Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus. (PubMed id 16699373)9 Mikhailova A.A....Petrov R.V. (2006)
    1158. A relative resistance of T cells to dexamethasone in bipolar disorder. (PubMed id 17156159)9 Knijff E.M....Drexhage H.A. (2006)
    1159. Basiliximab: a comparative study between the use of t he recommended two doses versus a single dose in living donor kidney transplant ation. (PubMed id 16647506)9 Baquero A....Figueroa J. (2006)
    1160. Effect of Kang'ai Injection on serum level of soluble interleukin-2 receptor and vascular endothelial growth factor in patients with esophageal carcinoma during radiotherapy. (PubMed id 17361523)9 He Z.F....Wang W.D. (2006)
    1161. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. (PubMed id 16818678)9 Liu W....Bluestone J.A. (2006)
    1162. [Detection of expression of Th1/Th2 cytokines in jurkat cell treated with gamma-interferon by cytometric bead array] (PubMed id 16638214)9 Li W.H. and Wang L.L. (2006)
    1163. Persistence of naive CD45RA+ regulatory T cells in adult life. (PubMed id 16332974)9 Seddiki N....Fazekas de Saint Groth B. (2006)
    1164. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. (PubMed id 16551859)9 Osenga K.L....Sondel P.M. (2006)
    1165. Effect of interleukin-15 on alloreactivity in umbilical cord blood. (PubMed id 16860714)9 Lin S.J....Hsaio H.S. (2006)
    1166. Regression of extranodal natural killer/T-cell lymphoma, nasal type with denileukin diftitox (Ontak) and bexarotene (Targretin): report of a case. (PubMed id 16634908)9 Kerl K....French L.E. (2006)
    1167. [Extensive cutaneous candidiasis revealing cutaneous T-cell lymphoma: 2 cases] (PubMed id 16885846)9 Duong T....Sigal-Grinberg M. (2006)
    1168. A safe immunosuppressive protocol in adult-to-adult l iving related liver transplantation. (PubMed id 16757278)9 Gruttadauria S....Gridelli B. (2006)
    1169. Noninvasive immune monitoring assessed by flow cytometry and real time RT-PCR in urine of renal transplantation recipients. (PubMed id 16860708)9 Galante N.Z....Medina-Pestana J.O. (2006)
    1170. Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. (PubMed id 17034576)9 Brahmbhatt S....Walzl G. (2006)
    1171. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. (PubMed id 16616153)9 Friedman J....Berrebi A. (2006)
    1172. Commensal oral bacteria antigens prime human dendritic cells to induce Th1, Th2 or Treg differentiation. (PubMed id 16390334)9 Kopitar A.N....Ihan A. (2006)
    1173. Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells. (PubMed id 16762027)9 Kriegel M.A....Lorenz H.M. (2006)
    1174. Chronic allograft nephropathy. (PubMed id 16412971)9 Baluja P....Laszik Z. (2006)
    1175. The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor alpha in pediatric asthma. (PubMed id 16948354)9 Can M....TomaAs N. (2006)
    1176. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. (PubMed id 16815150)9 Wang Y. and McCusker C. (2006)
    1177. The anti-CD25 monoclonal antibody 7G7/B6, armed with the alpha-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia. (PubMed id 16912202)9 Zhang M....Waldmann T.A. (2006)
    1178. Rabbit antithymocyte globulin versus basiliximab in r enal transplantation. (PubMed id 17093248)9 Brennan D.C....Del Castillo D. (2006)
    1179. Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. (PubMed id 16501042)9 So T....Croft M. (2006)
    1180. Phase II clinical studies of denileukin diftitox diph theria toxin fusion protein in patients with previously treated chronic lymphoc ytic leukemia. (PubMed id 16586495)9 Frankel A.E....Cripe L.D. (2006)
    1181. Treatment of steroid-resistant acute liver transplant rejection with basiliximab. (PubMed id 15964372)9 Fernandes M.L....Lee K.H. (2005)
    1182. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. (PubMed id 15920010)9 Ishikawa F....Harada M. (2005)
    1183. Evaluation of daclizumab to reduce delayed graft func tion in non-heart-beating renal transplantation: a prospective, randomized tria l. (PubMed id 15919462)9 Wilson C....Talbot D. (2005)
    1184. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant. (PubMed id 16048606)9 Hymes L.C. and Warshaw B.L. (2005)
    1185. Detection of channel proximity by nanoparticle-assisted delaying of toxin binding; a combined patch-clamp and flow cytometric energy transfer study. (PubMed id 15375639)9 Rubovszky B....Bene L. (2005)
    1186. Production and characterization of an active single-chain variable fragment antibody recognizing CD25. (PubMed id 15978327)9 Muramatsu H....Ueda R. (2005)
    1187. Open-label, multicenter study on the safety, tolerabi lity, and efficacy of Simulect in pediatric renal transplant recipients receivi ng triple therapy with cyclosporin, mycophenolate, and corticosteroids. (PubMed id 15848497)9 Turconi A....Otero A. (2005)
    1188. Systemic mastocytosis: bone marrow pathology, classification, and current therapies. (PubMed id 15995324)9 Pardanani A. (2005)
    1189. Thalidomide in combination with dexamethasone for pre treated patients with multiple myeloma: serum level of soluble interleukin-2 re ceptor as a predictive factor for response rate and for survival. (PubMed id 15744524)9 SchA1tt P....Nowrousian M.R. (2005)
    1190. Experience with single-dose daclizumab in the prevent ion of acute rejection in heart transplantation. (PubMed id 16386620)9 Cuppoletti A....Roig E. (2005)
    1191. [Multiple sclerosis: between wish and reality] (PubMed id 15968879)9 KA1mpfel T. and Hohlfeld R. (2005)
    1192. Immunomodulatory effects of blood letting cupping therapy in patients with rheumatoid arthritis. (PubMed id 17977209)9 Ahmed S.M....Abu-Shady E.A. (2005)
    1193. The impact of biological agents interfering with receptor/ligand binding in the immune system. (PubMed id 16479734)9 Cianci R....Pandolfi F. (2005)
    1194. T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway. (PubMed id 15817705)9 Terrazzano G....Ruggiero G. (2005)
    1195. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients. (PubMed id 16047057)9 Zailaie M.Z. (2005)
    1196. Mycophenolate mofetil in pediatric renal transplantat ion: non-induction vs. induction with basiliximab. (PubMed id 15667617)9 Ojogho O....Concepcion W. (2005)
    1197. The involvement of immunoregulatory T cells in the pathogenesis of lichen sclerosus. (PubMed id 15614194)9 TchA^rzewski H....GA8owacka E. (2005)
    1198. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. (PubMed id 15895898)9 Kuuliala A....Repo H. (2005)
    1199. [Epstein-Barr virus related B-cell lymphoproliferative disorder complicated with bone marrow fibrosis, which was successfully treated with 2 courses of CHOP regimen] (PubMed id 16440776)9 Hagihara M....Sato K. (2005)
    1200. Functional characterization of T cells in abdominal a ortic aneurysms. (PubMed id 15885133)9 Forester N.D....Carding S.R. (2005)
    1201. Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor. (PubMed id 16219533)9 Stroncek D....Panelli M.C. (2005)
    1202. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis. (PubMed id 15902475)9 Schneider A....Bennek J. (2005)
    1203. Serum cytokine receptor levels in noninfectious uveitis. (PubMed id 15746567)9 Torun N....Pleyer U. (2005)
    1204. Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review. (PubMed id 16313313)9 Sandrini S. (2005)
    1205. Daclizumab to prevent rejection after cardiac transpl antation. (PubMed id 15987919)9 Hershberger R.E....Mamelok R.D. (2005)
    1206. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. (PubMed id 15843513)9 Li Z....Nussenblatt R.B. (2005)
    1207. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naive and antigenic-specific cord blood Treg cells. (PubMed id 16338494)9 Chang C.C....Cairo M.S. (2005)
    1208. Methyl-parathion and organophosphorous pesticide metabolites modify the activation status and interleukin-2 secretion of human peripheral blood mononuclear cells. (PubMed id 15993741)9 Lima A. and Vega L. (2005)
    1209. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases. (PubMed id 16115126)9 Panteli K.E....Bourantas K.L. (2005)
    1210. The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis. (PubMed id 16361727)9 Izu K. and Tokura Y. (2005)
    1211. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor. (PubMed id 16006772)9 Kaminska J....Chechlinska M. (2005)
    1212. Characterization of surface interleukin-2 receptor ex pression on gated populations of peripheral blood mononuclear cells from manate es, Trichechus manatus latirostris. (PubMed id 16112745)9 Sweat J.M....Gibbs E.P. (2005)
    1213. T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls. (PubMed id 15993451)9 Antas P.R....Sampaio E.P. (2005)
    1214. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. (PubMed id 15880049)9 Luo X....Suthanthiran M. (2005)
    1215. Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection. (PubMed id 15866221)9 Andersen L.P....WadstrAPm T. (2005)
    1216. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. (PubMed id 16129099)9 Rojas B....Foster C.S. (2005)
    1217. Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies. (PubMed id 16210965)9 Bay J.O....Vernant J.P. (2005)
    1218. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular BehAset's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. (PubMed id 16273760)9 KAPtter I....StA1biger N. (2005)
    1219. Case report: severe heat stroke with multiple organ dysfunction - a novel intravascular treatment approach. (PubMed id 16285034)9 Broessner G....Schmutzhard E. (2005)
    1220. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. (PubMed id 16182762)9 Gruttadauria S....Gridelli B. (2005)
    1221. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. (PubMed id 16319383)9 Muthukumar T....Suthanthiran M. (2005)
    1222. Induction therapy with basiliximab allows delayed ini tiation of cyclosporine and preserves renal function after cardiac transplantat ion. (PubMed id 16143252)9 Rosenberg P.B....Yancy C.W. (2005)
    1223. Poststorage leuko-depleted plasma inhibits T-cell proliferation and Th1 response in vitro: characterization of TGFbeta-1 as an important immunomodulatory component in stored blood. (PubMed id 16003239)9 Hodge G.L....Reynolds P.N. (2005)
    1224. Polyclonal proliferation of plasma cells associated with marked hypergammaglobulinemia in an elderly patient. (PubMed id 15717691)9 Ohno H....Yoshida Y. (2005)
    1225. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions. (PubMed id 16219576)9 Mutis T....Verdonck L.F. (2005)
    1226. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. (PubMed id 15562014)9 Carrillo-Vico A....Guerrero J.M. (2005)
    1227. Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain. (PubMed id 16207471)9 Goebel J....Wills-Karp M. (2005)
    1228. Coculture of Th cells with interleukin (IL)-7 in the absence of antigenic stimuli induced T-cell anergy reversed by IL-15. (PubMed id 15993713)9 Chen Y.Z....Nishimura Y. (2005)
    1229. Herpes simplex virus 2-associated hemophagocytic lymphohistiocytosis in a pregnant patient. (PubMed id 15863596)9 Yamaguchi K....Murashima A. (2005)
    1230. Lipoprotein-dependent and -independent immune responses to spirochetal infection. (PubMed id 16085913)9 Salazar J.C....Radolf J.D. (2005)
    1231. Study of the effect of leeching on plasma endothelin and soluble interleukin-2 receptor in patients with systemic lupus erythematosus. (PubMed id 15975313)9 Cheng S.P....Yuan J. (2005)
    1232. Induction therapy for pediatric and adult heart trans plantation: comparison between OKT3 and daclizumab. (PubMed id 16123721)9 Chin C....Valantine H. (2005)
    1233. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies. (PubMed id 15899555)9 Nakase K....Shiku H. (2005)
    1234. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. (PubMed id 16274628)9 Xu L....He X. (2005)
    1235. Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratory tract infections in patients with COPD. (PubMed id 15763456)9 Takabatake N....Kubota I. (2005)
    1236. Monogenic autoimmune diseases - lessons of self-tolerance. (PubMed id 16226439)9 Ulmanen I....Peltonen L. (2005)
    1237. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. (PubMed id 15723745)9 Persson C....Nygren P. (2005)
    1238. Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells. (PubMed id 15720434)9 Managlia E.Z....Al-Harthi L. (2005)
    1239. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells. (PubMed id 15946308)9 Vilpo J....Rosenquist R. (2005)
    1240. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes. (PubMed id 16275621)9 Tenorio E.P. and Saavedra R. (2005)
    1241. Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. (PubMed id 16180249)9 Jarvis L.B....Gaston J.S. (2005)
    1242. Initial data on basiliximab in critically ill childre n undergoing heart transplantation. (PubMed id 16143246)9 Ford K.A....Burch M. (2005)
    1243. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells. (PubMed id 16400900)9 Lin S.J....Tsai T.L. (2005)
    1244. [Kidney transplantation in children] (PubMed id 16267794)9 Coppo R....Amoroso A. (2005)
    1245. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens. (PubMed id 15919467)9 KrAomer B.K....Schlitt H.J. (2005)
    1246. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure. (PubMed id 15678692)9 Meier P....Blanc E. (2005)
    1247. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. (PubMed id 15878055)9 Nussenblatt R.B....Buggage R.R. (2005)
    1248. Postoperative changes in serum cytokines profile and nitric oxide levels in patients with cystic echinococcosis. (PubMed id 16218215)9 Refik M....Durmaz R. (2005)
    1249. Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease. (PubMed id 16098072)9 Schmidt-Hieber M....Blau I.W. (2005)
    1250. Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease. (PubMed id 15744237)9 Shaughnessy P.J....Lemaistre C.F. (2005)
    1251. Recent developments in the first detection of hepatocellular carcinoma. (PubMed id 16450014)9 Lopez J.B. (2005)
    1252. Effect of influenza vaccine on markers of inflammation and lipid profile. (PubMed id 15976761)9 Tsai M.Y....Arnett D.K. (2005)
    1253. Bone marrow mast cell immunophenotyping in adults wit h mast cell disease: a prospective study of 33 patients. (PubMed id 15203275)9 Pardanani A....Tefferi A. (2004)
    1254. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. (PubMed id 15162466)9 Liu C.L....Wong J. (2004)
    1255. Continuity of cytokine activation in patients with familial Mediterranean fever. (PubMed id 15293095)9 Bagci S....Dagalp K. (2004)
    1256. Anti-interleukin-2 receptor antibodies in transplanta tion: what is the basis for choice? (PubMed id 15301558)9 Van Gelder T....Ter Meulen R.G. (2004)
    1257. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect. (PubMed id 14709642)9 HAortel C....MA1ller-Steinhardt M. (2004)
    1258. Lipopolysaccharide induces CD25-positive, IL-10-producing lymphocytes without secretion of proinflammatory cytokines in the human colon: low MD-2 mRNA expression in colonic macrophages. (PubMed id 14997033)9 Shirai Y....Dohi T. (2004)
    1259. Basiliximab-chimeric anti-IL2-R monoclonal antibody i n pediatric liver transplantation: comparative study. (PubMed id 15194332)9 Gibelli N.E....Maksoud J.G. (2004)
    1260. Outcome of low-dose ganciclovir for cytomegalovirus d isease prophylaxis in renal-transplant recipients. (PubMed id 15591961)9 Ahmed J....Venkat K.K. (2004)
    1261. Drug immunosuppression therapy for adult heart transp lantation. Part 1: immune response to allograft and mechanism of action of immu nosuppressants. (PubMed id 14726104)9 Mueller X.M. (2004)
    1262. Early experience with two-dose daclizumab in the prev ention of acute rejection in cardiac transplantation. (PubMed id 15344949)9 Joyal D....Giannetti N. (2004)
    1263. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. (PubMed id 15157953)9 Haack M....Mullington J.M. (2004)
    1264. [Expression of the chosen proapoptotic and activation markers in adenoids in children with allergic rhinitis] (PubMed id 15603384)9 Zakrzewska A....GryczyA8ska D. (2004)
    1265. Antigen-induced regulatory T cells. (PubMed id 15026316)9 Vigouroux S....Brenner M.K. (2004)
    1266. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system. (PubMed id 15010848)9 Tamakawa N....Takami T. (2004)
    1267. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. (PubMed id 15166264)9 Horny H.P....Valent P. (2004)
    1268. Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. (PubMed id 15449032)9 Zeiser R....Finke J. (2004)
    1269. Clathrin-lndependent endocytosis and signalling of in terleukin 2 receptors IL-2R endocytosis and signalling. (PubMed id 15645712)9 Gesbert F....Dautry-Varsat A. (2004)
    1270. [Expression of leucocyte cell-surface antigens on colon cancer cell line HR8348] (PubMed id 15067730)9 Yang S.L....Xu W.Q. (2004)
    1271. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells. (PubMed id 14630083)9 Cheng J....Marasco W.A. (2004)
    1272. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. (PubMed id 15239023)9 Mangge H....Borkenstein M. (2004)
    1273. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. (PubMed id 15070693)9 Cosmi L....Romagnani S. (2004)
    1274. Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody. (PubMed id 15041394)9 Praditpornsilpa K....Tungsanga K. (2004)
    1275. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer. (PubMed id 15337523)9 Rocha-Zavaleta L....Rangel-Corona R. (2004)
    1276. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. (PubMed id 15281434)9 De Vries J....Drent M. (2004)
    1277. [The role of polyclonal anti-T-lymphocyte antibodies (ATG) in the kidney transplantation] (PubMed id 16042064)9 Nikolovski M....Panchev P. (2004)
    1278. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. (PubMed id 15367216)9 Fu S....Bromberg J.S. (2004)
    1279. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. (PubMed id 15240743)9 Miranda-CarA_s M.E....MartA-n-Mola E. (2004)
    1280. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. (PubMed id 15569925)9 van Bilsen J.H....Toes R.E. (2004)
    1281. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype. (PubMed id 15108287)9 Ginn S.L....Alexander I.E. (2004)
    1282. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. (PubMed id 15110223)9 Limas C.J....Cokkinos D.V. (2004)
    1283. Redox status and immune function in type I diabetes families. (PubMed id 15147359)9 Matteucci E....Giampietro O. (2004)
    1284. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. (PubMed id 15256474)9 Saha A....Bhattacharya-Chatterjee M. (2004)
    1285. [Immunotherapy of inflammatory bowel diseases] (PubMed id 15603345)9 Wichan P....WojtuA8 S. (2004)
    1286. Results of kidney transplantation in patients receivi ng MMF- or MMF and basiliximab-containing immunosuppression. (PubMed id 15518755)9 Tojimbara T....Teraoka S. (2004)
    1287. Efficacy and safety of basiliximab with a tacrolimus- based regimen in liver transplant recipients. (PubMed id 15385809)9 Marino I.R....Gruttadauria S. (2004)
    1288. Evaluation of a CD25-specific immunotoxin for prevent ion of graft-versus-host disease after unrelated marrow transplantation. (PubMed id 15282533)9 Martin P.J....Vitetta E.S. (2004)
    1289. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis. (PubMed id 15182256)9 Adikari S.B....Link H. (2004)
    1290. Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. (PubMed id 15099362)9 Lew W....Krueger J.G. (2004)
    1291. Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals. (PubMed id 15248139)9 Torre D....Poli G. (2004)
    1292. Experience with cyclosporine in endogenous uveitis po sterior. (PubMed id 15041371)9 Hesselink D.A....van Hagen P.M. (2004)
    1293. Endogenous IL-15 sustains recruitment of IL-2Rbeta and common gamma and IL-2-mediated chemokine production in normal and inflamed human gingival fibroblasts. (PubMed id 15470063)9 Ozawa A....Sugawara S. (2004)
    1294. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma. (PubMed id 15073128)9 Niitsu N....Hirano M. (2004)
    1295. Does immune activation continue during an attack-free period in familial Mediterranean fever? (PubMed id 15544632)9 Musabak U....Bagci S. (2004)
    1296. Clinical and laboratory aspects of common variable immunodeficiency. (PubMed id 15558152)9 Kokron C.M....Rizzo L.V. (2004)
    1297. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. (PubMed id 15090474)9 Weber M.S....Farina C. (2004)
    1298. Effects of IL-7 and dexamethasone: induction of CD25, the high affinity IL-2 receptor, on human CD4+ cells. (PubMed id 15922716)9 Chung I.Y....Chen X. (2004)
    1299. Treatment of multiple sclerosis with an anti-interleu kin-2 receptor monoclonal antibody. (PubMed id 15499632)9 Rose J.W....Carlson N.G. (2004)
    1300. The fractional excretion of soluble interleukin-2 rec eptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha statu s after treatment with daclizumab. (PubMed id 14742994)9 ter Meulen C.G....Hoitsma A.J. (2004)
    1301. [CD5- CD11c+ CD23- small lymphocytic lymphoma evolving from aplastic anemia] (PubMed id 15387287)9 Kikuchi M....Ueda R. (2004)
    1302. A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. (PubMed id 14660677)9 Moon J.J....Nelson B.H. (2004)
    1303. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. (PubMed id 12688308)9 Scrivener S....Prentice A.G. (2003)
    1304. DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia. (PubMed id 12718740)9 Frankel A.E....Gartenhaus R. (2003)
    1305. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation. (PubMed id 12777860)9 Baan C.C....Weimar W. (2003)
    1306. Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. (PubMed id 12848627)9 Creed T.J....Hearing S.D. (2003)
    1307. Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis. (PubMed id 12617264)9 Salama H.H....Zhang J. (2003)
    1308. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. (PubMed id 14506141)9 Frankel A.E....Gartenhaus R. (2003)
    1309. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes. (PubMed id 12744774)9 HAortel C....MA1ller-Steinhardt M. (2003)
    1310. Comparative effects of L-tryptophan and 1-methyl-tryptophan on immunoregulation induced by sperm, human pre-implantation embryo and trophoblast supernatants. (PubMed id 14672333)9 GutiAcrrez G....Markert U.R. (2003)
    1311. Cytokine mRNA expression in isocyanate-induced hypersensitivity pneumonitis. (PubMed id 12915748)9 Sumi Y....Yoshizawa Y. (2003)
    1312. Calcineurin-free protocols with basiliximab induction allow patients included in 'old to old' programs achieve standard ki dney transplant function. (PubMed id 12826150)9 Emparan C....Senninger N. (2003)
    1313. Evaluation of serum levels of cytokines and intercellular adhesion molecule-1 (ICAM-1) in astrocytic tumours. (PubMed id 12899444)9 Nano R....Gerzeli G. (2003)
    1314. Cytokine soluble receptors in perinatal and early neonatal life. (PubMed id 12857603)9 Protonotariou E....Salamalekis E. (2003)
    1315. Strategies for optimizing immunosuppression in adoles cent transplant recipients: a focus on liver transplantation. (PubMed id 12608882)9 Kelly D.A. (2003)
    1316. Assessment of immunosuppressive drug interactions: in hibition of lymphocyte function in peripheral human blood. (PubMed id 14659903)9 Barten M.J....Gummert J.F. (2003)
    1317. A pilot study on the use of the humanized anti-interl eukin-2 receptor antibody daclizumab in active ulcerative colitis. (PubMed id 12591057)9 Van Assche G....Rutgeerts P. (2003)
    1318. Basiliximab (Simulect) for the treatment of steroid-r esistant rejection in pediatric liver transpland recipients: a preliminary expe rience. (PubMed id 12660504)9 Aw M.M....Dhawan A. (2003)
    1319. Dendritic cell density and activation status of tumour-infiltrating lymphocytes in metastatic human melanoma: possible implications for sentinel node metastases. (PubMed id 12777981)9 Barbour A.H. and Coventry B.J. (2003)
    1320. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells. (PubMed id 14973427)9 Sellitto A....Lucivero G. (2003)
    1321. Pyrethroids used indoors--immune status of humans exposed to pyrethroids following a pest control operation--a one year follow-up study. (PubMed id 12708230)9 Hadnagy W....Idel H. (2003)
    1322. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. (PubMed id 12928233)9 Rothkrantz-Kos S....Drent M. (2003)
    1323. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease. (PubMed id 12764738)9 Wieland A....Urban C. (2003)
    1324. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. (PubMed id 12740672)9 Baykal Y....Inal A. (2003)
    1325. The effect of labor on neonatal T-cell phenotype and function. (PubMed id 12672906)9 Thornton C.A....Warner J.O. (2003)
    1326. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. (PubMed id 14559836)9 Zhang Z....Waldmann T.A. (2003)
    1327. Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. (PubMed id 14501232)9 Omagari K....Kohno S. (2003)
    1328. [Expression of markers of immunocompetent cells, cyto kine level, and L-arginine metabolism in complex extremely high frequency and i nterferon therapy of inflammatory diseases in women of highlands] (PubMed id 12918255)9 TaradiA- N.N....Volkova L.N. (2003)
    1329. Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion. (PubMed id 14585364)9 Chen H.R....Xun C.Q. (2003)
    1330. Quantification of immunosuppression by flow cytometry in stable renal transplant recipients. (PubMed id 12548140)9 Stalder M....Morris R.E. (2003)
    1331. Defective interleukin-2 production and interleukin-2 receptor expression in pulmonary tuberculosis. (PubMed id 15562950)9 Khanna M....Kumar P. (2003)
    1332. [Immune-regulating Th1- and Th2-cytokines in chronic infections caused by hepatitis B and C viruses] (PubMed id 12945206)9 PriA-miagi L.S....TuA-sk T.P. (2003)
    1333. Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves' disease with subclinical hyperthyroidism. (PubMed id 14682468)9 Ugur-Altun B....Tugrul A. (2003)
    1334. Comparison of daclizumab, an interleukin 2 receptor a ntibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney trans plantation. (PubMed id 12835081)9 Abou-Jaoude M.M....Almawi W.Y. (2003)
    1335. Alterations in skeletal muscle structure are minimize d with steroid withdrawal after renal transplantation. (PubMed id 12973106)9 Topp K.S....Stock P. (2003)
    1336. IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. (PubMed id 12496450)9 Schwaiger S....Grubeck-Loebenstein B. (2003)
    1337. [Anti interleukin-2 receptor alpha antibodies (dacliz umab) application for the treatment of kidney recipients] (PubMed id 12761441)9 Izvolskaja N....Dainys B. (2003)
    1338. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. (PubMed id 12517932)9 Bennett F....Carreno B.M. (2003)
    1339. HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. (PubMed id 14623703)9 Skov L....Baadsgaard O. (2003)
    1340. Diagnostic significance of interferon-gamma in tuberculous pleural effusions. (PubMed id 12628872)9 Aoe K....Takeyama H. (2003)
    1341. Analysis of lymphocyte subpopulations in systemic scl erosis. (PubMed id 12968391)9 Ercole L.P....Rachid A. (2003)
    1342. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with BehAset's syndrome. (PubMed id 14636202)9 Cekmen M....Ozerol I.H. (2003)
    1343. Atypical hemophagocytic lymphohistiocytosis following bacterial tonsillitis in acute lymphoblastic leukemia. (PubMed id 12916881)9 Kakihara T....Uchiyama M. (2003)
    1344. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma. (PubMed id 12779014)9 BAPhm M....Allhoff E.P. (2003)
    1345. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. (PubMed id 12827664)9 Braun R.K....Kroegel C. (2003)
    1346. Non-Hodgkin's lymphoma developing in a pacemaker pock et. (PubMed id 12774929)9 Hojo N....Fujita S. (2003)
    1347. Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. (PubMed id 12901854)9 Ege T....Duran E. (2003)
    1348. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with BehAset's disease: original contributions/clinical and laboratory investigations. (PubMed id 12775361)9 ErkiliAs K....Dogan H. (2003)
    1349. Treatment of graft-versus-host disease after liver tr ansplantation with basiliximab followed by bowel resection. (PubMed id 12859540)9 Sudhindran S....Gibbs P. (2003)
    1350. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. (PubMed id 12667670)9 Nguyen X.D....KlA1ter H. (2003)
    1351. Zinc-altered immune function. (PubMed id 12730441)9 Ibs K.H. and Rink L. (2003)
    1352. Soluble interleukin-2 receptors increase during the active periods in cluster headache. (PubMed id 12864761)9 Empl M....Straube A. (2003)
    1353. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. (PubMed id 12595862)9 Blum A....Ben-Ami M. (2003)
    1354. Recombinant humanized anti-IL-2 receptor antibody (da clizumab) produces responses in patients with moderate aplastic anemia. (PubMed id 12881307)9 Maciejewski J.P....Young N.S. (2003)
    1355. SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients. (PubMed id 12766168)9 Sanzone S....Parolini O. (2003)
    1356. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial. (PubMed id 12556688)9 Levy Y....Aboulker J.P. (2003)
    1357. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? (PubMed id 12753529)9 Hodge G....Han P. (2003)
    1358. Clinical-scale generation of dendritic cells in a closed system. (PubMed id 12843800)9 Sorg R.V....Wernet P. (2003)
    1359. [Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody] (PubMed id 12812665)9 Lu J....Lu D.P. (2003)
    1360. Low serum beta-carotene reflects immune activation in patients with coronary artery disease. (PubMed id 12955792)9 Jonasson L....Olsson A.G. (2003)
    1361. Humanized anti-interleukin-2 (IL-2) receptor alpha th erapy: long-term results in uveitis patients and preliminary safety and activit y data for establishing parameters for subcutaneous administration. (PubMed id 14599854)9 Nussenblatt R.B....Buggage R.R. (2003)
    1362. Influence of ethyl acetate extract and quercetin-3-methyl ether from Polygonum amphibium on activation lymphocytes from peripheral blood of healthy donor in vitro. (PubMed id 12916071)9 Smolarz H.D....RoliA8ski J. (2003)
    1363. Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens. (PubMed id 12890804)9 Horny H.P....Valent P. (2003)
    1364. Cost evaluation of basiliximab treatment for renal tr ansplant patients in Japan. (PubMed id 12859220)9 Hasegawa T....Miki S. (2003)
    1365. Systemic inflammation and innate immune response in patients with previous anterior uveitis. (PubMed id 11914210)9 Huhtinen M....Leirisalo-Repo M. (2002)
    1366. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure. (PubMed id 12170032)9 Rumalla V.K....Lowry S.F. (2002)
    1367. Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells. (PubMed id 12398919)9 Zhou X....Zepp F. (2002)
    1368. Endovascular approach to abdominal aortic aneurysms limits the postoperative systemic immune response. (PubMed id 11991690)9 Sweeney K.J....Reynolds J.V. (2002)
    1369. Multiple gammac-receptor expression in adult T-cell leukemia. (PubMed id 12225394)9 Baba H....Kamihira S. (2002)
    1370. [Soluble interleukin 2 receptor (SIL-2R) in bronchoalveolar lavage fluid (BALF) of patients with sarcoidosis and atopic bronchial asthma] (PubMed id 12708075)9 Jankowska R....Krasnowska M. (2002)
    1371. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. (PubMed id 12438424)9 Levings M.K....Roncarolo M.G. (2002)
    1372. Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2. (PubMed id 12015902)9 Fortis C....Poli G. (2002)
    1373. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome. (PubMed id 12139945)9 Goldman F.D....Cook R.T. (2002)
    1374. Peripheral decrease and pulmonary homing of CD4+CD45RO+ helper memory T cells in cystic fibrosis. (PubMed id 11860174)9 HAousler M....Heimann G. (2002)
    1375. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans. (PubMed id 11777556)9 Lenzlinger P.M....Morganti-Kossmann M.C. (2002)
    1376. Diagnostic value of peripheral blood T-cell activation and soluble IL-2 receptor for acute rejection in liver transplantation. (PubMed id 11983203)9 Lun A....Renz H. (2002)
    1377. Inhibition of the IL-15 pathway in anti-CD25 mAb treated renal allograft recipients. (PubMed id 12182469)9 Baan C.C....Weimar W. (2002)
    1378. An elderly patient with hemophagocytic syndrome due to severe mycoplasma pneumonia with marked hypercytokinemia. (PubMed id 11844970)9 Mizukane R....Kohno S. (2002)
    1379. [Study on effect of Salvia injection in treating primary nephrotic syndrome and on endothelin and serum interleukin-2 receptor in children] (PubMed id 12585167)9 Bao H.Y....Wang L. (2002)
    1380. Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells. (PubMed id 12438963)9 Brunetti M....Aiello F.B. (2002)
    1381. A rational dosing algorithm for basiliximab (Simulect ) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluatio ns. (PubMed id 12394838)9 Kovarik J.M....Hall M. (2002)
    1382. Current practices: immunosuppression induction, maint enance, and rejection regimens in contemporary post-heart transplant patient tr eatment. (PubMed id 11981249)9 Baran D.A....Gass A.L. (2002)
    1383. Abnormal expression of CD antigens in mastocytosis. (PubMed id 11919422)9 Escribano L....Orfao A. (2002)
    1384. Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox. (PubMed id 12149223)9 Gorgun G. and Foss F. (2002)
    1385. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers. (PubMed id 12230932)9 Martins M.L....Bonjardim C.A. (2002)
    1386. Role of soluble receptors for tumor necrosis factor alpha in the development of hypoalbuminemia in hemodialysis patients. (PubMed id 11919406)9 Odamaki M....Hishida A. (2002)
    1387. Options for induction immunosuppression in liver tran splant recipients. (PubMed id 11985487)9 Moser M.A. (2002)
    1388. Characterization of a novel human anaplastic large cell lymphoma cell line tumorigenic in SCID mice. (PubMed id 11908723)9 Merz H....Feller A.C. (2002)
    1389. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. (PubMed id 12215865)9 GA1r A....Erdogan F. (2002)
    1390. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases. (PubMed id 12414777)9 Monsalve-De Castillo F....Callejas D. (2002)
    1391. [Contribution of interleukin 2 and interleukin 12 receptors in signal transduction during cell activation of the immune system] (PubMed id 12661403)9 L/yszkiewicz M. and Pajtasz-Piasecka E. (2002)
    1392. Immunoregulatory and antioxidant performance of alpha-tocopherol and selenium on human lymphocytes. (PubMed id 12008975)9 Lee C.Y. and Wan J.M. (2002)
    1393. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. (PubMed id 11929485)9 Belleguic C....Lagente V. (2002)
    1394. Pancreatic T-cell lymphoma with high level of soluble interleukin-2 receptor. (PubMed id 12424573)9 Matsubayashi H....Kijima H. (2002)
    1395. The influence of methylene blue infusion on cytokine levels during severe sepsis. (PubMed id 12500513)9 Memis D....Pamukcu Z. (2002)
    1396. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. (PubMed id 12193748)9 McDyer J.F....Ragheb J.A. (2002)
    1397. Inhibition of human T cell activation by novel Src ki nase inhibitors is dependent upon the complexity of the signal delivered to the cell. (PubMed id 12438558)9 Rapecki S. and Allen R. (2002)
    1398. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. (PubMed id 11842294)9 Stelmach I....Kuna P. (2002)
    1399. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. (PubMed id 12476283)9 Massenkeil G....Arnold R. (2002)
    1400. Type 1 vs. type 2 cytokine secretion in vitro and its regulation by hydrocortisone in humans subjected to 120-day anti-orthostatic bed-rest regime. (PubMed id 14638461)9 Uchakin P.N....Cubbage M.L. (2002)
    1401. [Primary cardiac lymphoma: a case report] (PubMed id 12463097)9 Tanaka J....Saito T. (2002)
    1402. Impact of immunosuppressive therapy on recurrence of hepatitis C. (PubMed id 12362294)9 Everson G.T. (2002)
    1403. Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. (PubMed id 11786088)9 Strehlau J....Strom T.B. (2002)
    1404. Lymphocyte phenotype analysis and chromosome aberration frequency of workers occupationally exposed to styrene, benzene, polycyclic aromatic hydrocarbons or mixed solvents. (PubMed id 11852118)9 BirA^ A....Tompa A. (2002)
    1405. Immunological mechanisms of recovery from an acute st age in patients with atopic bronchial asthma. (PubMed id 12674936)9 Poryadin G.V....Chervinskaya T.A. (2002)
    1406. Selective action of the photosensitizer QLT0074 on activated human T lymphocytes. (PubMed id 12194221)9 Jiang H....Hunt D.W. (2002)
    1407. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. (PubMed id 12399232)9 Lautenschlager I....Taskinen E. (2002)
    1408. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. (PubMed id 12193749)9 Quemeneur L....Bonnefoy-Berard N. (2002)
    1409. Immunoprophylaxis with basiliximab, a chimeric anti-i nterleukin-2 receptor monoclonal antibody, in combination with azathioprine-con taining triple therapy in liver transplant recipients. (PubMed id 11862588)9 Calmus Y....Girault D. (2002)
    1410. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. (PubMed id 11896536)9 Cioca D.P. and Kitano K. (2002)
    1411. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. (PubMed id 12010811)9 Damle R.N....Chiorazzi N. (2002)
    1412. The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2. (PubMed id 11947931)9 Magno C....Ferlazzo G. (2002)
    1413. Dyskeratosis congenita with isolated neutropenia and granulocyte colony-stimulating factor treatment. (PubMed id 12010344)9 Yilmaz K....GA1ler E. (2002)
    1414. [Th1-cytokines in chronic hepatitis B and C] (PubMed id 12173430)9 PriA-miagi L.S....Lisitsyna S.A. (2002)
    1415. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. (PubMed id 11368440)9 Eriksen K.W....Odum N. (2001)
    1416. Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapy. (PubMed id 11427636)9 van Riemsdijk-Van Overbeeke I.C....Weimar W. (2001)
    1417. Economic analysis of basiliximab in renal transplanta tion. (PubMed id 11435967)9 Keown P.A....Baladi J.F. (2001)
    1418. Cell fusion experiments reveal distinctly different a ssociation characteristics of cell-surface receptors. (PubMed id 11739638)9 Nagy P....Damjanovich S. (2001)
    1419. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. (PubMed id 11505128)9 Gordon B.R....Rubin A.L. (2001)
    1420. Induction immunosuppression with interleukin-2 recept or antibodies (basiliximab and daclizumab) in renal transplant recipients. (PubMed id 11498153)9 Nair M.P....Al-Mousawi M. (2001)
    1421. [Immunogenetic cytokine restriction in multiple sclerosis] (PubMed id 11586702)9 Odinak M.M....Davydova N.I. (2001)
    1422. Soluble interleukin-2 receptor in SjAPgren's syndrome: relation to main serum immunological and immunohistochemical parameters. (PubMed id 11642512)9 Spadaro A....Taccari E. (2001)
    1423. Positive responses to imipramine in the popliteal lymph node assay are due to primary irritation. (PubMed id 11926614)9 Choquet-Kastvlevsky G....Descot J. (2001)
    1424. L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. (PubMed id 11300497)9 Taheri F....Ochoa A.C. (2001)
    1425. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis. (PubMed id 11327251)9 Gardinali M....Stabilini R. (2001)
    1426. Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication. (PubMed id 11707845)9 Foss F.M....Kuzel T. (2001)
    1427. Multicenter trial exploring calcineurin inhibitors av oidance in renal transplantation. (PubMed id 11397963)9 Vincenti F....Nashan B. (2001)
    1428. [Antibodies and immunomodulation] (PubMed id 11577588)9 Berthoux F. (2001)
    1429. A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function. (PubMed id 11397971)9 Hong J.C. and Kahan B.D. (2001)
    1430. Preoperative prediction of postoperative edema and effusion in pediatric cardiac surgery by altered antigen expression patterns on granulocytes and monocytes. (PubMed id 11514959)9 TA!rnok A....Hambsch J. (2001)
    1431. Limited benefits of induction with monoclonal antibod y to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofet il, and steroids in simultaneous kidney-pancreas transplantation. (PubMed id 11267477)9 Lo A....Gaber A.O. (2001)
    1432. [Lymphocyte subpopulation, interleukin-2 and high affinity interleukin-2 receptor expression in primary nephrotic syndrome] (PubMed id 12733363)9 Fu P....Yu T. (2001)
    1433. Autologous lymphocyte-monocyte co-culture increases NMR-visible and cytoplasmic lipids in the absence of increased markers of lymphocyte activation. (PubMed id 11731334)9 Delikatny E.J....King N.J. (2001)
    1434. HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. (PubMed id 11485409)9 Selliah N. and Finkel T.H. (2001)
    1435. Expression of VLA-4 on eosinophils decreases in patients with eosinophilia. (PubMed id 11408770)9 Kayaba H....Chihara J. (2001)
    1436. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. (PubMed id 11377681)9 Escribano L....Orfao A. (2001)
    1437. Anti-interleukin-2 receptor therapy in combination wi th mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. (PubMed id 11753908)9 Nelson D.R....Davis G.L. (2001)
    1438. Lack of induction of interleukin-2-receptor-alpha in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis. (PubMed id 11579894)9 Lawn S.D....Lal R.B. (2001)
    1439. Cytokine profile of patients with mycosis fungoides and the immunomodulatory effect of AS101. (PubMed id 11720171)9 Shohat M....David M. (2001)
    1440. Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitro. (PubMed id 11680566)9 Zuo X.J....Jordan S.C. (2001)
    1441. Preceding infections, immune factors, and outcome in Guillain-BarrAc syndrome. (PubMed id 11274311)9 Hadden R.D....Toyka K.V. (2001)
    1442. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. (PubMed id 11152488)9 Esser M.T....Lifson J.D. (2001)
    1443. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion. (PubMed id 11891607)9 Kim Y.K....Park S.H. (2001)
    1444. Immunopathologic characterization of the tissue response in endemic pemphigus foliaceus (fogo selvagem). (PubMed id 11209113)9 Santi C.G. and Sotto M.N. (2001)
    1445. Acute rejection after liver transplantation despite i ntragraft coating by interleukin-2 receptor-alpha with basiliximab. (PubMed id 11267195)9 Kwekkeboom J....Metselaar H.J. (2001)
    1446. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. (PubMed id 11740974)9 Bonaccorso S....Maes M. (2001)
    1447. Further support for a role for Th2-like cytokines in blister formation of pemphigus. (PubMed id 11161984)9 Caproni M....Fabbri P. (2001)
    1448. Epidermolysis bullosa acquisita treated with basilixi mab, an interleukin-2 receptor antibody. (PubMed id 11411931)9 Haufs M.G. and Haneke E. (2001)
    1449. Immune responsiveness following academic stress in first-year medical students. (PubMed id 11576463)9 Uchakin P.N....Sams C. (2001)
    1450. [Monoclonal antibodies in oncology] (PubMed id 11676247)9 Baryshnikov A.I.u. and Polosukhina E.R. (2001)
    1451. Regeneration and tolerance factor is expressed during T-lymphocyte activation and plays a role in apoptosis. (PubMed id 11390032)9 Boomer J.S....Beaman K.D. (2001)
    1452. Uncoupling p70(s6) kinase activation and proliferatio n: rapamycin-resistant proliferation of human CD8(+) T lymphocytes. (PubMed id 11207273)9 Slavik J.M....Hafler D.A. (2001)
    1453. Early effects of insulin-like growth factor-1 in activated human T lymphocytes. (PubMed id 11493623)9 Brocardo M.G....RoldA!n A. (2001)
    1454. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients] (PubMed id 11464716)9 BiliA8ska M....Podemski R. (2001)
    1455. Antiviral activity and anergy of gammadeltaT lymphocytes in cord blood and immuno-compromised host. (PubMed id 11693434)9 Montesano C....Poccia F. (2001)
    1456. Basiliximab versus antithymocyte globulin for prevent ion of acute renal allograft rejection. (PubMed id 11773888)9 Sollinger H....Somberg K. (2001)
    1457. A population pharmacokinetic screen to identify demog raphic-clinical covariates of basiliximab in liver transplantation. (PubMed id 11309548)9 Kovarik J.M....Korn A. (2001)
    1458. Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans. (PubMed id 11393251)9 Lenzlinger P.M....Kossmann T. (2001)
    1459. Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass. (PubMed id 11603453)9 Schurr U.P....Turina M.I. (2001)
    1460. Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha. (PubMed id 11478799)9 Alileche A....Waldmann T.A. (2001)
    1461. Levels of insulin-like growth factor after stem cell transplantation. (PubMed id 11309231)9 Munker R....Yu H. (2001)
    1462. Pathogenesis of drug-induced exanthema. (PubMed id 11307008)9 Yawalkar N. and Pichler W.J. (2001)
    1463. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. (PubMed id 11222361)9 Niitsu N....Honma Y. (2001)
    1464. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas] (PubMed id 11494447)9 Iaguzhinskaia O.E....Pivnik A.V. (2001)
    1465. In situ activation of helper T cells in the lung. (PubMed id 11447152)9 Raju B....Tse D.B. (2001)
    1466. [A study on the relations of soluble interleukin-2 receptor and CD+25 cell with acute graft-versus-host disease] (PubMed id 11798579)9 Ju X....Gong S. (2001)
    1467. Adult T-cell leukemia with anti-HTLV-I antibody but no HTLV-I DNA in tumor cells. (PubMed id 11408714)9 Fujiwara H....Tei C. (2001)
    1468. Carbohydrate recognition site of interleukin-2 in rel ation to cell proliferation. (PubMed id 11390392)9 Fukushima K....Yamashita K. (2001)
    1469. Initial clinical experience with interleukin-2 recept or antagonist induction in combination with tacrolimus, mycophenolate mofetil a nd steroids in simultaneous kidney-pancreas transplantation. (PubMed id 11793037)9 Lo A....Gaber A.O. (2001)
    1470. Inflammatory BAL-fluid and serum parameters in HLA DR17 positive vs. DR17 negative patients with pulmonary sarcoidosis. (PubMed id 11354549)9 Planck A....Grunewald J. (2001)
    1471. Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane. (PubMed id 11669153)9 Konttinen Y.T....Virtanen I. (2001)
    1472. Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. (PubMed id 11750110)9 Rutella S....Leone G. (2001)
    1473. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). (PubMed id 11174203)9 Panhans-Gross A....Bieber T. (2001)
    1474. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma. (PubMed id 11168504)9 Niitsu N....Chizuka A. (2001)
    1475. Results of 3-year phase III clinical trials with dacl izumab prophylaxis for prevention of acute rejection after renal transplantatio n. (PubMed id 11571447)9 Bumgardner G.L....Vincenti F. (2001)
    1476. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15. (PubMed id 11418694)9 Campbell J.D....Franklin I.M. (2001)
    1477. Elevation of soluble interleukin-2 receptor levels in the bronchoalveolar lavage from patients with systemic sclerosis. (PubMed id 11765225)9 Martinez J.A....King T.E. (2001)
    1478. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab. (PubMed id 11683573)9 Egan C.A....Yancey K.B. (2001)
    1479. Role for lipid rafts in regulating interleukin-2 receptor signaling. (PubMed id 11520799)9 Marmor M.D. and Julius M. (2001)
    1480. Use of daclizumab as initial immunosuppression in liv er transplant recipients with impaired renal function. (PubMed id 11244163)9 Emre S....Miller C.M. (2001)
    1481. Signaling domains of the interleukin 2 receptor. (PubMed id 11356007)9 Gaffen S.L. (2001)
    1482. [Comparative study of the functional expression of the Na/K-pump in human lymphocytes, activated by phytohemagglutinin, phorbol ester, ionomycin, and interleukin-2] (PubMed id 11347470)9 Toropova F.V....Marakhova I.I. (2001)
    1483. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. (PubMed id 11241503)9 Braylan R.C....Davis B.H. (2001)
    1484. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. (PubMed id 11468172)9 Hanon E....Bangham C.R. (2001)
    1485. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid. (PubMed id 11055766)9 Porcel J.M....Rivas M.C. (2000)
    1486. Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients. (PubMed id 10689713)9 Vlk V....PospA-silovA! D. (2000)
    1487. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. (PubMed id 10632660)9 Araki K....Miyakuni T. (2000)
    1488. Denileukin diftitox. (PubMed id 11702307)9 Figgitt D.P....Goa K.L. (2000)
    1489. Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer. (PubMed id 10815893)9 Visonneau S....Santoli D. (2000)
    1490. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative c olitis. (PubMed id 10940280)9 Frieri G....Caprilli R. (2000)
    1491. Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation? (PubMed id 10979210)9 Honda K....Hara T. (2000)
    1492. Human amniotic fluid lacks interleukin-2 and interleukin-15 but can interact with the beta-chain of the interleukin-2 receptor. (PubMed id 10712671)9 Searle R.F....Lang A.K. (2000)
    1493. Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation. (PubMed id 10894361)9 Mathias C....Porter D.L. (2000)
    1494. Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies. (PubMed id 10861457)9 Keppler-Hafkemeyer A....Pastan I. (2000)
    1495. In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel disease. (PubMed id 11094868)9 Dejaco C....Gasche C. (2000)
    1496. One-year immunological evaluation of chronic hemodialysis in end-stage renal disease patients. (PubMed id 10838472)9 Meier P....Wauters J.P. (2000)
    1497. Effects of whole-body UVB irradiation on cytokine production by peripheral blood mononuclear cells from stage I melanoma patients. (PubMed id 10966059)9 Weichenthal M....Breitbart E.W. (2000)
    1498. [Two cases of intravascular lymphomatosis diagnosed antemortem by transbronchial lung biopsy] (PubMed id 10723949)9 Taura Y....Katou T. (2000)
    1499. [Pregnancy after four recurrent pregnancy losses: a case report] (PubMed id 11002558)9 DarmochwaA8-Kolarz D....Oleszczuk J. (2000)
    1500. Cytomegalovirus infection is not necessarily a poor prognostic factor in adult T-cell leukemia/lymphoma. (PubMed id 11002241)9 Fujiwara H....Tei C. (2000)
    1501. Costimulatory effect of Fas in mouse T lymphocytes. (PubMed id 11211868)9 Chun D.H....Bae Y. (2000)
    1502. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. (PubMed id 10843677)9 Yu T.K....Grimm E.A. (2000)
    1503. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. (PubMed id 10752921)9 Huang J.L....Hsieh K.H. (2000)
    1504. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to preve nt acute rejection in liver transplantation. (PubMed id 10670644)9 Hirose R....Stock P.G. (2000)
    1505. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. (PubMed id 10848903)9 Yawalkar N....Pichler W.J. (2000)
    1506. Human leptin enhances activation and proliferation of human circulating T lymphocytes. (PubMed id 10675271)9 MartA-n-Romero C....SA!nchez-Margalet V. (2000)
    1507. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy. (PubMed id 11051235)9 Grimm E.A....Buzaid A.C. (2000)
    1508. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine. (PubMed id 10842199)9 Mantovani G....Mudu M.C. (2000)
    1509. Tryptophan degradation and immune activation in Alzheimer's disease. (PubMed id 10821443)9 Widner B....Fuchs D. (2000)
    1510. Specific detection of epstein-barr virus in inflammatory pseudotumor of the spleen in a patient with a high serum level of soluble IL-2 receptor. (PubMed id 10905367)9 Yamaguchi M....Kumada K. (2000)
    1511. Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. (PubMed id 10823948)9 Vereb G....Damjanovich S. (2000)
    1512. Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease. (PubMed id 10673741)9 Mattsson J....Zetterquist H. (2000)
    1513. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. (PubMed id 10606982)9 Boehme M.W....Scherbaum W.A. (2000)
    1514. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. (PubMed id 10684857)9 Blair P.J....June C.H. (2000)